0001104659-21-133045.txt : 20211102 0001104659-21-133045.hdr.sgml : 20211102 20211102163136 ACCESSION NUMBER: 0001104659-21-133045 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 211371842 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 10-Q 1 pahc-20210930x10q.htm FORM 10-Q
0.00010.00010001069899--06-302022Q1false203375742033757400201660342016603400000000002016603420166034PHIBRO ANIMAL HEALTH CORP2.00%, 1.75% or 1.50%2023-02-280001069899us-gaap:RetainedEarningsMember2021-09-300001069899us-gaap:AdditionalPaidInCapitalMember2021-09-300001069899us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001069899us-gaap:RetainedEarningsMember2021-06-300001069899us-gaap:AdditionalPaidInCapitalMember2021-06-300001069899us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001069899us-gaap:RetainedEarningsMember2020-09-300001069899us-gaap:AdditionalPaidInCapitalMember2020-09-300001069899us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300001069899us-gaap:RetainedEarningsMember2020-06-300001069899us-gaap:AdditionalPaidInCapitalMember2020-06-300001069899us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001069899us-gaap:CommonStockMember2021-09-300001069899us-gaap:CommonStockMember2021-06-300001069899us-gaap:CommonStockMember2020-09-300001069899us-gaap:CommonStockMember2020-06-300001069899pahc:VaccinesMemberpahc:AnimalHealthMember2021-07-012021-09-300001069899pahc:NutritionalSpecialtiesMemberpahc:AnimalHealthMember2021-07-012021-09-300001069899pahc:MedicatedFeedAdditivesAndOthersMemberpahc:AnimalHealthMember2021-07-012021-09-300001069899srt:AsiaPacificMember2021-07-012021-09-300001069899pahc:PerformanceProductsMember2021-07-012021-09-300001069899pahc:MineralNutritionMember2021-07-012021-09-300001069899pahc:LatinAmericaAndCanadaMember2021-07-012021-09-300001069899pahc:EuropeMiddleEastAndAfricaMember2021-07-012021-09-300001069899pahc:AnimalHealthMember2021-07-012021-09-300001069899country:US2021-07-012021-09-300001069899pahc:VaccinesMemberpahc:AnimalHealthMember2020-07-012020-09-300001069899pahc:NutritionalSpecialtiesMemberpahc:AnimalHealthMember2020-07-012020-09-300001069899pahc:MedicatedFeedAdditivesAndOthersMemberpahc:AnimalHealthMember2020-07-012020-09-300001069899srt:AsiaPacificMember2020-07-012020-09-300001069899pahc:PerformanceProductsMember2020-07-012020-09-300001069899pahc:MineralNutritionMember2020-07-012020-09-300001069899pahc:LatinAmericaAndCanadaMember2020-07-012020-09-300001069899pahc:EuropeMiddleEastAndAfricaMember2020-07-012020-09-300001069899pahc:AnimalHealthMember2020-07-012020-09-300001069899country:US2020-07-012020-09-300001069899pahc:CompensationAndBenefitForServicesMemberus-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember2021-07-012021-09-300001069899pahc:CompensationAndBenefitForServicesMemberus-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember2020-07-012020-09-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMemberus-gaap:OtherComprehensiveIncomeMember2021-07-012021-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherComprehensiveIncomeMemberus-gaap:LongMember2021-07-012021-09-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMemberus-gaap:OtherComprehensiveIncomeMember2020-07-012020-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:OtherComprehensiveIncomeMemberus-gaap:LongMember2020-07-012020-09-300001069899us-gaap:RevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMember2021-04-300001069899pahc:TermALoansAndRevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-07-012021-09-300001069899pahc:TermALoansAndRevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMemberus-gaap:EurodollarMember2021-07-012021-09-300001069899pahc:TermALoansAndRevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMemberus-gaap:BaseRateMember2021-07-012021-09-300001069899us-gaap:RevolvingCreditFacilityMemberpahc:CreditAgreementMember2021-09-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMemberus-gaap:InterestExpenseMember2021-07-012021-09-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMemberus-gaap:InterestExpenseMember2020-07-012020-09-300001069899us-gaap:RevolvingCreditFacilityMember2021-07-012021-09-300001069899pahc:TermLoanMember2021-07-012021-09-300001069899us-gaap:RevolvingCreditFacilityMember2020-07-012020-09-300001069899pahc:TermLoanMember2020-07-012020-09-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-07-012021-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-07-012021-09-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2020-07-012020-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2020-07-012020-09-3000010698992020-07-012021-06-3000010698992022-07-310001069899pahc:March2020AgreementMember2021-09-300001069899us-gaap:InterestRateSwapMemberpahc:March2020AgreementMember2020-03-310001069899us-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-09-300001069899pahc:AccruedAndOtherCurrentLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-09-300001069899pahc:AccruedAndOtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-09-300001069899pahc:AccruedAndOtherCurrentLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-06-300001069899pahc:AccruedAndOtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-06-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-06-300001069899us-gaap:InterestRateSwapMemberpahc:July2017AgreementMember2017-07-310001069899us-gaap:OtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-09-300001069899us-gaap:OtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-06-300001069899us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-06-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-06-300001069899us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:SwapMember2021-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:ShortMember2021-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:LongMember2021-09-300001069899us-gaap:CorporateNonSegmentMember2021-07-012021-09-300001069899us-gaap:CorporateNonSegmentMember2020-07-012020-09-300001069899us-gaap:RevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMember2020-09-300001069899pahc:TermALoanMemberpahc:TwoThousandTwentyOneCreditAgreementMember2020-09-300001069899us-gaap:RevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMember2021-09-300001069899us-gaap:InterestRateSwapMemberpahc:March2020AgreementMember2021-09-300001069899us-gaap:InterestRateSwapMemberpahc:July2017AgreementMember2021-09-300001069899pahc:TermALoanMemberpahc:TwoThousandTwentyOneCreditAgreementMember2021-09-300001069899pahc:TermALoanMemberpahc:TwoThousandTwentyOneCreditAgreementMember2021-04-300001069899pahc:TermALoansAndRevolvingCreditFacilityMemberpahc:TwoThousandTwentyOneCreditAgreementMember2021-07-012021-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:LongMember2021-07-012021-09-300001069899us-gaap:ForeignExchangeOptionMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:LongMember2020-07-012020-09-300001069899us-gaap:RetainedEarningsMember2021-07-012021-09-300001069899us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001069899us-gaap:RetainedEarningsMember2020-07-012020-09-300001069899us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300001069899us-gaap:CommonClassBMember2021-09-300001069899us-gaap:CommonClassAMember2021-09-300001069899us-gaap:CommonClassBMember2021-06-300001069899us-gaap:CommonClassAMember2021-06-3000010698992020-09-3000010698992020-06-300001069899us-gaap:FairValueInputsLevel3Member2021-09-300001069899us-gaap:FairValueInputsLevel2Member2021-09-300001069899us-gaap:FairValueInputsLevel1Member2021-09-300001069899us-gaap:FairValueInputsLevel3Member2021-06-300001069899us-gaap:FairValueInputsLevel2Member2021-06-300001069899us-gaap:FairValueInputsLevel1Member2021-06-300001069899us-gaap:OperatingSegmentsMemberpahc:PerformanceProductsMember2021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:MineralNutritionMember2021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:AnimalHealthMember2021-09-300001069899us-gaap:OperatingSegmentsMember2021-09-300001069899us-gaap:CorporateNonSegmentMember2021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:PerformanceProductsMember2021-06-300001069899us-gaap:OperatingSegmentsMemberpahc:MineralNutritionMember2021-06-300001069899us-gaap:OperatingSegmentsMemberpahc:AnimalHealthMember2021-06-300001069899us-gaap:OperatingSegmentsMember2021-06-300001069899us-gaap:CorporateNonSegmentMember2021-06-300001069899us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-3000010698992020-07-012020-09-300001069899pahc:CurrentAndLongTermLiabilitiesMember2021-09-300001069899pahc:CurrentAndLongTermLiabilitiesMember2021-06-300001069899us-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001069899us-gaap:FairValueInputsLevel2Member2021-07-012021-09-300001069899us-gaap:FairValueInputsLevel1Member2021-07-012021-09-300001069899us-gaap:FairValueInputsLevel3Member2020-07-012021-06-300001069899us-gaap:FairValueInputsLevel2Member2020-07-012021-06-300001069899us-gaap:FairValueInputsLevel1Member2020-07-012021-06-300001069899us-gaap:CostOfSalesMember2021-09-300001069899pahc:CustomerMembersrt:MinimumMember2021-07-012021-09-300001069899pahc:CustomerMembersrt:MaximumMember2021-07-012021-09-3000010698992021-10-012021-10-310001069899pahc:CustomerMember2021-07-012021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:PerformanceProductsMember2021-07-012021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:MineralNutritionMember2021-07-012021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:AnimalHealthMember2021-07-012021-09-300001069899us-gaap:OperatingSegmentsMember2021-07-012021-09-300001069899us-gaap:OperatingSegmentsMemberpahc:PerformanceProductsMember2020-07-012020-09-300001069899us-gaap:OperatingSegmentsMemberpahc:MineralNutritionMember2020-07-012020-09-300001069899us-gaap:OperatingSegmentsMemberpahc:AnimalHealthMember2020-07-012020-09-300001069899us-gaap:OperatingSegmentsMember2020-07-012020-09-3000010698992021-09-3000010698992021-06-300001069899us-gaap:CommonClassBMember2021-10-270001069899us-gaap:CommonClassAMember2021-10-2700010698992021-07-012021-09-30xbrli:sharesiso4217:USDpahc:itemiso4217:USDxbrli:sharesxbrli:pureiso4217:BRL

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to            

Commission File Number: 001-36410

Phibro Animal Health Corporation

(Exact name of registrant as specified in its charter)

Delaware

13-1840497

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

Glenpointe Centre East, 3rd Floor

300 Frank W. Burr Boulevard, Suite 21

Teaneck, New Jersey

07666-6712

(Address of Principal Executive Offices)

(Zip Code)

(201) 329-7300

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Class A Common Stock, $0.0001
par value per share

PAHC

Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of October 27, 2021, there were 20,337,574 shares of the registrant’s Class A common stock, par value $0.0001 per share, and 20,166,034 shares of the registrant’s Class B common stock, par value $0.0001 per share, outstanding.

PHIBRO ANIMAL HEALTH CORPORATION

TABLE OF CONTENTS

Page

PART I—FINANCIAL INFORMATION

Item 1.

Financial Statements (unaudited)

3

 

Consolidated Statements of Operations

3

 

Consolidated Statements of Comprehensive Income

4

 

Consolidated Balance Sheets

5

 

Consolidated Statements of Cash Flows

6

 

Consolidated Statements of Changes in Stockholders’ Equity

7

 

Notes to Consolidated Financial Statements

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

32

Item 4.

Controls and Procedures

32

PART II—OTHER INFORMATION

Item 1.

Legal Proceedings

33

Item 1A.

Risk Factors

33

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

33

Item 3.

Defaults Upon Senior Securities

33

Item 4.

Mine Safety Disclosures

33

Item 5.

Other Information

33

SIGNATURES

34

2

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months

For the Periods Ended September 30

    

2021

    

2020

(unaudited)

(in thousands, except per share amounts)

Net sales

$

214,665

$

195,194

Cost of goods sold

 

149,987

 

131,075

Gross profit

 

64,678

 

64,119

Selling, general and administrative expenses

 

50,066

 

48,431

Operating income

 

14,612

 

15,688

Interest expense, net

 

2,889

 

2,810

Foreign currency (gains) losses, net

 

2,128

 

(3,631)

Income before income taxes

 

9,595

 

16,509

Provision for income taxes

 

3,061

 

4,207

Net income

$

6,534

$

12,302

Net income per share

 

  

 

  

basic

$

0.16

$

0.30

diluted

$

0.16

$

0.30

Weighted average common shares outstanding

 

 

basic

 

40,504

 

40,454

diluted

 

40,504

 

40,504

The accompanying notes are an integral part of these consolidated financial statements

3

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Three Months

For the Periods Ended September 30

    

2021

    

2020

(unaudited)

(in thousands)

Net income

$

6,534

$

12,302

Change in fair value of derivative instruments

 

(29)

 

1,089

Foreign currency translation adjustment

 

(6,964)

 

(4,723)

Unrecognized net pension gains

 

117

 

135

Provision for income taxes

 

(22)

 

(306)

Other comprehensive loss

 

(6,898)

 

(3,805)

Comprehensive income (loss)

$

(364)

$

8,497

The accompanying notes are an integral part of these consolidated financial statements

4

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

September 30, 

June 30, 

As of

    

2021

    

2021

(unaudited)

 

(in thousands, except share and per share amounts)

ASSETS

Cash and cash equivalents

$

41,175

$

50,212

Short-term investments

 

56,000

 

43,000

Accounts receivable, net

 

140,644

 

146,852

Inventories, net

 

221,313

 

216,312

Other current assets

 

39,498

 

42,533

Total current assets

 

498,630

 

498,909

Property, plant and equipment, net

 

152,830

 

154,706

Intangibles, net

 

60,125

 

62,282

Goodwill

 

52,679

 

52,679

Other assets

 

71,780

 

72,749

Total assets

$

836,044

$

841,325

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

  

Current portion of long-term debt

$

11,250

$

9,375

Accounts payable

 

66,805

 

68,362

Accrued expenses and other current liabilities

 

74,531

 

86,379

Total current liabilities

 

152,586

 

164,116

Revolving credit facility

 

110,000

 

95,000

Long-term debt

 

284,014

 

287,710

Other liabilities

 

56,139

 

55,970

Total liabilities

 

602,739

 

602,796

Commitments and contingencies (Note 7)

 

 

  

Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2021 and June 30, 2021; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2021 and June 30, 2021

 

4

 

4

Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding

 

Paid-in capital

 

135,803

 

135,803

Retained earnings

 

219,689

 

218,015

Accumulated other comprehensive loss

 

(122,191)

 

(115,293)

Total stockholders’ equity

 

233,305

 

238,529

Total liabilities and stockholders’ equity

$

836,044

$

841,325

The accompanying notes are an integral part of these consolidated financial statements

5

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Three Months

For the Periods Ended September 30

    

2021

    

2020

(unaudited)

(in thousands)

OPERATING ACTIVITIES

 

  

 

  

Net income

$

6,534

$

12,302

Adjustments to reconcile net income to

 

 

net cash provided by operating activities:

 

 

Depreciation and amortization

 

7,854

 

8,036

Amortization of debt issuance costs

 

148

 

221

Stock-based compensation

 

-

 

565

Deferred income taxes

 

(31)

 

(277)

Foreign currency (gains) losses, net

 

2,155

 

(4,349)

Other

 

70

 

97

Changes in operating assets and liabilities, net of business acquisitions:

 

 

Accounts receivable, net

 

4,373

 

1,002

Inventories, net

 

(9,873)

 

(9,501)

Other current assets

 

14

 

(632)

Other assets

 

(741)

 

(205)

Accounts payable

 

514

 

(1,188)

Accrued expenses and other liabilities

 

(7,196)

 

(4,373)

Net cash provided by operating activities

 

3,821

 

1,698

INVESTING ACTIVITIES

 

  

 

  

Purchases of short-term investments

 

(32,000)

 

(6,000)

Maturities of short-term investments

 

19,000

 

Capital expenditures

(7,449)

(7,420)

Other, net

 

(217)

 

(215)

Net cash used by investing activities

 

(20,666)

 

(13,635)

FINANCING ACTIVITIES

 

 

Revolving credit facility borrowings

 

86,000

 

36,000

Revolving credit facility repayments

 

(71,000)

 

(20,000)

Payments of long-term debt and other

 

(1,875)

 

(4,688)

Dividends paid

 

(4,860)

 

(4,854)

Net cash provided by financing activities

 

8,265

 

6,458

Effect of exchange rate changes on cash

 

(457)

 

105

Net decrease in cash and cash equivalents

 

(9,037)

 

(5,374)

Cash and cash equivalents at beginning of period

 

50,212

 

36,343

Cash and cash equivalents at end of period

$

41,175

$

30,969

The accompanying notes are an integral part of these consolidated financial statements

6

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Accumulated

Shares of

Other

Common

Common

Preferred

Paid-in

Retained

Comprehensive

    

Stock

    

Stock

    

Stock

    

Capital

    

Earnings

    

Income (Loss)

    

Total

(unaudited)

(in thousands, except share and per share amounts)

As of June 30, 2021

    

40,503,608

$

4

$

$

135,803

$

218,015

$

(115,293)

$

238,529

Comprehensive income (loss)

6,534

(6,898)

(364)

Dividends declared ($0.12 per share)

 

 

 

 

 

(4,860)

 

 

(4,860)

As of September 30, 2021

40,503,608

$

4

$

$

135,803

$

219,689

$

(122,191)

$

233,305

    

    

  

    

  

Accumulated

Shares of

Other

Common

Common

Preferred

Paid-in

Retained

Comprehensive

    

Stock

    

Stock

    

Stock

    

Capital

    

Earnings

    

Income (Loss)

    

Total

(unaudited)

(in thousands, except share and per share amounts)

As of June 30, 2020

40,453,608

$

4

$

$

135,525

$

183,060

$

(130,385)

$

188,204

Comprehensive income (loss)

 

 

 

 

 

12,302

 

(3,805)

 

8,497

Dividends declared ($0.12 per share)

 

 

 

 

 

(4,854)

 

 

(4,854)

Stock-based compensation expense

 

 

 

 

565

 

 

 

565

As of September 30, 2020

40,453,608

$

4

$

$

136,090

$

190,508

$

(134,190)

$

192,412

The accompanying notes are an integral part of these consolidated financial statements

7

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share amounts)

(unaudited)

1.  Description of Business

Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, dairy and beef cattle, swine, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.

The unaudited consolidated financial information for the three months ended September 30, 2021 and 2020, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (the “Annual Report”), filed with the Securities and Exchange Commission on August 25, 2021 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2021, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are now available, distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods.

The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.

8

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

2.  Summary of Significant Accounting Policies and New Accounting Standards

Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2021, there have been no material changes to any of the significant accounting policies contained therein.

Net Income per Share and Weighted Average Shares

Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed vesting of restricted stock units. All common share equivalents were included in the calculation of diluted net income per share in the periods included in the consolidated financial statements. There are no outstanding stock option awards or restricted stock units as of September 30, 2021.

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net income

$

6,534

$

12,302

Weighted average number of shares – basic

 

40,504

 

40,454

Dilutive effect of restricted stock units

 

 

50

Weighted average number of shares – diluted

 

40,504

 

40,504

Net income per share

 

 

  

basic

$

0.16

$

0.30

diluted

$

0.16

$

0.30

New Accounting Standards

Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2020-04 and 2021-01, Reference Rate Reform (Topic 848), provide optional expedients and exceptions to GAAP guidance, if certain criteria are met, for contracts, hedging relationships and derivative instruments that reference the London Interbank Offered Rate (LIBOR) and other interbank offered rates expected to be discontinued or modified by rate reform. The overall purpose of Topic 848 is to ease the financial reporting burdens related to the expected market transition to alternative reference rates. These ASUs may be applied prospectively to contract modifications made and hedging relationships entered on or before December 31, 2022. We continue to evaluate the effect of adoption of this guidance on our consolidated financial statements.

ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, removes certain exceptions and amends certain requirements in the existing income tax guidance to ease accounting requirements. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and must be applied on a retrospective basis. The adoption did not have a material effect on our consolidated financial statements.

3.  Statements of Operations — Additional Information

Disaggregated revenue, deferred revenue and customer payment terms

We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, and aquaculture. The products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. The animal health and mineral nutrition products are sold directly to integrated poultry, cattle, and swine integrators and through commercial animal feed manufacturers, wholesalers and distributors. The animal health industry and demand for many of the animal health products in a particular region are affected by changing disease pressures and by weather conditions, as product usage follows varying weather patterns and seasons. Our operations are primarily focused in regions where the majority of livestock production is consolidated in large commercial farms.

9

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

We have a diversified portfolio of products that are classified within our three business segments — Animal Health, Mineral Nutrition and Performance Products. Each segment has its own dedicated management and sales team.

Animal Health

The Animal Health business develops, manufactures and markets products in three main categories:

MFAs and other: MFAs and other products primarily consist of concentrated medicated products that are administered through animal feeds, commonly referred to as Medicated Feed Additives (“MFAs”). Specific product classifications include antibacterials, which inhibit the growth of pathogenic bacteria that cause bacterial infections in animals; anticoccidials, which inhibit the growth of coccidia (parasites) that damage the intestinal tract of animals; and other related products.
Nutritional specialties: Nutritional specialty products enhance nutrition to help improve health and performance in areas such as immune system function and digestive health. We are also a developer, manufacturer and marketer of microbial products and bioproducts for a variety of applications serving animal health and nutrition, environmental, industrial and agricultural customers.
Vaccines: Our vaccines are primarily focused on preventing diseases in poultry and swine. They protect animals from either viral or bacterial disease challenges. We develop, manufacture and market conventionally licensed and autogenous vaccine products and produce and market adjuvants to vaccine manufacturers. We have developed and market an innovative and proprietary delivery platform for vaccines.

Mineral Nutrition

The Mineral Nutrition business is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Our customers use these products to fortify the daily feed requirements of their livestock’s diets and maintain an optimal balance of trace elements in each animal. We manufacture and market a broad range of mineral nutrition products for food animals including beef and dairy cattle, swine and poultry.

Performance Products

The Performance Products business manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.

The following tables present our revenues disaggregated by major product category and geographic region:

Net Sales by Product Type

Three Months

For the Periods Ended September 30

    

2021

    

2020

Animal Health

 

  

 

  

MFAs and other

$

83,758

$

78,703

Nutritional specialties

 

35,997

 

32,600

Vaccines

 

21,249

 

17,066

Total Animal Health

$

141,004

$

128,369

Mineral Nutrition

 

54,432

 

51,440

Performance Products

 

19,229

 

15,385

Total

$

214,665

$

195,194

10

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Net Sales by Region

Three Months

For the Periods Ended September 30

    

2021

    

2020

United States

$

126,319

$

118,771

Latin America and Canada

 

42,660

 

37,756

Europe, Middle East and Africa

 

30,935

 

26,872

Asia Pacific

 

14,751

 

11,795

Total

$

214,665

$

195,194

Net sales by region are based on country of destination.

Deferred revenue was $3,130 and $3,674 as of September 30, 2021 and June 30, 2021, respectively. Accrued expenses and other current liabilities included $1,396 and $1,560 of the total deferred revenue as of September 30, 2021 and June 30, 2021, respectively. The deferred revenue resulted primarily from certain customer arrangements, including technology licensing fees and discounts on future product sales. The transaction price associated with our deferred revenue arrangements is generally based on the stand-alone sales prices of the individual products or services.

Our customer payment terms generally range from 30 to 120 days globally and do not include any significant financing components. Payment terms vary based on industry and business practices within the regions in which we operate. Our average worldwide collection period for accounts receivable is approximately 60 days after the revenue is recognized.

Interest Expense and Depreciation and Amortization

Three Months

For the Periods Ended September 30

    

2021

    

2020

Interest expense, net

Term loan

$

2,273

$

1,875

Revolving credit facility

 

599

 

946

Amortization of debt issuance costs

 

148

 

221

Other

 

45

 

67

Interest expense

 

3,065

 

3,109

Interest income

 

(176)

 

(299)

$

2,889

$

2,810

Three Months

For the Periods Ended September 30

    

2021

    

2020

Depreciation and amortization

 

 

  

Depreciation of property, plant and equipment

$

5,714

$

5,831

Amortization of intangible assets

 

2,135

 

2,205

Amortization of other assets

 

5

 

$

7,854

$

8,036

11

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

4.  Balance Sheets — Additional Information

September 30, 

June 30, 

As of

    

2021

    

2021

Inventories

  

Raw materials

$

72,774

$

59,775

Work-in-process

10,053

12,738

Finished goods

138,486

143,799

$

221,313

$

216,312

    

September 30, 

June 30, 

As of

    

2021

    

2021

Other assets

ROU operating lease assets

$

31,688

 

$

32,962

Deferred income taxes

 

9,446

 

9,861

Deposits

 

5,337

 

5,663

Insurance investments

 

6,054

 

5,964

Equity method investments

 

4,759

 

4,141

Derivative instruments

2,634

2,696

U.S. pension plan

 

1,616

 

1,184

Debt issuance costs

 

1,717

 

1,811

Other

8,529

8,467

$

71,780

 

$

72,749

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

Accrued expenses and other current liabilities

 

  

 

  

Employee related

$

26,553

$

35,375

Current operating lease liabilities

 

6,406

 

6,618

Commissions and rebates

5,230

6,312

Professional fees

 

4,288

 

4,380

Income and other taxes

4,706

6,107

Derivative instruments

3,357

3,486

Contingent consideration

 

4,840

 

4,840

Restructuring costs

 

 

735

Insurance-related

 

1,203

 

1,176

Other

 

17,948

 

17,350

$

74,531

$

86,379

12

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

Other liabilities

Long-term operating lease liabilities

$

27,150

$

28,003

Long-term and deferred income taxes

 

7,297

6,646

Supplemental retirement benefits, deferred compensation and other

8,506

8,382

International retirement plans

 

5,453

 

5,345

Derivative instruments

95

Other long-term liabilities

 

7,638

 

7,594

$

56,139

$

55,970

September 30, 

    

June 30, 

As of

    

2021

    

2021

Accumulated other comprehensive loss

  

  

Derivative instruments

$

(819)

$

(790)

Foreign currency translation adjustment

 

(107,059)

 

(100,095)

Unrecognized net pension losses

 

(19,856)

 

(19,973)

Benefit for income taxes on derivative instruments

 

104

 

97

Benefit for incomes taxes on long-term intercompany investments

8,166

8,166

Provision for income taxes on net pension losses

(2,727)

(2,698)

$

(122,191)

$

(115,293)

5.  Debt

Term Loans and Revolving Credit Facilities

In April 2021, we entered into an amended and restated credit agreement (the “2021 Credit Agreement”) under which we have a term A loan in an aggregate initial principal amount of $300,000 (the “2021 Term A Loan”) and a revolving credit facility under which we can borrow up to an aggregate amount of $250,000, subject to the terms of the 2021 Credit Agreement (the “2021 Revolver” and together with the 2021 Term A Loan, the “2021 Credit Facilities”). The 2021 Term A Loan is repayable in quarterly installments, with the balance payable at maturity. The 2021 Revolver contains a letter of credit facility. The interest rate per annum applicable to the loans under the 2021 Credit Facilities is based on a fluctuating rate of interest plus an applicable rate equal to 2.00%, 1.75% or 1.50%, in the case of LIBOR and Eurodollar rate loans and 1.00%, 0.75% or 0.50%, in the case of base rate loans; the applicable rates are based on the First Lien Net Leverage Ratio (as defined in the 2021 Credit Agreement). The 2021 Credit Facilities mature in April 2026.

The 2021 Credit Agreement requires, among other things, compliance with financial covenants that permit: (i) a maximum First Lien Net Leverage Ratio of 4.00:1.00 and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis. The 2021 Credit Agreement contains an acceleration clause should an event of default (as defined in the 2021 Credit Agreement) occur. As of September 30, 2021, we were in compliance with the financial covenants.

As of September 30, 2021, we had $110,000 in borrowings drawn under the 2021 Revolver and had outstanding letters of credit of $2,709, leaving $137,291 available for further borrowings and letters of credit under the 2021 Revolver, subject to restrictions in our 2021 Credit Facilities. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The terms of these letters of credit are all less than one year.

In July 2017, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed interest rate of 1.8325%. The agreement matures in June 2022. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 8 — Derivatives.”

13

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In March 2020, we entered into an interest rate swap agreement on an additional $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increases to a notional principal amount of $300,000 through June 2025, and effectively converts the floating LIBOR portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.62%. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 8 — Derivatives.”

The 2017 and 2020 interest rate swap agreements will continue to remain in place on our interest obligations associated with the 2021 Credit Facilities.

As of September 30, 2021, the interest rates for the 2021 Revolver and the 2021 Term A Loan were 1.85% and 2.98%, respectively. The weighted-average interest rates for the 2021 Revolver and the prior revolving credit facility were 1.83% and 2.12% for the three months ended September 30, 2021, and 2020, respectively. The weighted-average interest rates for the 2021 Term A Loan and the prior term A loan were 2.98% and 3.19% for three months ended September 30, 2021 and 2020, respectively.

Long-Term Debt

    

September 30, 

    

June 30, 

As of

2021

2021

2021 Term A Loan due April 2026

$

296,250

$

298,125

Unamortized debt issuance costs

 

(986)

 

(1,040)

 

295,264

 

297,085

Less: current maturities

 

(11,250)

 

(9,375)

$

284,014

$

287,710

6.  Related Party Transactions

Certain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to the Company as employees or consultants and received aggregate compensation and benefits of approximately $829 and $532 during the three months ended September 30, 2021, and 2020, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.

7.  Commitments and Contingencies

Environmental

Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination, and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the period during which such costs are likely to be incurred are difficult to predict.

14

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.

The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based on our experience, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of the Santa Fe Springs, California facility of our subsidiary, Phibro-Tech, Inc. ("Phibro-Tech"). The EPA has entered into a settlement agreement with a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling ("OPOG") to remediate the contaminated groundwater that has migrated from the Omega Chemical Site in accordance with a general remedy selected by EPA. The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that any groundwater contamination at its site is localized and due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, the members of OPOG filed a complaint under the Comprehensive Environmental Response, Compensation, and Liability Act and the Resource Conservation and Recovery Act in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation, the preliminary stage of the ongoing litigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.

Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be approximately $4,321 and $4,293 at September 30 and June 30, 2021, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries are liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.

15

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Claims and Litigation

PAHC and its subsidiaries are party to various claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

8.  Derivatives

We monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in accumulated other comprehensive income (loss).

We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.

We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “Note 9 — Fair Value Measurements.”

In July 2017, we entered into an interest rate swap agreement on the first $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed interest rate of 1.8325%. The agreement matures in June 2022. In March 2020, we entered into an interest rate swap agreement on an additional $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. On the maturity of the July 2017 agreement, this agreement increases to a notional principal amount of $300,000 through June 2025, and effectively converts the floating LIBOR portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.62%. The forecasted transactions are probable of occurring, and the interest rate swaps have been designated as highly effective cash flow hedges.

We entered into foreign currency option contracts to hedge cash flows related to monthly inventory purchases. The individual option contracts mature monthly through February 2023. The forecasted inventory purchases are probable of occurring and the individual option contracts were designated as highly effective cash flow hedges.

16

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The consolidated balance sheet includes the net fair values of our outstanding foreign currency option contracts within the respective line items, based on the net financial position and maturity date of the individual contracts. The consolidated balance sheet includes the net fair values of our outstanding interest rate swaps within the respective balance sheet line items, based on the expected timing of the cash flows. The consolidated balance sheet includes assets and liabilities for the fair values of outstanding derivatives that are designated and effective as cash flow hedges as follows:

September 30, 

June 30, 

As of

    

2021

    

2021

Other assets

 

  

 

  

Brazil Real options, net

$

$

355

Interest rate swaps

 

2,634

 

2,341

Accrued expense and other current liabilities

 

  

 

  

Brazil Real options, net

 

(467)

 

(150)

Interest rate swaps

 

(2,891)

 

(3,336)

Other liabilities

 

  

 

  

Brazil Real options, net

 

(95)

 

Interest rate swaps

 

 

Total Fair Value

 

 

  

Brazil Real options, net

 

(562)

 

205

Interest rate swaps

 

(257)

 

(995)

Notional amounts of the derivatives as of the balance sheet date were:

September 30, 

As of

    

2021

Brazil Real call options

R$

96,000

Brazil Real put options

 

R$

96,000

Interest rate swaps

$

300,000

The consolidated statements of operations and statements of other comprehensive income (“OCI”) for the periods ended September 30, 2021 and 2020 included the effects of derivatives as follows:

    

Three Months

For the Periods Ended September 30

2021

2020

Brazil Real options, net

 

  

 

  

(Income) expense recorded in consolidated statement of operations

$

428

$

(3)

Consolidated statement of operations - total cost of goods sold

$

149,987

$

131,075

(Income) expense recorded in OCI

$

767

$

(376)

Interest rate swaps

 

  

 

  

Expense recorded in consolidated statements of operations

 

868

 

813

Consolidated statement of operations - total interest expense, net

$

2,889

$

2,810

(Income) expense recorded in OCI

$

(738)

$

(713)

We recognize gains and losses related to foreign currency derivatives as a component of cost of goods sold at the time the hedged item is sold. Inventory as of September 30, 2021, included realized net losses of $1,527 related to matured contracts. We anticipate the net losses included in inventory will be recognized in cost of goods sold within the next twelve to eighteen months.

9.  Fair Value Measurements

Short-term investments

Our short-term investments consist of cash deposits held at financial institutions. We consider the carrying amounts of these short-term investments to be representative of their fair value.

17

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Current Assets and Liabilities

We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.

Contingent Consideration on Acquisitions

We determine the fair value of contingent consideration on acquisitions based on contractual terms, our current forecast of performance factors related to the acquired business and an applicable discount rate.

Debt

We record debt, including term loans and revolver balances, at amortized cost in our consolidated financial statements. We believe the carrying value of the debt is approximately equal to its fair value, due to the variable nature of the instruments and our evaluation of estimated market prices.

Derivatives

We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.

Non-financial assets

Our non-financial assets, which primarily consist of goodwill, other intangible assets, property and equipment, and lease-related ROU assets, are not required to be measured at fair value on a recurring basis, and instead are reported at carrying value in the consolidated balance sheet. We assess the carrying values of non-financial assets for impairment on a periodic basis or whenever events or changes in circumstances indicate an asset may not be fully recoverable.

Fair Value of Assets (Liabilities)

As of

September 30, 2021

June 30, 2021

    

Level 1

    

Level 2

    

Level 3

    

Level 1

    

Level 2

    

Level 3

Short-term investments

$

56,000

$

$

$

43,000

$

$

Foreign currency derivatives

$

$

(562)

$

$

$

205

$

Interest rate swaps

$

$

(257)

$

$

$

(995)

$

Contingent consideration on acquisitions

$

$

$

(4,840)

$

$

$

(4,840)

There were no transfers between levels during the periods presented. There were no changes in the fair value of the Level 3 liabilities.

The contingent consideration on acquisitions is the minimum amount payable in accordance with the acquisition agreement for Osprey. The contingent consideration of $4,840 was paid in October 2021.

10.  Business Segments

We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development.

18

Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, and (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and certain items that we consider to be unusual, non-operational or non-recurring.

The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

    

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net sales

 

 

 

 

 

 

Animal Health

$

141,004

$

128,369

Mineral Nutrition

 

54,432

 

51,440

Performance Products

 

19,229

 

15,385

Total segments

$

214,665

$

195,194

Depreciation and amortization

Animal Health

$

6,420

$

6,521

Mineral Nutrition

 

639

 

649

Performance Products

 

419

 

445

Total segments

$

7,478

$

7,615

Adjusted EBITDA

Animal Health

$

27,637

$

30,101

Mineral Nutrition

 

4,533

 

3,047

Performance Products

 

2,138

 

1,972

Total segments

$

34,308

$

35,120

Reconciliation of income before income taxes to Adjusted EBITDA

Income before income taxes

$

9,595

$

16,509

Interest expense, net

 

2,889

 

2,810

Depreciation and amortization – Total segments

 

7,478

 

7,615

Depreciation and amortization – Corporate

 

376

 

421

Corporate costs

11,842

10,831

Stock-based compensation

 

 

565

Foreign currency (gains) losses, net

 

2,128

 

(3,631)

Adjusted EBITDA – Total segments

$

34,308

$

35,120

September 30, 

    

June 30, 

As of

    

2021

    

2021

Identifiable assets

 

  

 

  

Animal Health

$

579,432

$

595,315

Mineral Nutrition

 

74,218

 

67,338

Performance Products

 

37,111

 

36,847

Total segments

 

690,761

 

699,500

Corporate

 

145,283

 

141,825

Total

$

836,044

$

841,325

The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax related assets and certain other assets.

19

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

Our management’s discussion and analysis of financial condition and results of operations (“MD&A”) is provided to assist readers in understanding our performance, as reflected in the results of our operations, our financial condition and our cash flows. The following discussion summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and cash flows as of and for the periods presented below. This MD&A should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Our future results could differ materially from our historical performance as a result of various factors such as those discussed in “Risk Factors” in Item 1A of our Annual Report and “Forward-Looking Statements.”

Overview of our business

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, and aquaculture. Our products help prevent, control and treat diseases, enhance nutrition to help improve health and performance and contribute to balanced mineral nutrition. In addition to animal health and mineral nutrition products, we manufacture and market specific ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Effects of the COVID-19 pandemic

The global food and animal production industry has experienced demand disruption, production impacts, price declines and currency volatility in international markets due to the COVID-19 pandemic. The response to the global outbreak of COVID-19 continues to evolve. Governmental authorities continue to implement measures to contain virus outbreaks, such as travel bans, quarantines, shelter-in-place orders, site closures and business shutdowns. Although vaccines are now available, distribution efforts vary widely country-by-country and state-by-state. The pandemic may have significant economic impacts on customers, suppliers and markets. New information may continue to emerge concerning COVID-19 and the actions required to contain or treat it may affect the duration and severity of the economic impact. We believe the global food and animal production industry is returning to stability, but the potential impact of COVID-19 continues to evolve and future industry outlooks remain uncertain.

Phibro is an integral participant in the essential production of meat, milk, eggs and fish for human consumption. In the face of the pandemic, we have focused on the safety of our employees, while continuing to supply our customers. Our global production facilities have continued to operate without interruption, despite supply chain and logistical challenges. Our sales and technical service people remain in close virtual contact with our customers, as most travel and in-person meetings remain limited. Some of our administrative and management staff are still working remotely, while others have returned to the office with varying frequency. We have experienced some cost increases from the safety measures implemented to protect our employees as well as from supply chain disruptions. We have maintained headcount and compensation at or above constant levels. We continue to monitor sales trends, cash flow and liquidity.

The uncertainties surrounding the COVID-19 pandemic remain fluid, particularly regarding the emergence of virus variants and the effectiveness of vaccines against the current and any future variants. We are still unable to predict with confidence the effectiveness of measures to contain COVID-19 and hence the impact on the economies where we manufacture and sell our products. While we continue to adapt our operations and mitigate the risks and challenges posed by COVID-19, the demand for our products will be dependent upon economic conditions and the ability of our customers and end users of our products to operate their businesses and production facilities. Our business and future operational results may be impacted by government mandated response efforts, supply chain and manufacturing disruptions, increased volatility in raw material costs and decreased demand due to changes in our customer purchasing patterns and preferences. We are unable to predict with confidence the nature and timing of when any of these events may occur and the effects COVID-19 will have on our business, our consolidated results and the broader economic environment going forward. We will continue to evaluate the nature and extent of the effects of COVID-19 on our business, consolidated results of operations, financial condition, and liquidity. For additional considerations and risks associated with COVID-19 on our business, see “Risk Factors” in Item 1A of our Annual Report.

20

Trends and uncertainties

In April 2016, the Food and Drug Administration ("FDA") began initial steps to withdraw approval of carbadox via a regulatory process known as a Notice of Opportunity for Hearing ("NOOH"), due to concerns that certain residues from the product may persist in animal tissues for longer than previously determined. The NOOH process provided Phibro with an opportunity to defend the safety of carbadox prior to the FDA taking final steps to remove carbadox from the market. Over the next four years, as part of an ongoing process of responding to the inquiries from the FDA's Center for Veterinary Medicine ("CVM"), we provided extensive and meticulous research and data that confirmed the safety of carbadox. In March 2018, the FDA indefinitely stayed the withdrawal proceedings. In July 2020, the FDA announced it does not agree with Phibro's scientific conclusions that carbadox is safe under the current conditions of use. Instead of proceeding to a hearing on the scientific concerns raised in the 2016 NOOH, consistent with the normal regulatory procedure, the FDA announced that it was withdrawing the current NOOH, and issuing a proposed order to review the regulatory method for carbadox. The approved regulatory method determines if there are residues of carcinogenic concern in animal tissue at the time of slaughter. If the order is finalized, the FDA has indicated it plans to issue a new NOOH proposing the withdrawal of carbadox from the market because of a lack of an approved regulatory method.

In September 2020, Phibro commented on the proposed order, reiterating the safety of carbadox and the appropriateness of the regulatory method, and further offered to work with the CVM to generate additional data to support the existing regulatory method or select a suitable alternative regulatory method. Phibro disagrees with the agency's actions and has submitted a request to the FDA Office of the Commissioner that the agency continue the NOOH process it started in 2016 and proceed with a hearing to review the substantial body of data supporting the safety of carbadox. There is no defined timeline for the conclusion of this matter. Should we be unable to successfully defend the safety of the product, the loss of carbadox sales would have an adverse effect on our financial condition and results of operations. Sales of carbadox for the twelve months ended September 30, 2021, were $20 million. As of the date of this Quarterly Report on Form 10-Q, Mecadox continues to be available for use by swine producers.

21

Analysis of the consolidated statements of operations

Summary Results of Operations

Three Months

For the Periods Ended September 30

    

2021

    

2020

    

Change

    

(in thousands, except per share amounts and percentages)

Net sales

    

$

214,665

    

$

195,194

    

$

19,471

    

10

%  

Gross profit

 

64,678

 

64,119

 

559

1

%  

Selling, general and administrative expenses

 

50,066

 

48,431

 

1,635

3

%  

Operating income

 

14,612

 

15,688

 

(1,076)

(7)

%  

Interest expense, net

 

2,889

 

2,810

 

79

3

%  

Foreign currency (gains) losses, net

 

2,128

 

(3,631)

 

5,759

*

Income before income taxes

 

9,595

 

16,509

 

(6,914)

(42)

%  

Provision for income taxes

 

3,061

 

4,207

 

(1,146)

(27)

%  

Net income

$

6,534

$

12,302

$

(5,768)

(47)

%  

Net income per share

 

  

 

 

 

 

basic

$

0.16

$

0.30

$

(0.14)

diluted

$

0.16

$

0.30

$

(0.14)

Weighted average number of shares outstanding

 

  

 

 

  

 

basic

 

40,504

 

40,454

 

  

 

diluted

 

40,504

 

40,504

 

  

 

Ratio to net sales

 

  

 

 

  

 

Gross profit

 

30.1

%  

 

32.8

%  

 

  

 

Selling, general and administrative expenses

 

23.3

%  

 

24.8

%  

 

  

 

Operating income

 

6.8

%  

 

8.0

%  

 

  

 

Income before income taxes

 

4.5

%  

 

8.5

%  

 

  

 

Net income

 

3.0

%  

 

6.3

%  

 

  

 

Effective tax rate

 

31.9

%  

 

25.5

%  

 

  

 

Certain amounts and percentages may reflect rounding adjustments.

*

Calculation not meaningful

Net sales, Adjusted EBITDA and reconciliation of GAAP net income to Adjusted EBITDA

We report Net sales and Adjusted EBITDA by segment to understand the operating performance of each segment. This enables us to monitor changes in net sales, costs and other actionable operating metrics at the segment level. See “—General description of non-GAAP financial measures.”

22

Segment net sales and Adjusted EBITDA:

Three Months

For the Periods Ended September 30

    

2021

    

2020

    

Change

Net sales

(in thousands, except percentages)

MFAs and other

$

83,758

$

78,703

$

5,055

 

6

%  

Nutritional specialties

 

35,997

 

32,600

 

3,397

 

10

%  

Vaccines

 

21,249

 

17,066

 

4,183

 

25

%  

Animal Health

 

141,004

 

128,369

 

12,635

 

10

%  

Mineral Nutrition

 

54,432

 

51,440

 

2,992

 

6

%  

Performance Products

 

19,229

 

15,385

 

3,844

 

25

%

Total

$

214,665

$

195,194

$

19,471

 

10

%

Adjusted EBITDA

 

  

 

  

 

  

 

  

Animal Health

$

27,637

$

30,101

$

(2,464)

 

(8)

%  

Mineral Nutrition

 

4,533

 

3,047

 

1,486

 

49

%  

Performance Products

 

2,138

 

1,972

 

166

 

8

%  

Corporate

 

(11,842)

 

(10,831)

 

(1,011)

 

(9)

%  

Total

$

22,466

$

24,289

$

(1,823)

 

(8)

%  

Adjusted EBITDA ratio to segment net sales

 

  

 

 

  

 

  

Animal Health

 

19.6

%  

 

23.4

%  

 

  

 

  

Mineral Nutrition

 

8.3

%  

 

5.9

%  

 

  

 

  

Performance Products

 

11.1

%  

 

12.8

%  

 

  

 

  

Corporate(1)

 

(5.5)

%  

 

(5.5)

%  

 

  

 

  

Total(1)

 

10.5

%  

 

12.4

%  

 

  

 

  

(1)Reflects ratio to total net sales

The table below sets forth a reconciliation of net income, as reported under GAAP, to Adjusted EBITDA:

    

Three Months

For the Periods Ended September 30

    

2021

    

2020

    

Change

    

(in thousands, except percentages)

Net income

$

6,534

$

12,302

$

(5,768)

    

(47)

%

Interest expense, net

2,889

2,810

79

3

%

Provision for income taxes

3,061

4,207

(1,146)

(27)

%

Depreciation and amortization

7,854

8,036

(182)

(2)

%

EBITDA

20,338

27,355

(7,017)

(26)

%

Stock-based compensation

565

(565)

*

Foreign currency (gains) losses, net

2,128

 

(3,631)

 

5,759

 

*

Adjusted EBITDA

$

22,466

$

24,289

$

(1,823)

 

(8)

%

Certain amounts may reflect rounding adjustments.

* Calculation not meaningful

Comparison of three months ended September 30, 2021 and 2020

Net sales

Net sales of $214.7 million for the three months ended September 30, 2021, increased $19.5 million, or 10%, as compared to the three months ended September 30, 2020. Animal Health, Mineral Nutrition and Performance Products net sales increased $12.6 million, $3.0 million and $3.8 million, respectively.

23

Animal Health

Net sales of $141.0 million for the three months ended September 30, 2021, increased $12.6 million, or 10%. Net sales of MFAs and other increased $5.1 million, or 6%, driven by stronger international demand, primarily for poultry and cattle products in the Latin America and Southeast Asia regions, partially offset by timing of certain domestic and other international customer orders. Net sales of nutritional specialty products increased $3.4 million, or 10%, driven by strong international demand in dairy products. Net sales of vaccines increased $4.2 million, or 25%, driven by growth across all major markets, but primarily stronger demand in Eastern Europe and India.

Mineral Nutrition

Net sales of $54.4 million for the three months ended September 30, 2021, increased $3.0 million, or 6%, driven by increased average selling prices, partially offset by lower volumes. The increase in average selling prices is correlated with the movement of the underlying raw material costs.

Performance Products

Net sales of $19.2 million for the three months ended September 30, 2021, increased $3.8 million, or 25%. The increase was driven by strong demand for copper-based products coupled with increased selling prices correlated with underlying raw material costs.

Gross profit

Gross profit of $64.7 million for the three months ended September 30, 2021, increased $0.6 million, or 1%, as compared to the three months ended September 30, 2020. Gross margin decreased 270 basis points to 30.1% of net sales for the three months ended September 30, 2021, as compared to 32.8% for the three months ended September 30, 2020.

Animal Health gross profit decreased $1.3 million due to higher logistics and manufacturing costs, as well as unfavorable geographic and product mix. Mineral Nutrition gross profit increased $1.6 million, driven primarily by higher average selling prices and favorable product mix. Performance Products gross profit increased $0.2 million driven by volumes.

Selling, general and administrative expenses

Selling, general and administrative expenses (“SG&A”) of $50.1 million for the three months ended September 30, 2021, increased $1.6 million, or 3%, as compared to the three months ended September 30, 2020. SG&A for the three months ended September 30, 2020, included $0.6 million of stock-based compensation. Excluding these costs, SG&A increased $2.2 million, or 5%.

Animal Health SG&A increased $1.1 million, due to investments in market expansion initiatives in certain international regions, as well as increased marketing and sales team travel costs. Mineral Nutrition and Performance Products SG&A were comparable to the prior year. Corporate SG&A increased $0.4 million due to incremental investments in strategic initiatives and higher compensation costs, partially offset by the decrease in stock-based compensation.

Interest expense, net

Interest expense, net of $2.9 million for the three months ended September 30, 2021, increased $0.1 million, or 3%, as compared to the three months ended September 30, 2020. Interest expense, net increased primarily due to higher levels of debt outstanding and lower interest income, partially offset by favorable variable borrowing rates.

Foreign currency (gains) losses, net

Foreign currency (gains) losses, net for the three months ended September 30, 2021, amounted to net losses of $2.1 million, as compared to $3.6 million of net gains for the three months ended September 30, 2020. Foreign currency (gains) losses, net primarily arose from intercompany balances, driven by the weakening of the Turkish, Mexican and Brazilian currencies relative to the U.S. dollar.

24

Provision for income taxes

The provision for income taxes was $3.1 million and $4.2 million for the three months ended September 30, 2021 and 2020, respectively. The effective income tax rate was 31.9% and 25.5% for the three months ended September 30, 2021 and 2020, respectively. The provision for income taxes during the three months ended September 30, 2021, included a $0.4 million expense resulting from changes in uncertain tax positions related to prior years. The effective income tax rate without this expense would have been 27.4% for the three months ended September 30, 2021.

Net income

Net income of $6.5 million for the three months ended September 30, 2021, decreased $5.8 million, as compared to net income of $12.3 million for the three months ended September 30, 2020. Operating income declined $1.1 million, driven by increased SG&A expenses, partially offset by higher gross profit. The increase in gross profit in the Mineral Nutrition and Performance Products segments was partially offset by a decrease in gross profit and gross margin in the Animal Health segment driven by higher logistics and manufacturing costs, as well as unfavorable geographic and product mix. SG&A expenses increased due to investments in strategic initiatives and increased travel costs. The variance in foreign currency (gains) losses resulted in a $5.8 million unfavorable impact on income before income taxes, while income tax expense decreased $1.1 million.

Adjusted EBITDA

Adjusted EBITDA of $22.5 million for the three months ended September 30, 2021, declined $1.8 million, or 8%, as compared to the three months ended September 30, 2020. Animal Health Adjusted EBITDA decreased $2.5 million on lower gross profit and increased SG&A costs. Mineral Nutrition Adjusted EBITDA increased $1.5 million, driven by increased gross profit on higher average selling prices and favorable product mix. Performance Products Adjusted EBITDA increased $0.2 million driven by increased gross profit. Corporate expenses increased $1.0 million, primarily due to incremental investments in strategic initiatives and higher compensation costs.

Analysis of financial condition, liquidity and capital resources

Net decrease in cash and cash equivalents was:

    

Three Months

For the Periods Ended September 30

    

2021

    

2020

    

Change

    

(in thousands)

Cash provided (used) by:

Operating activities

$

3,821

$

1,698

$

2,123

Investing activities

 

(20,666)

 

(13,635)

 

(7,031)

Financing activities

 

8,265

 

6,458

 

1,807

Effect of exchange-rate changes on cash and cash equivalents

 

(457)

 

105

 

(562)

Net decrease in cash and cash equivalents

$

(9,037)

$

(5,374)

$

(3,663)

Certain amounts may reflect rounding adjustments.

25

Net cash provided (used) by operating activities was comprised of:

    

Three Months

For the Periods Ended September 30

    

2021

    

2020

    

Change

    

(in thousands)

EBITDA

$

20,338

$

27,355

$

(7,017)

Adjustments:

 

  

 

 

Stock-based compensation

 

 

565

 

(565)

Foreign currency (gains) losses, net

 

2,128

 

(3,631)

 

5,759

Interest paid, net

 

(2,700)

 

(2,527)

 

(173)

Income taxes paid

 

(2,977)

 

(4,967)

 

1,990

Changes in operating assets and liabilities and other items

 

(12,968)

 

(15,097)

 

2,129

Net cash provided by operating activities

$

3,821

$

1,698

$

2,123

Certain amounts may reflect rounding adjustments.

Operating activities

Operating activities provided $3.8 million of net cash for the three months ended September 30, 2021. Cash provided by net income and non-cash items, including depreciation and amortization, was $16.7 million. Cash used in the ordinary course of business for changes in operating assets and liabilities and other items was $13.0 million. Accounts receivable provided $4.4 million of cash due to timing of collections. Cash used for inventory was $9.9 million. Inventory increases were primarily due to forecasted future demand and internal production schedules. For certain products, we are maintaining safety stocks to mitigate potential disruptions in production. Accrued expenses and other liabilities used cash of $7.4 million due to timing of payments for annual incentive compensation.

Investing activities

Investing activities used $20.7 million of net cash for the three months ended September 30, 2021. Capital expenditures were $7.4 million as we continue to invest in expanding production capacity and productivity improvements. In addition, we invested $13.0 million in short-term investments.

Financing activities

Financing activities provided $8.3 million of net cash for the three months ended September 30, 2021. Net borrowings drawn on our 2021 Revolver provided $15.0 million. We paid $4.9 million in dividends to holders of our Class A and Class B common stock. We paid $1.9 million in scheduled debt service.

26

Liquidity and capital resources

We believe our cash on hand, operating cash flow and financing arrangements, including the availability of borrowings under the 2021 Revolver and foreign credit lines, will be sufficient to support our ongoing cash needs. We are aware of the current and potential future effects of COVID-19 on the financial markets. We expect adequate liquidity for at least the next twelve months. However, we can provide no assurance that our liquidity and capital resources will be adequate for future funding requirements. We believe we will be able to comply with the terms of the covenants under the 2021 Credit Facilities and foreign credit lines based on our operating plan. In the event of adverse operating results and/or violation of covenants under the facilities, there can be no assurance we would be able to obtain waivers or amendments. Other risks to our meeting future funding requirements include global economic conditions and macroeconomic, business and financial disruptions that could arise, including those caused by COVID-19, as well as shipping and labor costs and material availability. There can be no assurance that a challenging economic environment or an economic downturn would not affect our liquidity or our ability to obtain future financing or fund operations or investment opportunities. In addition, our debt covenants may restrict our ability to invest.

Certain relevant measures of our liquidity and capital resources follow:

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

(in thousands, except ratios)

Cash and cash equivalents and short-term investments

$

97,175

$

93,212

Working capital

 

260,118

 

250,956

Ratio of current assets to current liabilities

 

2.84:1

 

2.62:1

We define working capital as total current assets (excluding cash and cash equivalents and short-term investments) less total current liabilities (excluding current portion of long-term debt). We calculate the ratio of current assets to current liabilities based on this definition.

As of September 30, 2021, we had $110.0 million in outstanding borrowings drawn under the 2021 Revolver and had outstanding letters of credit and other commitments of $2.7 million, leaving $137.3 million available for further borrowings and letters of credit, subject to restrictions in our 2021 Credit Facilities.

We currently intend to pay quarterly dividends on our Class A and Class B common stock, subject to approval from the Board of Directors. Our Board of Directors declared a cash dividend of $0.12 per share on Class A and Class B common stock, payable on December 15, 2021. Our future ability to pay dividends will depend upon our results of operations, financial condition, capital requirements, our ability to obtain funds from our subsidiaries and other factors that our Board of Directors deems relevant. Additionally, the terms of our current and any future agreements governing our indebtedness could limit our ability to pay dividends or make other distributions.

As of September 30, 2021, our cash and cash equivalents and short-term investments included $95.4 million held by our international subsidiaries. There are no restrictions on cash distributions to PAHC from our international subsidiaries.

Contractual obligations

As of September 30, 2021, there were no material changes in payments due under contractual obligations from those disclosed in the Annual Report.

Off-balance sheet arrangements

We do not currently use off-balance sheet arrangements for the purpose of credit enhancement, hedging transactions, investment or other financial purposes.

27

In the ordinary course of business, we may indemnify our counterparties against certain liabilities that may arise. These indemnifications typically pertain to environmental matters. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications generally are subject to certain restrictions and limitations.

General description of non-GAAP financial measures

Adjusted EBITDA

Adjusted EBITDA is an alternative view of performance used by management as our primary operating measure, and we believe that investors’ understanding of our performance is enhanced by disclosing this performance measure. We report Adjusted EBITDA to portray the results of our operations prior to considering certain income statement elements. We have defined EBITDA as net income (loss) plus (i) interest expense, net, (ii) provision for income taxes or less benefit for income taxes, and (iii) depreciation and amortization. We have defined Adjusted EBITDA as EBITDA plus (a) (income) loss from, and disposal of, discontinued operations, (b) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses, and (c) certain items that we consider to be unusual, non-operational or non-recurring. The Adjusted EBITDA measure is not, and should not be viewed as, a substitute for GAAP reported net income.

The Adjusted EBITDA measure is an important internal measurement for us. We measure our overall performance on this basis in conjunction with other performance metrics. The following are examples of how our Adjusted EBITDA measure is utilized:

senior management receives a monthly analysis of our operating results that is prepared on an Adjusted EBITDA basis;
our annual budgets are prepared on an Adjusted EBITDA basis; and
other goal setting and performance measurements are prepared on an Adjusted EBITDA basis.

Despite the importance of this measure to management in goal setting and performance measurement, Adjusted EBITDA is a non-GAAP financial measure that has no standardized meaning prescribed by GAAP and, therefore, has limits in its usefulness to investors. Because of its non-standardized definition, Adjusted EBITDA, unlike GAAP net income, may not be comparable to the calculation of similar measures of other companies. Adjusted EBITDA is presented to permit investors to more fully understand how management assesses performance.

We also recognize that, as an internal measure of performance, the Adjusted EBITDA measure has limitations, and we do not restrict our performance management process solely to this metric. A limitation of the Adjusted EBITDA measure is that it provides a view of our operations without including all events during a period, such as the depreciation of property, plant and equipment or amortization of purchased intangibles, and does not provide a comparable view of our performance to other companies.

Certain significant items

Adjusted EBITDA is calculated prior to considering certain items. We evaluate such items on an individual basis. Such evaluation considers both the quantitative and the qualitative aspect of their unusual or non-operational nature. Unusual, in this context, may represent items that are not part of our ongoing business and items that, either as a result of their nature or size, we would not expect to occur as part of our normal business on a regular basis.

We consider acquisition-related activities and business restructuring costs related to productivity and cost-saving initiatives, including employee separation costs, to be unusual items that we do not expect to occur as part of our normal business on a regular basis. We consider foreign currency gains and losses to be non-operational because they arise principally from intercompany transactions and are largely non-cash in nature.

28

New accounting standards

For discussion of new accounting standards, see “Notes to Consolidated Financial Statements—Summary of Significant Accounting Policies and New Accounting Standards.”

Critical Accounting Policies

Critical accounting policies are those that require application of management’s most difficult, subjective and/or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all accounting policies require management to make difficult, subjective or complex judgments or estimates. In presenting our consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (GAAP), we are required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Actual results that differ from our estimates and assumptions could have an unfavorable effect on our financial position and results of operations. Critical accounting policies include revenue recognition, business combinations, long-lived assets, goodwill, and income taxes.

The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. The pandemic may affect our future sales, expenses, reserves and allowances, manufacturing operations and employee-related costs. The pandemic may have significant economic impacts on our customers, suppliers and markets where we compete and operate. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected earnings, revenues, costs, expenditures, cash flows, growth rates and financial results, our plans and objectives for future operations, growth or initiatives, strategies, or the expected outcome or impact of pending or threatened litigation are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Examples of such risks and uncertainties include:

the negative effects of a pandemic, epidemic, or outbreak of an infectious disease in humans, such as COVID-19, on our business, financial results, manufacturing facilities and supply chain, as well as our customers, protein processors and markets;
perceived adverse effects on human health linked to the consumption of food derived from animals that utilize our products could cause a decline in the sales of those products;
restrictions on the use of antibacterials in food-producing animals may become more prevalent;
the potential FDA withdrawal of approval of our Mecadox (carbadox) product;
a material portion of our sales and gross profits are generated by antibacterials and other related products;
competition in each of our markets from a number of large and small companies, some of which have greater financial, research and development (“R&D”), production and other resources than we have;

29

outbreaks of animal diseases could significantly reduce demand for our products;
our business may be negatively affected by weather conditions and the availability of natural resources;
climate change could have a material adverse impact on our operations and our customers’ businesses;
the continuing trend toward consolidation of certain customer groups as well as the emergence of large buying groups;
our ability to control costs and expenses;
any unforeseen material loss or casualty;
exposure relating to rising costs and reduced customer income;
competition deriving from advances in veterinary medical practices and animal health technologies;
unanticipated safety or efficacy concerns;
our dependence on suppliers having current regulatory approvals;
our raw materials are subject to price fluctuations and their availability can be limited;
natural and man-made disasters, including but not limited to fire, snow and ice storms, flood, hail, hurricanes and earthquakes;
terrorist attacks, particularly attacks on or within markets in which we operate;
our ability to successfully implement our strategic initiatives;
our reliance on the continued operation of our manufacturing facilities and application of our intellectual property;
adverse U.S. and international economic market conditions, including currency fluctuations;
failure of our product approval, R&D, acquisition and licensing efforts to generate new products;
the risks of product liability claims, legal proceedings and general litigation expenses;
the impact of current and future laws and regulatory changes;
modification of foreign trade policy may harm our food animal product customers;
our dependence on our Israeli and Brazilian operations;
our substantial level of indebtedness and related debt-service obligations;
restrictions imposed by covenants in our debt agreements;
the risk of work stoppages; and
other factors as described in “Risk Factors” in Item 1A of our Annual Report.

30

While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, are disclosed under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences we anticipate or affect us or our operations in the way we expect. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

31

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

In the normal course of operations, we are exposed to market risks arising from adverse changes in interest rates, foreign currency exchange rates and commodity prices. As a result, future earnings, cash flows and fair values of assets and liabilities are subject to uncertainty. We use, from time to time, foreign currency contracts and interest rate swaps as a means of hedging exposure to foreign currency risks and fluctuating interest rates, respectively. We do not utilize derivative instruments for trading or speculative purposes. We do not hedge our exposure to market risks in a manner that eliminates the effects of changing market conditions on earnings, cash flows and fair values. We monitor the financial stability and credit standing of our major counterparties.

For financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Qualitative and Quantitative Disclosures about Market Risk” section in the Annual Report and to the notes to the consolidated financial statements included therein. As of the date of this report, there were no material changes in the Company’s financial market risks from the risks disclosed in the Annual Report.

Item 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

An evaluation was carried out under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)). Based upon that evaluation as of September 30, 2021, our Chief Executive Officer and Chief Financial Officer each concluded that, as of the end of such period, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter ended September 30, 2021.

32

PART II—OTHER INFORMATION

Item 1.Legal Proceedings

Information required by this Item is incorporated herein by reference to “Notes to the Consolidated Financial Statements—Commitments and Contingencies” in Part I, Item 1, of this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in the “Risk Factors” section in the Annual Report, which could materially affect our business, financial condition or future results.

There were no material changes in the Company’s risk factors from the risks disclosed in the Annual Report.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not applicable.

Item 5.Other Information

None.

Item 6.Exhibits

o

p

Exhibit 31.1

Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302

Exhibit 31.2

Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302

Exhibit 32.1

Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906

Exhibit 32.2

Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906

Exhibit 101 .INS

XBRL Instance Document

Exhibit 101.SCH

XBRL Taxonomy Extension Schema Document

Exhibit 101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

Exhibit 101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

Exhibit 101.LAB

XBRL Taxonomy Extension Label Linkbase Document

Exhibit 101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Phibro Animal Health Corporation

November 2, 2021

By:

/s/ Jack C. Bendheim

Jack C. Bendheim

Chairman, President and Chief Executive Officer

November 2, 2021

By:

/s/ Damian Finio

Damian Finio

 

Chief Financial Officer

34

EX-31.1 2 pahc-20210930xex31d1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Jack C. Bendheim, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 2, 2021

/s/ Jack C. Bendheim

Jack C. Bendheim

Chairman, President and Chief Executive Officer


EX-31.2 3 pahc-20210930xex31d2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Damian Finio, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 2, 2021

/s/ Damian Finio

Damian Finio

Chief Financial Officer


EX-32.1 4 pahc-20210930xex32d1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.

Dated: November 2, 2021

/s/ Jack C. Bendheim

Jack C. Bendheim

Chairman, President and Chief Executive Officer


EX-32.2 5 pahc-20210930xex32d2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.

Dated: November 2, 2021

/s/ Damian Finio

Damian Finio

Chief Financial Officer


EX-101.SCH 6 pahc-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Statements of Operations - Interest Expense and Depreciation and Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Balance Sheets - Additional Information - Schedule of inventory (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Balance Sheets - Additional Information - Other balance sheet items (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Debt - Summary of long-term debt (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Statements of Operations - Disaggregated Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Statements of Operations - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Derivatives - Company's Outstanding Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Derivatives - Effects of Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Derivatives - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Business Segments - Segments in Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00505 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Statements of Operations - Additional Information link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Balance Sheets - Additional Information link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Statements of Operations - Additional Information (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Balance Sheets - Additional Information (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pahc-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 pahc-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 pahc-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 pahc-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 pahc-20210930x10q_htm.xml IDEA: XBRL DOCUMENT 0001069899 us-gaap:RetainedEarningsMember 2021-09-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001069899 us-gaap:RetainedEarningsMember 2021-06-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001069899 us-gaap:RetainedEarningsMember 2020-09-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001069899 us-gaap:RetainedEarningsMember 2020-06-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001069899 us-gaap:CommonStockMember 2021-09-30 0001069899 us-gaap:CommonStockMember 2021-06-30 0001069899 us-gaap:CommonStockMember 2020-09-30 0001069899 us-gaap:CommonStockMember 2020-06-30 0001069899 pahc:VaccinesMember pahc:AnimalHealthMember 2021-07-01 2021-09-30 0001069899 pahc:NutritionalSpecialtiesMember pahc:AnimalHealthMember 2021-07-01 2021-09-30 0001069899 pahc:MedicatedFeedAdditivesAndOthersMember pahc:AnimalHealthMember 2021-07-01 2021-09-30 0001069899 srt:AsiaPacificMember 2021-07-01 2021-09-30 0001069899 pahc:PerformanceProductsMember 2021-07-01 2021-09-30 0001069899 pahc:MineralNutritionMember 2021-07-01 2021-09-30 0001069899 pahc:LatinAmericaAndCanadaMember 2021-07-01 2021-09-30 0001069899 pahc:EuropeMiddleEastAndAfricaMember 2021-07-01 2021-09-30 0001069899 pahc:AnimalHealthMember 2021-07-01 2021-09-30 0001069899 country:US 2021-07-01 2021-09-30 0001069899 pahc:VaccinesMember pahc:AnimalHealthMember 2020-07-01 2020-09-30 0001069899 pahc:NutritionalSpecialtiesMember pahc:AnimalHealthMember 2020-07-01 2020-09-30 0001069899 pahc:MedicatedFeedAdditivesAndOthersMember pahc:AnimalHealthMember 2020-07-01 2020-09-30 0001069899 srt:AsiaPacificMember 2020-07-01 2020-09-30 0001069899 pahc:PerformanceProductsMember 2020-07-01 2020-09-30 0001069899 pahc:MineralNutritionMember 2020-07-01 2020-09-30 0001069899 pahc:LatinAmericaAndCanadaMember 2020-07-01 2020-09-30 0001069899 pahc:EuropeMiddleEastAndAfricaMember 2020-07-01 2020-09-30 0001069899 pahc:AnimalHealthMember 2020-07-01 2020-09-30 0001069899 country:US 2020-07-01 2020-09-30 0001069899 pahc:CompensationAndBenefitForServicesMember us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember 2021-07-01 2021-09-30 0001069899 pahc:CompensationAndBenefitForServicesMember us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember 2020-07-01 2020-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember us-gaap:OtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:OtherComprehensiveIncomeMember us-gaap:LongMember 2021-07-01 2021-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember us-gaap:OtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:OtherComprehensiveIncomeMember us-gaap:LongMember 2020-07-01 2020-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember 2021-04-30 0001069899 pahc:TermALoansAndRevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-07-01 2021-09-30 0001069899 pahc:TermALoansAndRevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember us-gaap:EurodollarMember 2021-07-01 2021-09-30 0001069899 pahc:TermALoansAndRevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember us-gaap:BaseRateMember 2021-07-01 2021-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember pahc:CreditAgreementMember 2021-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember us-gaap:InterestExpenseMember 2021-07-01 2021-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2021-07-01 2021-09-30 0001069899 pahc:TermLoanMember 2021-07-01 2021-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2020-07-01 2020-09-30 0001069899 pahc:TermLoanMember 2020-07-01 2020-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-07-01 2021-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-07-01 2021-09-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2020-07-01 2020-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2020-07-01 2020-09-30 0001069899 2020-07-01 2021-06-30 0001069899 2022-07-31 0001069899 pahc:March2020AgreementMember 2021-09-30 0001069899 us-gaap:InterestRateSwapMember pahc:March2020AgreementMember 2020-03-31 0001069899 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-09-30 0001069899 pahc:AccruedAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-09-30 0001069899 pahc:AccruedAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-09-30 0001069899 pahc:AccruedAndOtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-06-30 0001069899 pahc:AccruedAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-06-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-06-30 0001069899 us-gaap:InterestRateSwapMember pahc:July2017AgreementMember 2017-07-31 0001069899 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-09-30 0001069899 us-gaap:OtherAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-06-30 0001069899 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-06-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-06-30 0001069899 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:SwapMember 2021-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:ShortMember 2021-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2021-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2021-07-01 2021-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2020-07-01 2020-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember 2020-09-30 0001069899 pahc:TermALoanMember pahc:TwoThousandTwentyOneCreditAgreementMember 2020-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember 2021-09-30 0001069899 us-gaap:InterestRateSwapMember pahc:March2020AgreementMember 2021-09-30 0001069899 us-gaap:InterestRateSwapMember pahc:July2017AgreementMember 2021-09-30 0001069899 pahc:TermALoanMember pahc:TwoThousandTwentyOneCreditAgreementMember 2021-09-30 0001069899 pahc:TermALoanMember pahc:TwoThousandTwentyOneCreditAgreementMember 2021-04-30 0001069899 pahc:TermALoansAndRevolvingCreditFacilityMember pahc:TwoThousandTwentyOneCreditAgreementMember 2021-07-01 2021-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:LongMember 2021-07-01 2021-09-30 0001069899 us-gaap:ForeignExchangeOptionMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:LongMember 2020-07-01 2020-09-30 0001069899 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001069899 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001069899 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001069899 us-gaap:CommonClassBMember 2021-09-30 0001069899 us-gaap:CommonClassAMember 2021-09-30 0001069899 us-gaap:CommonClassBMember 2021-06-30 0001069899 us-gaap:CommonClassAMember 2021-06-30 0001069899 2020-09-30 0001069899 2020-06-30 0001069899 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001069899 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001069899 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001069899 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001069899 us-gaap:FairValueInputsLevel2Member 2021-06-30 0001069899 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember 2021-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2021-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2021-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2021-06-30 0001069899 us-gaap:OperatingSegmentsMember 2021-06-30 0001069899 us-gaap:CorporateNonSegmentMember 2021-06-30 0001069899 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001069899 2020-07-01 2020-09-30 0001069899 pahc:CurrentAndLongTermLiabilitiesMember 2021-09-30 0001069899 pahc:CurrentAndLongTermLiabilitiesMember 2021-06-30 0001069899 us-gaap:FairValueInputsLevel3Member 2021-07-01 2021-09-30 0001069899 us-gaap:FairValueInputsLevel2Member 2021-07-01 2021-09-30 0001069899 us-gaap:FairValueInputsLevel1Member 2021-07-01 2021-09-30 0001069899 us-gaap:FairValueInputsLevel3Member 2020-07-01 2021-06-30 0001069899 us-gaap:FairValueInputsLevel2Member 2020-07-01 2021-06-30 0001069899 us-gaap:FairValueInputsLevel1Member 2020-07-01 2021-06-30 0001069899 us-gaap:CostOfSalesMember 2021-09-30 0001069899 pahc:CustomerMember srt:MinimumMember 2021-07-01 2021-09-30 0001069899 pahc:CustomerMember srt:MaximumMember 2021-07-01 2021-09-30 0001069899 2021-10-01 2021-10-31 0001069899 pahc:CustomerMember 2021-07-01 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2021-07-01 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2021-07-01 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2021-07-01 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2020-07-01 2020-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2020-07-01 2020-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2020-07-01 2020-09-30 0001069899 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0001069899 2021-09-30 0001069899 2021-06-30 0001069899 us-gaap:CommonClassBMember 2021-10-27 0001069899 us-gaap:CommonClassAMember 2021-10-27 0001069899 2021-07-01 2021-09-30 shares iso4217:USD pahc:item iso4217:USD shares pure iso4217:BRL 0.0001 0.0001 0001069899 --06-30 2022 Q1 false 20337574 20337574 0 0 20166034 20166034 0 0 0 0 0 0 0 0 0 0 20166034 20166034 PHIBRO ANIMAL HEALTH CORP 2.00%, 1.75% or 1.50% 2023-02-28 10-Q true 2021-09-30 false 001-36410 DE 13-1840497 Glenpointe Centre East, 3rd Floor 300 Frank W. Burr Boulevard, Suite 21 Teaneck NJ 07666-6712 201 329-7300 Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Yes Yes Accelerated Filer false false false 20337574 20166034 214665000 195194000 149987000 131075000 64678000 64119000 50066000 48431000 14612000 15688000 -2889000 -2810000 -2128000 3631000 9595000 16509000 3061000 4207000 6534000 12302000 0.16 0.30 0.16 0.30 40504000 40454000 40504000 40504000 6534000 12302000 -29000 1089000 -6964000 -4723000 -117000 -135000 22000 306000 -6898000 -3805000 -364000 8497000 41175000 50212000 56000000 43000000 140644000 146852000 221313000 216312000 39498000 42533000 498630000 498909000 152830000 154706000 60125000 62282000 52679000 52679000 71780000 72749000 836044000 841325000 11250000 9375000 66805000 68362000 74531000 86379000 152586000 164116000 110000000 95000000 284014000 287710000 56139000 55970000 602739000 602796000 0.0001 0.0001 300000000 300000000 20337574 20337574 30000000 30000000 4000 4000 0.0001 0.0001 16000000 16000000 0 0 135803000 135803000 219689000 218015000 -122191000 -115293000 233305000 238529000 836044000 841325000 6534000 12302000 7854000 8036000 148000 221000 0 565000 -31000 -277000 -2155000 4349000 -70000 -97000 -4373000 -1002000 9873000 9501000 -14000 632000 741000 205000 514000 -1188000 -7196000 -4373000 3821000 1698000 32000000 6000000 19000000 7449000 7420000 217000 215000 -20666000 -13635000 86000000 36000000 71000000 20000000 -1875000 -4688000 4860000 4854000 8265000 6458000 -457000 105000 -9037000 -5374000 50212000 36343000 41175000 30969000 40503608 4000 135803000 218015000 -115293000 238529000 6534000 -6898000 -364000 0.12 4860000 4860000 40503608 4000 135803000 219689000 -122191000 233305000 40453608 4000 135525000 183060000 -130385000 188204000 12302000 -3805000 8497000 0.12 4854000 4854000 565000 565000 40453608 4000 136090000 190508000 -134190000 192412000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1.  Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, dairy and beef cattle, swine, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The unaudited consolidated financial information for the three months ended September 30, 2021 and 2020, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (the “Annual Report”), filed with the Securities and Exchange Commission on August 25, 2021 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2021, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are now available, distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">2.  Summary of Significant Accounting Policies and New Accounting Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2021, there have been no material changes to any of the significant accounting policies contained therein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Net Income per Share and Weighted Average Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed vesting of restricted stock units. All common share equivalents were included in the calculation of diluted net income per share in the periods included in the consolidated financial statements. There are no outstanding stock option awards or restricted stock units as of September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,534</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,302</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares – basic </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,454</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dilutive effect of restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares – diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Net income per share</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">basic </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.16</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">New Accounting Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2020-04 and 2021-01, Reference Rate Reform (Topic 848), provide optional expedients and exceptions to GAAP guidance, if certain criteria are met, for contracts, hedging relationships and derivative instruments that reference the London Interbank Offered Rate (LIBOR) and other interbank offered rates expected to be discontinued or modified by rate reform. The overall purpose of Topic 848 is to ease the financial reporting burdens related to the expected market transition to alternative reference rates. These ASUs may be applied prospectively to contract modifications made and hedging relationships entered on or before December 31, 2022. We continue to evaluate the effect of adoption of this guidance on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, removes certain exceptions and amends certain requirements in the existing income tax guidance to ease accounting requirements. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and must be applied on a retrospective basis. The adoption did not have a material effect on our consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Net Income per Share and Weighted Average Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed vesting of restricted stock units. All common share equivalents were included in the calculation of diluted net income per share in the periods included in the consolidated financial statements. There are no outstanding stock option awards or restricted stock units as of September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,534</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,302</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares – basic </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,454</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dilutive effect of restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares – diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Net income per share</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">basic </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.16</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,534</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12,302</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares – basic </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,454</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dilutive effect of restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 50</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted average number of shares – diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 40,504</p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Net income per share</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">basic </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.16</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td></tr></table> 6534000 12302000 40504000 40454000 50000 40504000 40504000 0.16 0.30 0.16 0.30 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">New Accounting Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2020-04 and 2021-01, Reference Rate Reform (Topic 848), provide optional expedients and exceptions to GAAP guidance, if certain criteria are met, for contracts, hedging relationships and derivative instruments that reference the London Interbank Offered Rate (LIBOR) and other interbank offered rates expected to be discontinued or modified by rate reform. The overall purpose of Topic 848 is to ease the financial reporting burdens related to the expected market transition to alternative reference rates. These ASUs may be applied prospectively to contract modifications made and hedging relationships entered on or before December 31, 2022. We continue to evaluate the effect of adoption of this guidance on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, removes certain exceptions and amends certain requirements in the existing income tax guidance to ease accounting requirements. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and must be applied on a retrospective basis. The adoption did not have a material effect on our consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">3.  Statements of Operations — Additional Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Disaggregated revenue, deferred revenue and customer payment terms</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, and aquaculture. The products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. The animal health and mineral nutrition products are sold directly to integrated poultry, cattle, and swine integrators and through commercial animal feed manufacturers, wholesalers and distributors. The animal health industry and demand for many of the animal health products in a particular region are affected by changing disease pressures and by weather conditions, as product usage follows varying weather patterns and seasons. Our operations are primarily focused in regions where the majority of livestock production is consolidated in large commercial farms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have a diversified portfolio of products that are classified within our three business segments — Animal Health, Mineral Nutrition and Performance Products. Each segment has its own dedicated management and sales team.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Animal Health</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Animal Health business develops, manufactures and markets products in three main categories:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">MFAs and other: MFAs and other products primarily consist of concentrated medicated products that are administered through animal feeds, commonly referred to as Medicated Feed Additives (“MFAs”). Specific product classifications include antibacterials, which inhibit the growth of pathogenic bacteria that cause bacterial infections in animals; anticoccidials, which inhibit the growth of coccidia (parasites) that damage the intestinal tract of animals; and other related products.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Nutritional specialties: Nutritional specialty products enhance nutrition to help improve health and performance in areas such as immune system function and digestive health.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </span><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">We are also a developer, manufacturer and marketer of microbial products and bioproducts for a variety of applications serving animal health and nutrition, environmental, industrial and agricultural customers.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="color:#231f20;font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="color:#231f20;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Vaccines: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Our vaccines are primarily focused on preventing diseases in poultry and swine. They protect animals from either viral or bacterial disease challenges. We develop, manufacture and market conventionally licensed and autogenous vaccine products and produce and market adjuvants to vaccine manufacturers. We have developed and market an innovative and proprietary delivery platform for vaccines.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Mineral Nutrition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Mineral Nutrition business is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Our customers use these products to fortify the daily feed requirements of their livestock’s diets and maintain an optimal balance of trace elements in each animal. We manufacture and market a broad range of mineral nutrition products for food animals including beef and dairy cattle, swine and poultry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Performance Products</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Performance Products business manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following tables present our revenues disaggregated by major product category and geographic region:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Net Sales by Product Type</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Animal Health</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">MFAs and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 83,758</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 78,703</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Nutritional specialties</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,997</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 32,600</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Vaccines</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,066</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Animal Health</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 141,004</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 128,369</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Mineral Nutrition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,432</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51,440</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Performance Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,229</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,385</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195,194</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Net Sales by Region</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United States</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 126,319</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 118,771</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America and Canada</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37,756</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe, Middle East and Africa</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,935</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 26,872</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,795</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,665</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195,194</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Net sales by region are based on country of destination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Deferred revenue was $3,130 and $3,674 as of September 30, 2021 and June 30, 2021, respectively. Accrued expenses and other current liabilities included $1,396 and $1,560 of the total deferred revenue as of September 30, 2021 and June 30, 2021, respectively. The deferred revenue resulted primarily from certain customer arrangements, including technology licensing fees and discounts on future product sales. The transaction price associated with our deferred revenue arrangements is generally based on the stand-alone sales prices of the individual products or services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our customer payment terms generally range from 30 to 120 days globally and do not include any significant financing components. Payment terms vary based on industry and business practices within the regions in which we operate. Our average worldwide collection period for accounts receivable is approximately 60 days after the revenue is recognized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;">Interest Expense and Depreciation and Amortization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interest expense, net</b> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Term loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,875</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revolving credit facility</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 599</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 946</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 148</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 221</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,109</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest income</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (176)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (299)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,889</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,810</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Depreciation and amortization</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,714</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,831</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of intangible assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,135</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,205</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,854</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,036</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Net Sales by Product Type</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Animal Health</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">MFAs and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 83,758</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 78,703</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Nutritional specialties</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,997</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 32,600</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Vaccines</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 21,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,066</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Animal Health</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 141,004</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 128,369</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Mineral Nutrition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,432</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51,440</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Performance Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,229</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,385</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195,194</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Net Sales by Region</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">United States</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 126,319</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 118,771</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Latin America and Canada</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 42,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 37,756</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Europe, Middle East and Africa</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,935</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 26,872</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Asia Pacific</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 14,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,795</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,665</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195,194</p></td></tr></table> 83758000 78703000 35997000 32600000 21249000 17066000 141004000 128369000 54432000 51440000 19229000 15385000 214665000 195194000 126319000 118771000 42660000 37756000 30935000 26872000 14751000 11795000 214665000 195194000 3130000 3674000 1396000 1560000 P30D P120D P60D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;">Interest Expense and Depreciation and Amortization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interest expense, net</b> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Term loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,875</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Revolving credit facility</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 599</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 946</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 148</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 221</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 45</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 67</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,109</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest income</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (176)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (299)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,889</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,810</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Depreciation and amortization</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Depreciation of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,714</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,831</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of intangible assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,135</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,205</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of other assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,854</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,036</p></td></tr></table> 2273000 1875000 599000 946000 148000 221000 45000 67000 3065000 3109000 176000 299000 -2889000 -2810000 5714000 5831000 2135000 2205000 5000 7854000 8036000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">4.  Balance Sheets — Additional Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Inventories</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Raw materials </span></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">72,774</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 59,775</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Work-in-process</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,053</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 12,738</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Finished goods </span></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">138,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 143,799</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 221,313</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 216,312</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Other assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">ROU operating lease assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,688</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,962</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Deferred income taxes</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,446</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 9,861</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Deposits</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,337</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5,663</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Insurance investments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,054</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5,964</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Equity method investments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,759</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 4,141</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,634</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 2,696</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">U.S. pension plan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1,184</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Debt issuance costs</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,717</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1,811</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,529</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 8,467</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 71,780</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 72,749</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Accrued expenses and other current liabilities</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Employee related</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 26,553</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 35,375</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current operating lease liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,406</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,618</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Commissions and rebates</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 5,230</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,312</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Professional fees</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,288</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,380</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Income and other taxes</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,706</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,107</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 3,357</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 3,486</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Contingent consideration</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,840</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,840</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Restructuring costs</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> —</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 735</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Insurance-related</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 1,203</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 1,176</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Other</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 17,948</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 17,350</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 74,531</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 86,379</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Other liabilities</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Long-term operating lease liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,150</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,003</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Long-term and deferred income taxes</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,297</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,646</p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Supplemental retirement benefits, deferred compensation and other</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,506</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,382</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">International retirement plans</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,453</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,345</p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Other long-term liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,638</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,594</p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 56,139</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 55,970</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Accumulated other comprehensive loss</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (819)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (790)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Foreign currency translation adjustment</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (107,059)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (100,095)</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Unrecognized net pension losses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (19,856)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (19,973)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Benefit for income taxes on derivative instruments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 104</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 97</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Benefit for incomes taxes on long-term intercompany investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 8,166</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 8,166</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Provision for income taxes on net pension losses</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,727)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,698)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (122,191)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (115,293)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Inventories</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Raw materials </span></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">72,774</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 59,775</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Work-in-process</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,053</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 12,738</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Finished goods </span></p></td><td style="vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">138,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 143,799</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 221,313</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 216,312</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#231f20;font-weight:bold;">Other assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">ROU operating lease assets</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,688</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,962</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Deferred income taxes</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,446</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 9,861</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Deposits</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,337</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5,663</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Insurance investments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,054</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 5,964</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Equity method investments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,759</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 4,141</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,634</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 2,696</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">U.S. pension plan</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1,184</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">Debt issuance costs</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,717</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 1,811</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,529</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 8,467</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 71,780</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#231f20;"> 72,749</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Accrued expenses and other current liabilities</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Employee related</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 26,553</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 35,375</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Current operating lease liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,406</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,618</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Commissions and rebates</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 5,230</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,312</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Professional fees</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,288</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,380</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Income and other taxes</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,706</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 6,107</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 3,357</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 3,486</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Contingent consideration</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,840</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 4,840</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Restructuring costs</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> —</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 735</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Insurance-related</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 1,203</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 1,176</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Other</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 17,948</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 17,350</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 74,531</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 86,379</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.92%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Other liabilities</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Long-term operating lease liabilities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,150</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 28,003</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Long-term and deferred income taxes</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,297</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,646</p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Supplemental retirement benefits, deferred compensation and other</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,506</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,382</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">International retirement plans</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,453</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,345</p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Other long-term liabilities</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,638</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,594</p></td></tr><tr><td style="vertical-align:bottom;width:71.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 56,139</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 55,970</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;width:12.01%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Accumulated other comprehensive loss</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Derivative instruments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (819)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (790)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Foreign currency translation adjustment</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (107,059)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (100,095)</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Unrecognized net pension losses</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (19,856)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (19,973)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Benefit for income taxes on derivative instruments</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 104</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 97</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Benefit for incomes taxes on long-term intercompany investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 8,166</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 8,166</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Provision for income taxes on net pension losses</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,727)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,698)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (122,191)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (115,293)</span></p></td></tr></table> 72774000 59775000 10053000 12738000 138486000 143799000 221313000 216312000 31688000 32962000 9446000 9861000 5337000 5663000 6054000 5964000 4759000 4141000 2634000 2696000 1616000 1184000 1717000 1811000 8529000 8467000 71780000 72749000 26553000 35375000 6406000 6618000 5230000 6312000 4288000 4380000 4706000 6107000 3357000 3486000 4840000 4840000 0 735000 1203000 1176000 17948000 17350000 74531000 86379000 27150000 28003000 7297000 6646000 8506000 8382000 5453000 5345000 95000 7638000 7594000 56139000 55970000 -819000 -790000 -107059000 -100095000 19856000 19973000 104000 97000 8166000 8166000 -2727000 -2698000 -122191000 -115293000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">5.  Debt</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Term Loans and Revolving Credit Facilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In April 2021, we entered into an amended and restated credit agreement (the “2021 Credit Agreement”) under which we have a term A loan in an aggregate initial principal amount of $300,000 (the “2021 Term A Loan”) and a revolving credit facility under which we can borrow up to an aggregate amount of $250,000, subject to the terms of the 2021 Credit Agreement (the “2021 Revolver” and together with the 2021 Term A Loan, the “2021 Credit Facilities”). The 2021 Term A Loan is repayable in quarterly installments, with the balance payable at maturity. The 2021 Revolver contains a letter of credit facility. The interest rate per annum applicable to the loans under the 2021 Credit Facilities is based on a fluctuating rate of interest plus an applicable rate equal to 2.00%, 1.75% or 1.50%, in the case of LIBOR and <span style="-sec-ix-hidden:Hidden_-iy_dt-naEegLmyNT0SdbQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Eurodollar</span></span> rate loans and 1.00%, 0.75% or 0.50%, in the case of base rate loans; the applicable rates are based on the First Lien Net Leverage Ratio (as defined in the 2021 Credit Agreement). The 2021 Credit Facilities mature in April 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The 2021 Credit Agreement requires, among other things, compliance with financial covenants that permit: (i) a maximum First Lien Net Leverage Ratio of 4.00:1.00 and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis. The 2021 Credit Agreement contains an acceleration clause should an event of default (as defined in the 2021 Credit Agreement) occur. As of September 30, 2021, we were in compliance with the financial covenants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, we had $110,000 in borrowings drawn under the 2021 Revolver and had outstanding letters of credit of $2,709, leaving $137,291 available for further borrowings and letters of credit under the 2021 Revolver, subject to restrictions in our 2021 Credit Facilities. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The terms of these letters of credit are all less than one year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2017, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed interest rate of 1.8325%. The agreement matures in June 2022. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 8 — Derivatives.” </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In March 2020, we entered into an interest rate swap agreement on an additional $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increases to a notional principal amount of $300,000 through June 2025, and effectively converts the floating LIBOR portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.62%. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 8 — Derivatives.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The 2017 and 2020 interest rate swap agreements will continue to remain in place on our interest obligations associated with the 2021 Credit Facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2021, the interest rates for the 2021 Revolver and the 2021 Term A Loan were 1.85% and 2.98%, respectively. The weighted-average interest rates for the 2021 Revolver and the prior revolving credit facility were 1.83% and 2.12% for the three months ended September 30, 2021, and 2020, respectively. The weighted-average interest rates for the 2021 Term A Loan and the prior term A loan were 2.98% and 3.19% for three months ended September 30, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;">Long-Term Debt</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">2021 Term A Loan due April 2026</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 296,250</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 298,125</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Unamortized debt issuance costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (986)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (1,040)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 295,264</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 297,085</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Less: current maturities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (11,250)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (9,375)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 284,014</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 287,710</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> 300000000 250000000 2.00%, 1.75% or 1.50% 1.00%, 0.75% or 0.50% April 2026 a maximum First Lien Net Leverage Ratio of 4.00:1.00 and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis we were in compliance with the financial covenants 110000000 110000000 2709000 2709000 137291000 150000000 0.018325 150000000 0.0062 300000000 300000000 0.0062 0.0185 0.0298 0.0183 0.0212 0.0298 0.0319 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">2021 Term A Loan due April 2026</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 296,250</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 298,125</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">Unamortized debt issuance costs </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (986)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (1,040)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 295,264</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 297,085</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Less: current maturities</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (11,250)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="color:#231f20;"> (9,375)</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 284,014</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 287,710</span></p></td></tr></table> 296250000 298125000 986000 1040000 295264000 297085000 11250000 9375000 284014000 287710000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">6.  Related Party Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to the Company as employees or consultants and received aggregate compensation and benefits of approximately $829 and $532 during the three months ended September 30, 2021, and 2020, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.</p> 829000 532000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">7.  Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Environmental</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination, and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the period during which such costs are likely to be incurred are difficult to predict.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based on our experience, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of the Santa Fe Springs, California facility of our subsidiary, Phibro-Tech, Inc. ("Phibro-Tech"). The EPA has entered into a settlement agreement with a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling ("OPOG") to remediate the contaminated groundwater that has migrated from the Omega Chemical Site in accordance with a general remedy selected by EPA. The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that any groundwater contamination at its site is localized and due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, the members of OPOG filed a complaint under the Comprehensive Environmental Response, Compensation, and Liability Act and the Resource Conservation and Recovery Act in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation, the preliminary stage of the ongoing litigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be approximately $4,321 and $4,293 at September 30 and June 30, 2021, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries are liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Claims and Litigation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">PAHC and its subsidiaries are party to various claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.</p> 140 4321000 4293000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">8.  Derivatives</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in accumulated other comprehensive income (loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “Note 9 — Fair Value Measurements.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In July 2017, we entered into an interest rate swap agreement on the first $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed interest rate of 1.8325%. The agreement matures in June 2022. In March 2020, we entered into an interest rate swap agreement on an additional $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. On the maturity of the July 2017 agreement, this agreement increases to a notional principal amount of $300,000 through June 2025, and effectively converts the floating LIBOR portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.62%. The forecasted transactions are probable of occurring, and the interest rate swaps have been designated as highly effective cash flow hedges.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We entered into foreign currency option contracts to hedge cash flows related to monthly inventory purchases. The individual option contracts mature monthly through <span style="-sec-ix-hidden:Hidden_U005u7wleE-v6rKlIg8vCA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">February 2023</span></span>. The forecasted inventory purchases are probable of occurring and the individual option contracts were designated as highly effective cash flow hedges.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated balance sheet includes the net fair values of our outstanding foreign currency option contracts within the respective line items, based on the net financial position and maturity date of the individual contracts. The consolidated balance sheet includes the net fair values of our outstanding interest rate swaps within the respective balance sheet line items, based on the expected timing of the cash flows. The consolidated balance sheet includes assets and liabilities for the fair values of outstanding derivatives that are designated and effective as cash flow hedges as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 355</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,634</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,341</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued expense and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (467)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (150)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,891)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,336)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other liabilities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (95)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Fair Value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (562)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 205</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (257)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (995)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Notional amounts of the derivatives as of the balance sheet date were:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:84.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Brazil Real call options</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 96,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Brazil Real put options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 96,000</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 300,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The consolidated statements of operations and statements of other comprehensive income (“OCI”) for the periods ended September 30, 2021 and 2020 included the effects of derivatives as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brazil Real options, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">(Income) expense recorded in consolidated statement of operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 428</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Consolidated statement of operations - total cost of goods sold</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,987</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,075</p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">(Income) expense recorded in OCI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (376)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Expense recorded in consolidated statements of operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 868</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 813</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Consolidated statement of operations - total interest expense, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,889</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,810</p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">(Income) expense recorded in OCI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (738)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (713)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">We recognize gains and losses related to foreign currency derivatives as a component of cost of goods sold at the time the hedged item is sold. Inventory as of September 30, 2021, included realized net losses of $1,527 related to matured contracts. We anticipate the net losses included in inventory will be recognized in cost of goods sold within the next twelve to eighteen months.</p> 150000000 0.018325 150000000 0.0062 0.0062 300000000 300000000 0.0062 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 355</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,634</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,341</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued expense and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (467)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (150)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,891)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,336)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other liabilities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (95)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Fair Value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Brazil Real options, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (562)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 205</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Interest rate swaps</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (257)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (995)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Notional amounts of the derivatives as of the balance sheet date were:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:84.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Brazil Real call options</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 96,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Brazil Real put options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">R$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 96,000</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 300,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The consolidated statements of operations and statements of other comprehensive income (“OCI”) for the periods ended September 30, 2021 and 2020 included the effects of derivatives as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brazil Real options, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">(Income) expense recorded in consolidated statement of operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 428</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Consolidated statement of operations - total cost of goods sold</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 149,987</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 131,075</p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">(Income) expense recorded in OCI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (376)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Expense recorded in consolidated statements of operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 868</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 813</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Consolidated statement of operations - total interest expense, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,889</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,810</p></td></tr><tr><td style="vertical-align:bottom;width:75.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">(Income) expense recorded in OCI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (738)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (713)</p></td></tr></table> 355000 2634000 2341000 -467000 -150000 -2891000 -3336000 -95000 -562000 205000 -257000 -995000 96000000 96000000 300000000 -428000 3000 149987000 131075000 -767000 376000 -868000 -813000 -2889000 -2810000 738000 713000 1527000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">9.  Fair Value Measurements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Short-term investments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our short-term investments consist of cash deposits held at financial institutions. We consider the carrying amounts of these short-term investments to be representative of their fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Current Assets and Liabilities </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Contingent Consideration on Acquisitions </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We determine the fair value of contingent consideration on acquisitions based on contractual terms, our current forecast of performance factors related to the acquired business and an applicable discount rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Debt </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We record debt, including term loans and revolver balances, at amortized cost in our consolidated financial statements. We believe the carrying value of the debt is approximately equal to its fair value, due to the variable nature of the instruments and our evaluation of estimated market prices. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Derivatives</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Non-financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our non-financial assets, which primarily consist of goodwill, other intangible assets, property and equipment, and lease-related ROU assets, are not required to be measured at fair value on a recurring basis, and instead are reported at carrying value in the consolidated balance sheet. We assess the carrying values of non-financial assets for impairment on a periodic basis or whenever events or changes in circumstances indicate an asset may not be fully recoverable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;">Fair Value of Assets (Liabilities)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 3</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term investments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 56,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency derivatives</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (562)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 205</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (257)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (995)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration on acquisitions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,840)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,840)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">There were no transfers between levels during the periods presented. There were no changes in the fair value of the Level 3 liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The contingent consideration on acquisitions is the minimum amount payable in accordance with the acquisition agreement for Osprey. The contingent consideration of $4,840 was paid in October 2021.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:29.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">Level 3</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term investments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 56,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 43,000</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Foreign currency derivatives</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (562)</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 205</p></td><td style="vertical-align:top;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:top;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate swaps</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (257)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (995)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Contingent consideration on acquisitions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,840)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (4,840)</p></td></tr></table> 56000000 0 0 43000000 0 0 0 -562000 0 0 205000 0 0 257000 0 0 995000 0 0 0 4840000 0 0 4840000 0 0 0 4840000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">10.  Business Segments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, and (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and certain items that we consider to be unusual, non-operational or non-recurring.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Net sales</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 141,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 128,369</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,432</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51,440</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,229</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,385</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,665</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195,194</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Depreciation and amortization</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,521</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 639</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 649</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 419</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 445</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,478</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,615</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,637</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,101</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,533</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,047</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,138</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,972</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Total segments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 34,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,120</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Reconciliation of income before income taxes to Adjusted EBITDA</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Income before income taxes </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,595</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,509</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Interest expense, net </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,889</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,810</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Depreciation and amortization – Total segments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,478</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,615</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Depreciation and amortization – Corporate </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 376</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 421</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Corporate costs</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,831</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Stock-based compensation</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 565</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Foreign currency (gains) losses, net </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,631)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Adjusted EBITDA – Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 34,308</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,120</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Identifiable assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 579,432</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 595,315</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 74,218</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 67,338</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 37,111</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 36,847</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 690,761</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 699,500</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Corporate </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 145,283</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 141,825</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Total </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 836,044</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 841,325</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax related assets and certain other assets.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">For the Periods Ended September 30</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Net sales</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 141,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 128,369</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,432</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 51,440</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,229</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,385</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 214,665</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 195,194</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><span style="color:#231f20;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Depreciation and amortization</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,521</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 639</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 649</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 419</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 445</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,478</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,615</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Adjusted EBITDA</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,637</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 30,101</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,533</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,047</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,138</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,972</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Total segments </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 34,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,120</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Reconciliation of income before income taxes to Adjusted EBITDA</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Income before income taxes </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,595</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 16,509</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Interest expense, net </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,889</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,810</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Depreciation and amortization – Total segments</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,478</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,615</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Depreciation and amortization – Corporate </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 376</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 421</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Corporate costs</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,831</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Stock-based compensation</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 565</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Foreign currency (gains) losses, net </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,128</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,631)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;white-space:pre-wrap;">Adjusted EBITDA – Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 34,308</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,120</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">As of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="color:#231f20;font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="color:#231f20;font-weight:bold;">Identifiable assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Animal Health </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 579,432</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 595,315</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Mineral Nutrition </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 74,218</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 67,338</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Performance Products </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 37,111</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #231f20;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 36,847</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Total segments </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 690,761</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 699,500</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;">Corporate </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 145,283</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 141,825</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><span style="color:#231f20;white-space:pre-wrap;">Total </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 836,044</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#231f20;">$</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="color:#231f20;"> 841,325</span></p></td></tr></table> 141004000 128369000 54432000 51440000 19229000 15385000 214665000 195194000 6420000 6521000 639000 649000 419000 445000 7478000 7615000 27637000 30101000 4533000 3047000 2138000 1972000 34308000 35120000 9595000 16509000 -2889000 -2810000 7478000 7615000 376000 421000 11842000 10831000 565000 -2128000 3631000 34308000 35120000 579432000 595315000 74218000 67338000 37111000 36847000 690761000 699500000 145283000 141825000 836044000 841325000 XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information - shares
3 Months Ended
Sep. 30, 2021
Oct. 27, 2021
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2021  
Entity File Number 001-36410  
Entity Registrant Name PHIBRO ANIMAL HEALTH CORP  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 13-1840497  
Entity Address, Address Line One Glenpointe Centre East, 3rd Floor  
Entity Address, Address Line Two 300 Frank W. Burr Boulevard, Suite 21  
Entity Address, City or Town Teaneck  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07666-6712  
City Area Code 201  
Local Phone Number 329-7300  
Title of 12(b) Security Class A Common Stock, $0.0001 par value per share  
Trading Symbol PAHC  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Interactive Data Current Yes  
Entity Emerging Growth Company false  
Entity Shell Company false  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0001069899  
Amendment Flag false  
Common stock-Class A    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   20,337,574
Common stock-Class B    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   20,166,034
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS    
Net sales $ 214,665 $ 195,194
Cost of goods sold 149,987 131,075
Gross profit 64,678 64,119
Selling, general and administrative expenses 50,066 48,431
Operating income 14,612 15,688
Interest expense, net 2,889 2,810
Foreign currency (gains) losses, net 2,128 (3,631)
Income before income taxes 9,595 16,509
Provision for income taxes 3,061 4,207
Net income $ 6,534 $ 12,302
Net income per share    
basic (in dollars per share) $ 0.16 $ 0.30
diluted (in dollars per share) $ 0.16 $ 0.30
Weighted average common shares outstanding    
basic (in shares) 40,504 40,454
diluted (in shares) 40,504 40,504
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME    
Net income $ 6,534 $ 12,302
Change in fair value of derivative instruments (29) 1,089
Foreign currency translation adjustment (6,964) (4,723)
Unrecognized net pension gains 117 135
Provision for income taxes (22) (306)
Other comprehensive loss (6,898) (3,805)
Comprehensive income (loss) $ (364) $ 8,497
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Jun. 30, 2021
ASSETS    
Cash and cash equivalents $ 41,175 $ 50,212
Short-term investments 56,000 43,000
Accounts receivable, net 140,644 146,852
Inventories, net 221,313 216,312
Other current assets 39,498 42,533
Total current assets 498,630 498,909
Property, plant and equipment, net 152,830 154,706
Intangibles, net 60,125 62,282
Goodwill 52,679 52,679
Other assets 71,780 72,749
Total assets 836,044 841,325
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current portion of long-term debt 11,250 9,375
Accounts payable 66,805 68,362
Accrued expenses and other current liabilities 74,531 86,379
Total current liabilities 152,586 164,116
Revolving credit facility 110,000 95,000
Long-term debt 284,014 287,710
Other liabilities 56,139 55,970
Total liabilities 602,739 602,796
Commitments and contingencies (Note 7)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2021 and June 30, 2021; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2021 and June 30, 2021 4 4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding
Paid-in capital 135,803 135,803
Retained earnings 219,689 218,015
Accumulated other comprehensive loss (122,191) (115,293)
Total stockholders' equity 233,305 238,529
Total liabilities and stockholders' equity $ 836,044 $ 841,325
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares
Sep. 30, 2021
Jun. 30, 2021
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 16,000,000 16,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock-Class A    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 20,337,574 20,337,574
Common stock, shares outstanding 20,337,574 20,337,574
Common stock-Class B    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 20,166,034 20,166,034
Common stock, shares outstanding 20,166,034 20,166,034
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
OPERATING ACTIVITIES    
Net income $ 6,534 $ 12,302
Adjustments to reconcile net cash provided by operating activities:    
Depreciation and amortization 7,854 8,036
Amortization of debt issuance costs 148 221
Stock-based compensation 0 565
Deferred income taxes (31) (277)
Foreign currency (gains) losses, net 2,155 (4,349)
Other 70 97
Changes in operating assets and liabilities, net of business acquisitions:    
Accounts receivable, net 4,373 1,002
Inventories, net (9,873) (9,501)
Other current assets 14 (632)
Other assets (741) (205)
Accounts payable 514 (1,188)
Accrued expenses and other liabilities (7,196) (4,373)
Net cash provided by operating activities 3,821 1,698
INVESTING ACTIVITIES    
Purchases of short-term investments (32,000) (6,000)
Maturities of short-term investments 19,000  
Capital expenditures (7,449) (7,420)
Other, net (217) (215)
Net cash used by investing activities (20,666) (13,635)
FINANCING ACTIVITIES    
Revolving credit facility borrowings 86,000 36,000
Revolving credit facility repayments (71,000) (20,000)
Payments of long-term debt and other (1,875) (4,688)
Dividends paid (4,860) (4,854)
Net cash provided by financing activities 8,265 6,458
Effect of exchange rate changes on cash (457) 105
Net decrease in cash and cash equivalents (9,037) (5,374)
Cash and cash equivalents at beginning of period 50,212 36,343
Cash and cash equivalents at end of period $ 41,175 $ 30,969
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Jun. 30, 2020 $ 4 $ 135,525 $ 183,060 $ (130,385) $ 188,204
Balance (in shares) at Jun. 30, 2020 40,453,608        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss)     12,302 (3,805) 8,497
Dividends declared     (4,854)   (4,854)
Stock-based compensation expense   565     565
Balance at Sep. 30, 2020 $ 4 136,090 190,508 (134,190) 192,412
Balance (in shares) at Sep. 30, 2020 40,453,608        
Balance at Jun. 30, 2021 $ 4 135,803 218,015 (115,293) 238,529
Balance (in shares) at Jun. 30, 2021 40,503,608        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss)     6,534 (6,898) (364)
Dividends declared     (4,860)   (4,860)
Balance at Sep. 30, 2021 $ 4 $ 135,803 $ 219,689 $ (122,191) $ 233,305
Balance (in shares) at Sep. 30, 2021 40,503,608        
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) - $ / shares
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY    
Dividends declared per share $ 0.12 $ 0.12
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Business
3 Months Ended
Sep. 30, 2021
Description of Business  
Description of Business

1.  Description of Business

Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, dairy and beef cattle, swine, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.

The unaudited consolidated financial information for the three months ended September 30, 2021 and 2020, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (the “Annual Report”), filed with the Securities and Exchange Commission on August 25, 2021 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2021, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are now available, distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods.

The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies and New Accounting Standards
3 Months Ended
Sep. 30, 2021
Summary of Significant Accounting Policies and New Accounting Standards  
Summary of Significant Accounting Policies and New Accounting Standards

2.  Summary of Significant Accounting Policies and New Accounting Standards

Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2021, there have been no material changes to any of the significant accounting policies contained therein.

Net Income per Share and Weighted Average Shares

Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed vesting of restricted stock units. All common share equivalents were included in the calculation of diluted net income per share in the periods included in the consolidated financial statements. There are no outstanding stock option awards or restricted stock units as of September 30, 2021.

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net income

$

6,534

$

12,302

Weighted average number of shares – basic

 

40,504

 

40,454

Dilutive effect of restricted stock units

 

 

50

Weighted average number of shares – diluted

 

40,504

 

40,504

Net income per share

 

 

  

basic

$

0.16

$

0.30

diluted

$

0.16

$

0.30

New Accounting Standards

Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2020-04 and 2021-01, Reference Rate Reform (Topic 848), provide optional expedients and exceptions to GAAP guidance, if certain criteria are met, for contracts, hedging relationships and derivative instruments that reference the London Interbank Offered Rate (LIBOR) and other interbank offered rates expected to be discontinued or modified by rate reform. The overall purpose of Topic 848 is to ease the financial reporting burdens related to the expected market transition to alternative reference rates. These ASUs may be applied prospectively to contract modifications made and hedging relationships entered on or before December 31, 2022. We continue to evaluate the effect of adoption of this guidance on our consolidated financial statements.

ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, removes certain exceptions and amends certain requirements in the existing income tax guidance to ease accounting requirements. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and must be applied on a retrospective basis. The adoption did not have a material effect on our consolidated financial statements.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Operations - Additional Information
3 Months Ended
Sep. 30, 2021
Statements of Operations - Additional Information  
Statements of Operations - Additional Information

3.  Statements of Operations — Additional Information

Disaggregated revenue, deferred revenue and customer payment terms

We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, and aquaculture. The products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. The animal health and mineral nutrition products are sold directly to integrated poultry, cattle, and swine integrators and through commercial animal feed manufacturers, wholesalers and distributors. The animal health industry and demand for many of the animal health products in a particular region are affected by changing disease pressures and by weather conditions, as product usage follows varying weather patterns and seasons. Our operations are primarily focused in regions where the majority of livestock production is consolidated in large commercial farms.

We have a diversified portfolio of products that are classified within our three business segments — Animal Health, Mineral Nutrition and Performance Products. Each segment has its own dedicated management and sales team.

Animal Health

The Animal Health business develops, manufactures and markets products in three main categories:

MFAs and other: MFAs and other products primarily consist of concentrated medicated products that are administered through animal feeds, commonly referred to as Medicated Feed Additives (“MFAs”). Specific product classifications include antibacterials, which inhibit the growth of pathogenic bacteria that cause bacterial infections in animals; anticoccidials, which inhibit the growth of coccidia (parasites) that damage the intestinal tract of animals; and other related products.
Nutritional specialties: Nutritional specialty products enhance nutrition to help improve health and performance in areas such as immune system function and digestive health. We are also a developer, manufacturer and marketer of microbial products and bioproducts for a variety of applications serving animal health and nutrition, environmental, industrial and agricultural customers.
Vaccines: Our vaccines are primarily focused on preventing diseases in poultry and swine. They protect animals from either viral or bacterial disease challenges. We develop, manufacture and market conventionally licensed and autogenous vaccine products and produce and market adjuvants to vaccine manufacturers. We have developed and market an innovative and proprietary delivery platform for vaccines.

Mineral Nutrition

The Mineral Nutrition business is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Our customers use these products to fortify the daily feed requirements of their livestock’s diets and maintain an optimal balance of trace elements in each animal. We manufacture and market a broad range of mineral nutrition products for food animals including beef and dairy cattle, swine and poultry.

Performance Products

The Performance Products business manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.

The following tables present our revenues disaggregated by major product category and geographic region:

Net Sales by Product Type

Three Months

For the Periods Ended September 30

    

2021

    

2020

Animal Health

 

  

 

  

MFAs and other

$

83,758

$

78,703

Nutritional specialties

 

35,997

 

32,600

Vaccines

 

21,249

 

17,066

Total Animal Health

$

141,004

$

128,369

Mineral Nutrition

 

54,432

 

51,440

Performance Products

 

19,229

 

15,385

Total

$

214,665

$

195,194

Net Sales by Region

Three Months

For the Periods Ended September 30

    

2021

    

2020

United States

$

126,319

$

118,771

Latin America and Canada

 

42,660

 

37,756

Europe, Middle East and Africa

 

30,935

 

26,872

Asia Pacific

 

14,751

 

11,795

Total

$

214,665

$

195,194

Net sales by region are based on country of destination.

Deferred revenue was $3,130 and $3,674 as of September 30, 2021 and June 30, 2021, respectively. Accrued expenses and other current liabilities included $1,396 and $1,560 of the total deferred revenue as of September 30, 2021 and June 30, 2021, respectively. The deferred revenue resulted primarily from certain customer arrangements, including technology licensing fees and discounts on future product sales. The transaction price associated with our deferred revenue arrangements is generally based on the stand-alone sales prices of the individual products or services.

Our customer payment terms generally range from 30 to 120 days globally and do not include any significant financing components. Payment terms vary based on industry and business practices within the regions in which we operate. Our average worldwide collection period for accounts receivable is approximately 60 days after the revenue is recognized.

Interest Expense and Depreciation and Amortization

Three Months

For the Periods Ended September 30

    

2021

    

2020

Interest expense, net

Term loan

$

2,273

$

1,875

Revolving credit facility

 

599

 

946

Amortization of debt issuance costs

 

148

 

221

Other

 

45

 

67

Interest expense

 

3,065

 

3,109

Interest income

 

(176)

 

(299)

$

2,889

$

2,810

Three Months

For the Periods Ended September 30

    

2021

    

2020

Depreciation and amortization

 

 

  

Depreciation of property, plant and equipment

$

5,714

$

5,831

Amortization of intangible assets

 

2,135

 

2,205

Amortization of other assets

 

5

 

$

7,854

$

8,036

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheets - Additional Information
3 Months Ended
Sep. 30, 2021
Balance Sheets - Additional Information  
Balance Sheets - Additional Information

4.  Balance Sheets — Additional Information

September 30, 

June 30, 

As of

    

2021

    

2021

Inventories

  

Raw materials

$

72,774

$

59,775

Work-in-process

10,053

12,738

Finished goods

138,486

143,799

$

221,313

$

216,312

    

September 30, 

June 30, 

As of

    

2021

    

2021

Other assets

ROU operating lease assets

$

31,688

 

$

32,962

Deferred income taxes

 

9,446

 

9,861

Deposits

 

5,337

 

5,663

Insurance investments

 

6,054

 

5,964

Equity method investments

 

4,759

 

4,141

Derivative instruments

2,634

2,696

U.S. pension plan

 

1,616

 

1,184

Debt issuance costs

 

1,717

 

1,811

Other

8,529

8,467

$

71,780

 

$

72,749

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

Accrued expenses and other current liabilities

 

  

 

  

Employee related

$

26,553

$

35,375

Current operating lease liabilities

 

6,406

 

6,618

Commissions and rebates

5,230

6,312

Professional fees

 

4,288

 

4,380

Income and other taxes

4,706

6,107

Derivative instruments

3,357

3,486

Contingent consideration

 

4,840

 

4,840

Restructuring costs

 

 

735

Insurance-related

 

1,203

 

1,176

Other

 

17,948

 

17,350

$

74,531

$

86,379

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

Other liabilities

Long-term operating lease liabilities

$

27,150

$

28,003

Long-term and deferred income taxes

 

7,297

6,646

Supplemental retirement benefits, deferred compensation and other

8,506

8,382

International retirement plans

 

5,453

 

5,345

Derivative instruments

95

Other long-term liabilities

 

7,638

 

7,594

$

56,139

$

55,970

September 30, 

    

June 30, 

As of

    

2021

    

2021

Accumulated other comprehensive loss

  

  

Derivative instruments

$

(819)

$

(790)

Foreign currency translation adjustment

 

(107,059)

 

(100,095)

Unrecognized net pension losses

 

(19,856)

 

(19,973)

Benefit for income taxes on derivative instruments

 

104

 

97

Benefit for incomes taxes on long-term intercompany investments

8,166

8,166

Provision for income taxes on net pension losses

(2,727)

(2,698)

$

(122,191)

$

(115,293)

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Debt
3 Months Ended
Sep. 30, 2021
Debt  
Debt

5.  Debt

Term Loans and Revolving Credit Facilities

In April 2021, we entered into an amended and restated credit agreement (the “2021 Credit Agreement”) under which we have a term A loan in an aggregate initial principal amount of $300,000 (the “2021 Term A Loan”) and a revolving credit facility under which we can borrow up to an aggregate amount of $250,000, subject to the terms of the 2021 Credit Agreement (the “2021 Revolver” and together with the 2021 Term A Loan, the “2021 Credit Facilities”). The 2021 Term A Loan is repayable in quarterly installments, with the balance payable at maturity. The 2021 Revolver contains a letter of credit facility. The interest rate per annum applicable to the loans under the 2021 Credit Facilities is based on a fluctuating rate of interest plus an applicable rate equal to 2.00%, 1.75% or 1.50%, in the case of LIBOR and Eurodollar rate loans and 1.00%, 0.75% or 0.50%, in the case of base rate loans; the applicable rates are based on the First Lien Net Leverage Ratio (as defined in the 2021 Credit Agreement). The 2021 Credit Facilities mature in April 2026.

The 2021 Credit Agreement requires, among other things, compliance with financial covenants that permit: (i) a maximum First Lien Net Leverage Ratio of 4.00:1.00 and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis. The 2021 Credit Agreement contains an acceleration clause should an event of default (as defined in the 2021 Credit Agreement) occur. As of September 30, 2021, we were in compliance with the financial covenants.

As of September 30, 2021, we had $110,000 in borrowings drawn under the 2021 Revolver and had outstanding letters of credit of $2,709, leaving $137,291 available for further borrowings and letters of credit under the 2021 Revolver, subject to restrictions in our 2021 Credit Facilities. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The terms of these letters of credit are all less than one year.

In July 2017, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed interest rate of 1.8325%. The agreement matures in June 2022. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 8 — Derivatives.”

In March 2020, we entered into an interest rate swap agreement on an additional $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. In July 2022, this agreement increases to a notional principal amount of $300,000 through June 2025, and effectively converts the floating LIBOR portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.62%. We designated the interest rate swap as a highly effective cash flow hedge. For additional details, see “Note 8 — Derivatives.”

The 2017 and 2020 interest rate swap agreements will continue to remain in place on our interest obligations associated with the 2021 Credit Facilities.

As of September 30, 2021, the interest rates for the 2021 Revolver and the 2021 Term A Loan were 1.85% and 2.98%, respectively. The weighted-average interest rates for the 2021 Revolver and the prior revolving credit facility were 1.83% and 2.12% for the three months ended September 30, 2021, and 2020, respectively. The weighted-average interest rates for the 2021 Term A Loan and the prior term A loan were 2.98% and 3.19% for three months ended September 30, 2021 and 2020, respectively.

Long-Term Debt

    

September 30, 

    

June 30, 

As of

2021

2021

2021 Term A Loan due April 2026

$

296,250

$

298,125

Unamortized debt issuance costs

 

(986)

 

(1,040)

 

295,264

 

297,085

Less: current maturities

 

(11,250)

 

(9,375)

$

284,014

$

287,710

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
3 Months Ended
Sep. 30, 2021
Related Party Transactions  
Related Party Transactions

6.  Related Party Transactions

Certain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to the Company as employees or consultants and received aggregate compensation and benefits of approximately $829 and $532 during the three months ended September 30, 2021, and 2020, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
3 Months Ended
Sep. 30, 2021
Commitments and Contingencies  
Commitments and Contingencies

7.  Commitments and Contingencies

Environmental

Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination, and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the period during which such costs are likely to be incurred are difficult to predict.

While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.

The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based on our experience, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of the Santa Fe Springs, California facility of our subsidiary, Phibro-Tech, Inc. ("Phibro-Tech"). The EPA has entered into a settlement agreement with a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling ("OPOG") to remediate the contaminated groundwater that has migrated from the Omega Chemical Site in accordance with a general remedy selected by EPA. The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that any groundwater contamination at its site is localized and due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, the members of OPOG filed a complaint under the Comprehensive Environmental Response, Compensation, and Liability Act and the Resource Conservation and Recovery Act in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation, the preliminary stage of the ongoing litigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.

Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be approximately $4,321 and $4,293 at September 30 and June 30, 2021, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries are liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.

Claims and Litigation

PAHC and its subsidiaries are party to various claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives
3 Months Ended
Sep. 30, 2021
Derivatives  
Derivatives

8.  Derivatives

We monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in accumulated other comprehensive income (loss).

We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.

We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “Note 9 — Fair Value Measurements.”

In July 2017, we entered into an interest rate swap agreement on the first $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed interest rate of 1.8325%. The agreement matures in June 2022. In March 2020, we entered into an interest rate swap agreement on an additional $150,000 of notional principal that effectively converts the floating LIBOR portion of our interest obligation on that amount of debt to a fixed rate of 0.62%. On the maturity of the July 2017 agreement, this agreement increases to a notional principal amount of $300,000 through June 2025, and effectively converts the floating LIBOR portion of our interest obligation on $300,000 of debt to a fixed interest rate of 0.62%. The forecasted transactions are probable of occurring, and the interest rate swaps have been designated as highly effective cash flow hedges.

We entered into foreign currency option contracts to hedge cash flows related to monthly inventory purchases. The individual option contracts mature monthly through February 2023. The forecasted inventory purchases are probable of occurring and the individual option contracts were designated as highly effective cash flow hedges.

The consolidated balance sheet includes the net fair values of our outstanding foreign currency option contracts within the respective line items, based on the net financial position and maturity date of the individual contracts. The consolidated balance sheet includes the net fair values of our outstanding interest rate swaps within the respective balance sheet line items, based on the expected timing of the cash flows. The consolidated balance sheet includes assets and liabilities for the fair values of outstanding derivatives that are designated and effective as cash flow hedges as follows:

September 30, 

June 30, 

As of

    

2021

    

2021

Other assets

 

  

 

  

Brazil Real options, net

$

$

355

Interest rate swaps

 

2,634

 

2,341

Accrued expense and other current liabilities

 

  

 

  

Brazil Real options, net

 

(467)

 

(150)

Interest rate swaps

 

(2,891)

 

(3,336)

Other liabilities

 

  

 

  

Brazil Real options, net

 

(95)

 

Interest rate swaps

 

 

Total Fair Value

 

 

  

Brazil Real options, net

 

(562)

 

205

Interest rate swaps

 

(257)

 

(995)

Notional amounts of the derivatives as of the balance sheet date were:

September 30, 

As of

    

2021

Brazil Real call options

R$

96,000

Brazil Real put options

 

R$

96,000

Interest rate swaps

$

300,000

The consolidated statements of operations and statements of other comprehensive income (“OCI”) for the periods ended September 30, 2021 and 2020 included the effects of derivatives as follows:

    

Three Months

For the Periods Ended September 30

2021

2020

Brazil Real options, net

 

  

 

  

(Income) expense recorded in consolidated statement of operations

$

428

$

(3)

Consolidated statement of operations - total cost of goods sold

$

149,987

$

131,075

(Income) expense recorded in OCI

$

767

$

(376)

Interest rate swaps

 

  

 

  

Expense recorded in consolidated statements of operations

 

868

 

813

Consolidated statement of operations - total interest expense, net

$

2,889

$

2,810

(Income) expense recorded in OCI

$

(738)

$

(713)

We recognize gains and losses related to foreign currency derivatives as a component of cost of goods sold at the time the hedged item is sold. Inventory as of September 30, 2021, included realized net losses of $1,527 related to matured contracts. We anticipate the net losses included in inventory will be recognized in cost of goods sold within the next twelve to eighteen months.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
3 Months Ended
Sep. 30, 2021
Fair Value Measurements  
Fair Value Measurements

9.  Fair Value Measurements

Short-term investments

Our short-term investments consist of cash deposits held at financial institutions. We consider the carrying amounts of these short-term investments to be representative of their fair value.

Current Assets and Liabilities

We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.

Contingent Consideration on Acquisitions

We determine the fair value of contingent consideration on acquisitions based on contractual terms, our current forecast of performance factors related to the acquired business and an applicable discount rate.

Debt

We record debt, including term loans and revolver balances, at amortized cost in our consolidated financial statements. We believe the carrying value of the debt is approximately equal to its fair value, due to the variable nature of the instruments and our evaluation of estimated market prices.

Derivatives

We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.

Non-financial assets

Our non-financial assets, which primarily consist of goodwill, other intangible assets, property and equipment, and lease-related ROU assets, are not required to be measured at fair value on a recurring basis, and instead are reported at carrying value in the consolidated balance sheet. We assess the carrying values of non-financial assets for impairment on a periodic basis or whenever events or changes in circumstances indicate an asset may not be fully recoverable.

Fair Value of Assets (Liabilities)

As of

September 30, 2021

June 30, 2021

    

Level 1

    

Level 2

    

Level 3

    

Level 1

    

Level 2

    

Level 3

Short-term investments

$

56,000

$

$

$

43,000

$

$

Foreign currency derivatives

$

$

(562)

$

$

$

205

$

Interest rate swaps

$

$

(257)

$

$

$

(995)

$

Contingent consideration on acquisitions

$

$

$

(4,840)

$

$

$

(4,840)

There were no transfers between levels during the periods presented. There were no changes in the fair value of the Level 3 liabilities.

The contingent consideration on acquisitions is the minimum amount payable in accordance with the acquisition agreement for Osprey. The contingent consideration of $4,840 was paid in October 2021.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments
3 Months Ended
Sep. 30, 2021
Business Segments  
Business Segments

10.  Business Segments

We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development.

We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, and (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and certain items that we consider to be unusual, non-operational or non-recurring.

The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

    

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net sales

 

 

 

 

 

 

Animal Health

$

141,004

$

128,369

Mineral Nutrition

 

54,432

 

51,440

Performance Products

 

19,229

 

15,385

Total segments

$

214,665

$

195,194

Depreciation and amortization

Animal Health

$

6,420

$

6,521

Mineral Nutrition

 

639

 

649

Performance Products

 

419

 

445

Total segments

$

7,478

$

7,615

Adjusted EBITDA

Animal Health

$

27,637

$

30,101

Mineral Nutrition

 

4,533

 

3,047

Performance Products

 

2,138

 

1,972

Total segments

$

34,308

$

35,120

Reconciliation of income before income taxes to Adjusted EBITDA

Income before income taxes

$

9,595

$

16,509

Interest expense, net

 

2,889

 

2,810

Depreciation and amortization – Total segments

 

7,478

 

7,615

Depreciation and amortization – Corporate

 

376

 

421

Corporate costs

11,842

10,831

Stock-based compensation

 

 

565

Foreign currency (gains) losses, net

 

2,128

 

(3,631)

Adjusted EBITDA – Total segments

$

34,308

$

35,120

September 30, 

    

June 30, 

As of

    

2021

    

2021

Identifiable assets

 

  

 

  

Animal Health

$

579,432

$

595,315

Mineral Nutrition

 

74,218

 

67,338

Performance Products

 

37,111

 

36,847

Total segments

 

690,761

 

699,500

Corporate

 

145,283

 

141,825

Total

$

836,044

$

841,325

The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax related assets and certain other assets.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies and New Accounting Standards (Policies)
3 Months Ended
Sep. 30, 2021
Summary of Significant Accounting Policies and New Accounting Standards  
Net Income per Share and Weighted Average Shares

Net Income per Share and Weighted Average Shares

Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed vesting of restricted stock units. All common share equivalents were included in the calculation of diluted net income per share in the periods included in the consolidated financial statements. There are no outstanding stock option awards or restricted stock units as of September 30, 2021.

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net income

$

6,534

$

12,302

Weighted average number of shares – basic

 

40,504

 

40,454

Dilutive effect of restricted stock units

 

 

50

Weighted average number of shares – diluted

 

40,504

 

40,504

Net income per share

 

 

  

basic

$

0.16

$

0.30

diluted

$

0.16

$

0.30

New Accounting Standards

New Accounting Standards

Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2020-04 and 2021-01, Reference Rate Reform (Topic 848), provide optional expedients and exceptions to GAAP guidance, if certain criteria are met, for contracts, hedging relationships and derivative instruments that reference the London Interbank Offered Rate (LIBOR) and other interbank offered rates expected to be discontinued or modified by rate reform. The overall purpose of Topic 848 is to ease the financial reporting burdens related to the expected market transition to alternative reference rates. These ASUs may be applied prospectively to contract modifications made and hedging relationships entered on or before December 31, 2022. We continue to evaluate the effect of adoption of this guidance on our consolidated financial statements.

ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, removes certain exceptions and amends certain requirements in the existing income tax guidance to ease accounting requirements. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and must be applied on a retrospective basis. The adoption did not have a material effect on our consolidated financial statements.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies and New Accounting Standards (Tables)
3 Months Ended
Sep. 30, 2021
Summary of Significant Accounting Policies and New Accounting Standards  
Schedule of net income per share and weighted average shares

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net income

$

6,534

$

12,302

Weighted average number of shares – basic

 

40,504

 

40,454

Dilutive effect of restricted stock units

 

 

50

Weighted average number of shares – diluted

 

40,504

 

40,504

Net income per share

 

 

  

basic

$

0.16

$

0.30

diluted

$

0.16

$

0.30

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Operations - Additional Information (Tables)
3 Months Ended
Sep. 30, 2021
Statements of Operations - Additional Information  
Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type

Three Months

For the Periods Ended September 30

    

2021

    

2020

Animal Health

 

  

 

  

MFAs and other

$

83,758

$

78,703

Nutritional specialties

 

35,997

 

32,600

Vaccines

 

21,249

 

17,066

Total Animal Health

$

141,004

$

128,369

Mineral Nutrition

 

54,432

 

51,440

Performance Products

 

19,229

 

15,385

Total

$

214,665

$

195,194

Net Sales by Region

Three Months

For the Periods Ended September 30

    

2021

    

2020

United States

$

126,319

$

118,771

Latin America and Canada

 

42,660

 

37,756

Europe, Middle East and Africa

 

30,935

 

26,872

Asia Pacific

 

14,751

 

11,795

Total

$

214,665

$

195,194

Schedule of additional information of statements of operations

Interest Expense and Depreciation and Amortization

Three Months

For the Periods Ended September 30

    

2021

    

2020

Interest expense, net

Term loan

$

2,273

$

1,875

Revolving credit facility

 

599

 

946

Amortization of debt issuance costs

 

148

 

221

Other

 

45

 

67

Interest expense

 

3,065

 

3,109

Interest income

 

(176)

 

(299)

$

2,889

$

2,810

Three Months

For the Periods Ended September 30

    

2021

    

2020

Depreciation and amortization

 

 

  

Depreciation of property, plant and equipment

$

5,714

$

5,831

Amortization of intangible assets

 

2,135

 

2,205

Amortization of other assets

 

5

 

$

7,854

$

8,036

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheets - Additional Information (Tables)
3 Months Ended
Sep. 30, 2021
Balance Sheets - Additional Information  
Schedule of additional information of balance sheets

September 30, 

June 30, 

As of

    

2021

    

2021

Inventories

  

Raw materials

$

72,774

$

59,775

Work-in-process

10,053

12,738

Finished goods

138,486

143,799

$

221,313

$

216,312

    

September 30, 

June 30, 

As of

    

2021

    

2021

Other assets

ROU operating lease assets

$

31,688

 

$

32,962

Deferred income taxes

 

9,446

 

9,861

Deposits

 

5,337

 

5,663

Insurance investments

 

6,054

 

5,964

Equity method investments

 

4,759

 

4,141

Derivative instruments

2,634

2,696

U.S. pension plan

 

1,616

 

1,184

Debt issuance costs

 

1,717

 

1,811

Other

8,529

8,467

$

71,780

 

$

72,749

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

Accrued expenses and other current liabilities

 

  

 

  

Employee related

$

26,553

$

35,375

Current operating lease liabilities

 

6,406

 

6,618

Commissions and rebates

5,230

6,312

Professional fees

 

4,288

 

4,380

Income and other taxes

4,706

6,107

Derivative instruments

3,357

3,486

Contingent consideration

 

4,840

 

4,840

Restructuring costs

 

 

735

Insurance-related

 

1,203

 

1,176

Other

 

17,948

 

17,350

$

74,531

$

86,379

    

September 30, 

    

June 30, 

As of

    

2021

    

2021

Other liabilities

Long-term operating lease liabilities

$

27,150

$

28,003

Long-term and deferred income taxes

 

7,297

6,646

Supplemental retirement benefits, deferred compensation and other

8,506

8,382

International retirement plans

 

5,453

 

5,345

Derivative instruments

95

Other long-term liabilities

 

7,638

 

7,594

$

56,139

$

55,970

September 30, 

    

June 30, 

As of

    

2021

    

2021

Accumulated other comprehensive loss

  

  

Derivative instruments

$

(819)

$

(790)

Foreign currency translation adjustment

 

(107,059)

 

(100,095)

Unrecognized net pension losses

 

(19,856)

 

(19,973)

Benefit for income taxes on derivative instruments

 

104

 

97

Benefit for incomes taxes on long-term intercompany investments

8,166

8,166

Provision for income taxes on net pension losses

(2,727)

(2,698)

$

(122,191)

$

(115,293)

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Debt (Tables)
3 Months Ended
Sep. 30, 2021
Debt  
Schedule of long term debt

    

September 30, 

    

June 30, 

As of

2021

2021

2021 Term A Loan due April 2026

$

296,250

$

298,125

Unamortized debt issuance costs

 

(986)

 

(1,040)

 

295,264

 

297,085

Less: current maturities

 

(11,250)

 

(9,375)

$

284,014

$

287,710

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives (Tables)
3 Months Ended
Sep. 30, 2021
Derivatives  
Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges

September 30, 

June 30, 

As of

    

2021

    

2021

Other assets

 

  

 

  

Brazil Real options, net

$

$

355

Interest rate swaps

 

2,634

 

2,341

Accrued expense and other current liabilities

 

  

 

  

Brazil Real options, net

 

(467)

 

(150)

Interest rate swaps

 

(2,891)

 

(3,336)

Other liabilities

 

  

 

  

Brazil Real options, net

 

(95)

 

Interest rate swaps

 

 

Total Fair Value

 

 

  

Brazil Real options, net

 

(562)

 

205

Interest rate swaps

 

(257)

 

(995)

Notional amounts of the derivatives as of the balance sheet date were:

September 30, 

As of

    

2021

Brazil Real call options

R$

96,000

Brazil Real put options

 

R$

96,000

Interest rate swaps

$

300,000

The consolidated statements of operations and statements of other comprehensive income (“OCI”) for the periods ended September 30, 2021 and 2020 included the effects of derivatives as follows:

    

Three Months

For the Periods Ended September 30

2021

2020

Brazil Real options, net

 

  

 

  

(Income) expense recorded in consolidated statement of operations

$

428

$

(3)

Consolidated statement of operations - total cost of goods sold

$

149,987

$

131,075

(Income) expense recorded in OCI

$

767

$

(376)

Interest rate swaps

 

  

 

  

Expense recorded in consolidated statements of operations

 

868

 

813

Consolidated statement of operations - total interest expense, net

$

2,889

$

2,810

(Income) expense recorded in OCI

$

(738)

$

(713)

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
3 Months Ended
Sep. 30, 2021
Fair Value Measurements  
Schedule of fair value of derivative instruments based upon pricing models

As of

September 30, 2021

June 30, 2021

    

Level 1

    

Level 2

    

Level 3

    

Level 1

    

Level 2

    

Level 3

Short-term investments

$

56,000

$

$

$

43,000

$

$

Foreign currency derivatives

$

$

(562)

$

$

$

205

$

Interest rate swaps

$

$

(257)

$

$

$

(995)

$

Contingent consideration on acquisitions

$

$

$

(4,840)

$

$

$

(4,840)

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments (Tables)
3 Months Ended
Sep. 30, 2021
Business Segments  
Schedule of information regarding reportable segments

    

Three Months

For the Periods Ended September 30

    

2021

    

2020

Net sales

 

 

 

 

 

 

Animal Health

$

141,004

$

128,369

Mineral Nutrition

 

54,432

 

51,440

Performance Products

 

19,229

 

15,385

Total segments

$

214,665

$

195,194

Depreciation and amortization

Animal Health

$

6,420

$

6,521

Mineral Nutrition

 

639

 

649

Performance Products

 

419

 

445

Total segments

$

7,478

$

7,615

Adjusted EBITDA

Animal Health

$

27,637

$

30,101

Mineral Nutrition

 

4,533

 

3,047

Performance Products

 

2,138

 

1,972

Total segments

$

34,308

$

35,120

Reconciliation of income before income taxes to Adjusted EBITDA

Income before income taxes

$

9,595

$

16,509

Interest expense, net

 

2,889

 

2,810

Depreciation and amortization – Total segments

 

7,478

 

7,615

Depreciation and amortization – Corporate

 

376

 

421

Corporate costs

11,842

10,831

Stock-based compensation

 

 

565

Foreign currency (gains) losses, net

 

2,128

 

(3,631)

Adjusted EBITDA – Total segments

$

34,308

$

35,120

September 30, 

    

June 30, 

As of

    

2021

    

2021

Identifiable assets

 

  

 

  

Animal Health

$

579,432

$

595,315

Mineral Nutrition

 

74,218

 

67,338

Performance Products

 

37,111

 

36,847

Total segments

 

690,761

 

699,500

Corporate

 

145,283

 

141,825

Total

$

836,044

$

841,325

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies and New Accounting Standards (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Summary of Significant Accounting Policies and New Accounting Standards    
Net income $ 6,534 $ 12,302
Weighted average number of shares - basic (in shares) 40,504 40,454
Dilutive effect of restricted stock units   50
Weighted average number of shares - diluted (in shares) 40,504 40,504
Net income per share    
basic (in dollars per share) $ 0.16 $ 0.30
diluted (in dollars per share) $ 0.16 $ 0.30
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Operations - Disaggregated Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Statements Of Operations Additional Information [Line Items]    
Total $ 214,665 $ 195,194
United States    
Statements Of Operations Additional Information [Line Items]    
Total 126,319 118,771
Latin America and Canada    
Statements Of Operations Additional Information [Line Items]    
Total 42,660 37,756
Europe, Middle East and Africa    
Statements Of Operations Additional Information [Line Items]    
Total 30,935 26,872
Asia Pacific    
Statements Of Operations Additional Information [Line Items]    
Total 14,751 11,795
Animal Health    
Statements Of Operations Additional Information [Line Items]    
Total 141,004 128,369
Animal Health | MFAs and other    
Statements Of Operations Additional Information [Line Items]    
Total 83,758 78,703
Animal Health | Nutritional Specialties    
Statements Of Operations Additional Information [Line Items]    
Total 35,997 32,600
Animal Health | Vaccines    
Statements Of Operations Additional Information [Line Items]    
Total 21,249 17,066
Mineral Nutrition    
Statements Of Operations Additional Information [Line Items]    
Total 54,432 51,440
Performance Products    
Statements Of Operations Additional Information [Line Items]    
Total $ 19,229 $ 15,385
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Operations - Interest Expense and Depreciation and Amortization (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Interest expense, net    
Amortization of debt issuance costs $ 148 $ 221
Other 45 67
Interest expense 3,065 3,109
Interest income (176) (299)
Interest expense, net 2,889 2,810
Depreciation and amortization    
Depreciation of property, plant and equipment 5,714 5,831
Amortization of intangible assets 2,135 2,205
Amortization of other assets 5  
Depreciation and amortization 7,854 8,036
Term Loan    
Interest expense, net    
Interest expense 2,273 1,875
Revolving credit facility (the "Revolver")    
Interest expense, net    
Interest expense $ 599 $ 946
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Operations - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Statements Of Operations Additional Information [Line Items]    
Deferred revenue $ 3,130 $ 3,674
Current deferred revenue, included in accrued expense and other current liabilities $ 1,396 $ 1,560
Customer    
Statements Of Operations Additional Information [Line Items]    
Average worldwide collection period for accounts receivable 60 days  
Customer | Maximum    
Statements Of Operations Additional Information [Line Items]    
Payment term 120 days  
Customer | Minimum    
Statements Of Operations Additional Information [Line Items]    
Payment term 30 days  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheets - Additional Information - Schedule of inventory (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Jun. 30, 2021
Inventories    
Raw materials $ 72,774 $ 59,775
Work-in-process 10,053 12,738
Finished goods 138,486 143,799
Inventory, net $ 221,313 $ 216,312
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Balance Sheets - Additional Information - Other balance sheet items (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Jun. 30, 2021
Other assets    
ROU operating lease assets $ 31,688 $ 32,962
Deferred income taxes 9,446 9,861
Deposits 5,337 5,663
Insurance investments 6,054 5,964
Derivative instruments 2,634 2,696
U.S. pension plan 1,616 1,184
Equity method investments 4,759 4,141
Debt issuance costs 1,717 1,811
Other 8,529 8,467
Other assets, total 71,780 72,749
Accrued expenses and other current liabilities    
Employee-related 26,553 35,375
Current operating lease liabilities 6,406 6,618
Commissions and rebates 5,230 6,312
Professional fees 4,288 4,380
Income and other taxes 4,706 6,107
Derivative instruments 3,357 3,486
Contingent consideration 4,840 4,840
Restructuring costs 0 735
Insurance-related 1,203 1,176
Other 17,948 17,350
Accrued expenses and other current liabilities, total 74,531 86,379
Other liabilities    
Long-term operating lease liabilities 27,150 28,003
Long-term and deferred income taxes 7,297 6,646
Supplemental retirement benefits, deferred compensation and other 8,506 8,382
International retirement plans 5,453 5,345
Derivative instruments 95  
Other long term liabilities 7,638 7,594
Other liabilities, total 56,139 55,970
Accumulated other comprehensive loss    
Derivative instruments (819) (790)
Foreign currency translation adjustment (107,059) (100,095)
Unrecognized net pension losses (19,856) (19,973)
Benefit for income taxes on derivative instruments 104 97
Benefit for income taxes on long-term intercompany investments 8,166 8,166
Provision for income taxes on net pension losses (2,727) (2,698)
Accumulated other comprehensive loss $ (122,191) $ (115,293)
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Summary of long-term debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Jun. 30, 2021
Debt    
Term A Loan due April 2026 $ 296,250 $ 298,125
Unamortized debt issuance costs (986) (1,040)
Long-term debt after debt issuance costs 295,264 297,085
Less: current maturities (11,250) (9,375)
Long-term debt $ 284,014 $ 287,710
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Jul. 31, 2022
Jun. 30, 2021
Apr. 30, 2021
Sep. 30, 2020
Mar. 31, 2020
Jul. 31, 2017
Debt Instrument [Line Items]              
Revolving credit facility $ 110,000   $ 95,000        
Derivative, Notional Amount   $ 300,000          
Credit Agreement | Revolving credit facility (the "Revolver")              
Debt Instrument [Line Items]              
Revolving credit facility 110,000            
Outstanding letters of credit 2,709            
2021 Credit Agreement | Revolving credit facility (the "Revolver")              
Debt Instrument [Line Items]              
Maximum borrowing capacity       $ 250,000      
Revolving credit facility 110,000            
Outstanding letters of credit 2,709            
Remaining borrowing capacity $ 137,291            
Weighted-average interest rates 1.83%       2.12%    
Percentage of interest rate 1.85%            
2021 Credit Agreement | Term A Loans And Revolving Credit Facility [Member]              
Debt Instrument [Line Items]              
Maturity dates April 2026            
Covenant requirement, permitted leverage ratio a maximum First Lien Net Leverage Ratio of 4.00:1.00 and (ii) a minimum interest coverage ratio of 3.00:1.00, each calculated on a trailing four-quarter basis            
Debt instrument, covenant compliance we were in compliance with the financial covenants            
2021 Credit Agreement | Term A Loans And Revolving Credit Facility [Member] | one-month LIBOR              
Debt Instrument [Line Items]              
Interest rate, description 2.00%, 1.75% or 1.50%            
2021 Credit Agreement | Term A Loans And Revolving Credit Facility [Member] | Eurodollar [Member]              
Debt Instrument [Line Items]              
Interest rate, description 2.00%, 1.75% or 1.50%            
2021 Credit Agreement | Term A Loans And Revolving Credit Facility [Member] | Base Rate              
Debt Instrument [Line Items]              
Interest rate, description 1.00%, 0.75% or 0.50%            
2021 Credit Agreement | Term A Loan              
Debt Instrument [Line Items]              
Aggregate principal amount       $ 300,000      
Weighted-average interest rates 2.98%       3.19%    
Percentage of interest rate 2.98%            
July 2017 Agreement [Member] | Interest Rate Swap              
Debt Instrument [Line Items]              
Percentage of interest rate 1.8325%            
Derivative, Notional Amount $ 150,000           $ 150,000
March 2020 Agreement [Member]              
Debt Instrument [Line Items]              
Derivative, Notional Amount $ 300,000            
March 2020 Agreement [Member] | Interest Rate Swap              
Debt Instrument [Line Items]              
Percentage of interest rate 0.62%            
Derivative, Notional Amount           $ 150,000  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Certain relatives of Jack C. Bendheim | Compensation and benefit for services provided    
Related Party Transaction [Line Items]    
Aggregate compensation and benefits $ 829 $ 532
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Additional Information (Details)
$ in Thousands
3 Months Ended
Sep. 30, 2021
USD ($)
item
Jun. 30, 2021
USD ($)
Commitments And Contingencies [Line Items]    
Number of potentially responsible parties | item 140  
Current And Long Term Liabilities    
Commitments And Contingencies [Line Items]    
Accrual for environmental loss contingencies | $ $ 4,321 $ 4,293
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives - Company's Outstanding Derivatives (Details) - Cash Flow Hedging
R$ in Thousands, $ in Thousands
Sep. 30, 2021
USD ($)
Sep. 30, 2021
BRL (R$)
Jun. 30, 2021
USD ($)
Foreign Exchange Option | Brazilian Real calls      
Derivative [Line Items]      
Notional amount | R$   R$ 96,000  
Asset     $ 205
Liability $ (562)    
Foreign Exchange Option | Brazilian Real calls | Other assets      
Derivative [Line Items]      
Asset     355
Foreign Exchange Option | Brazilian Real calls | Accrued expenses and other current liabilities      
Derivative [Line Items]      
Liability (467)   (150)
Foreign Exchange Option | Brazilian Real calls | Other liabilities      
Derivative [Line Items]      
Liability (95)    
Foreign Exchange Option | Brazilian Real puts      
Derivative [Line Items]      
Notional amount | R$   R$ 96,000  
Swap | Interest Rate Swap      
Derivative [Line Items]      
Notional amount 300,000    
Liability (257)   (995)
Swap | Interest Rate Swap | Other assets      
Derivative [Line Items]      
Asset 2,634   2,341
Swap | Interest Rate Swap | Accrued expenses and other current liabilities      
Derivative [Line Items]      
Liability $ (2,891)   $ (3,336)
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives - Effects of Derivatives (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Derivative [Line Items]    
Consolidated statement of operations - total cost of goods sold $ 149,987 $ 131,075
Consolidated statement of operations - total interest expense, net 2,889 2,810
Foreign Exchange Option | Cash Flow Hedging | Brazilian Real calls    
Derivative [Line Items]    
(Income) expense recorded in consolidated statement of operations 428 (3)
Foreign Exchange Option | Cash Flow Hedging | Brazilian Real calls | Cost of Sales    
Derivative [Line Items]    
Consolidated statement of operations - total cost of goods sold 149,987 131,075
Foreign Exchange Option | Cash Flow Hedging | Brazilian Real calls | Other Comprehensive Income (Loss)    
Derivative [Line Items]    
(Income) expense recorded in OCI 767 (376)
Swap | Interest Rate Swap | Cash Flow Hedging    
Derivative [Line Items]    
(Income) expense recorded in consolidated statement of operations 868 813
Swap | Interest Rate Swap | Cash Flow Hedging | Interest expense, net    
Derivative [Line Items]    
Consolidated statement of operations - total interest expense, net 2,889 2,810
Swap | Interest Rate Swap | Cash Flow Hedging | Other Comprehensive Income (Loss)    
Derivative [Line Items]    
(Income) expense recorded in OCI $ (738) $ (713)
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Derivatives - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Jul. 31, 2022
Mar. 31, 2020
Jul. 31, 2017
Derivative [Line Items]        
Derivative, Notional Amount   $ 300,000    
Maximum maturity period for Foreign Currency Derivatives Feb. 28, 2023      
Cost of Sales        
Derivative [Line Items]        
Realized gains related to matured contracts recorded as a component of inventory $ 1,527      
March 2020 Agreement [Member]        
Derivative [Line Items]        
Derivative, Notional Amount $ 300,000      
March 2020 Agreement [Member] | Interest Rate Swap        
Derivative [Line Items]        
Derivative, Notional Amount     $ 150,000  
Percentage of interest rate 0.62%      
July 2017 Agreement [Member] | Interest Rate Swap        
Derivative [Line Items]        
Derivative, Notional Amount $ 150,000     $ 150,000
Percentage of interest rate       1.8325%
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Level 1    
Fair Value of Assets (Liabilities)    
Short-term investments $ 56,000 $ 43,000
Foreign currency derivatives 0 0
Interest rate swap 0 0
Contingent consideration on acquisitions 0 0
Level 2    
Fair Value of Assets (Liabilities)    
Short-term investments 0 0
Foreign currency derivatives (562) 205
Interest rate swap (257) (995)
Contingent consideration on acquisitions 0 0
Level 3    
Fair Value of Assets (Liabilities)    
Short-term investments 0 0
Foreign currency derivatives 0 0
Interest rate swap 0 0
Contingent consideration on acquisitions $ (4,840) $ (4,840)
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Oct. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Fair Value Measurements      
Fair value assets, transfer from level 1 to level 2   $ 0 $ 0
Fair value assets, transfer from level 2 to level 1   0 0
Fair value liabilities, transfer from level 1 to level 2   0 0
Fair value liabilities, transfer from level 2 to level 1   0 0
Fair value assets, transfer to and from level 3   0 0
Fair value liabilities, transfer to and from level 3   0 $ 0
Contingent consideration $ 4,840    
Change in fair value   $ 0  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments - Segments in Significant Accounting Policies (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Segment Reporting Information      
Net sales $ 214,665 $ 195,194  
Depreciation and amortization 7,854 8,036  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 9,595 16,509  
Interest expense, net 2,889 2,810  
Depreciation and amortization 7,854 8,036  
Stock-based compensation 0 565  
Foreign currency (gains) losses, net 2,128 (3,631)  
Identifiable assets 836,044   $ 841,325
Animal Health      
Segment Reporting Information      
Net sales 141,004 128,369  
Mineral Nutrition      
Segment Reporting Information      
Net sales 54,432 51,440  
Performance Products      
Segment Reporting Information      
Net sales 19,229 15,385  
Operating Segments      
Segment Reporting Information      
Net sales 214,665 195,194  
Depreciation and amortization 7,478 7,615  
Adjusted EBITDA 34,308 35,120  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 9,595 16,509  
Interest expense, net 2,889 2,810  
Depreciation and amortization 7,478 7,615  
Corporate costs 11,842 10,831  
Stock-based compensation   565  
Foreign currency (gains) losses, net 2,128 (3,631)  
Adjusted EBITDA - Total segments 34,308 35,120  
Identifiable assets 690,761   699,500
Operating Segments | Animal Health      
Segment Reporting Information      
Net sales 141,004 128,369  
Depreciation and amortization 6,420 6,521  
Adjusted EBITDA 27,637 30,101  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 6,420 6,521  
Adjusted EBITDA - Total segments 27,637 30,101  
Identifiable assets 579,432   595,315
Operating Segments | Mineral Nutrition      
Segment Reporting Information      
Net sales 54,432 51,440  
Depreciation and amortization 639 649  
Adjusted EBITDA 4,533 3,047  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 639 649  
Adjusted EBITDA - Total segments 4,533 3,047  
Identifiable assets 74,218   67,338
Operating Segments | Performance Products      
Segment Reporting Information      
Net sales 19,229 15,385  
Depreciation and amortization 419 445  
Adjusted EBITDA 2,138 1,972  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 419 445  
Adjusted EBITDA - Total segments 2,138 1,972  
Identifiable assets 37,111   36,847
Corporate      
Segment Reporting Information      
Depreciation and amortization 376 421  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 376 $ 421  
Identifiable assets $ 145,283   $ 141,825
EXCEL 54 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

0,6DH'W!X_9__L MO9.7!3,X4^('SVP^"CX$D.&25<+>J,T7;/ST7+Y4">.?L&EBHP#2REA5-&!2 M4'!9O]E#4X*C5!K2+IFQNX&OC MT>2&2W>*J*+BE8[$&F,Q@IJ3EXD/ MR4SK*'YV-(T/)IQC>0I)] [B*.[5/RGY<4#AK+N'[%M5+%"#6D*I+%%R)L0C73]3 M*KJ)"X%0,FT=\1/LJ=*T9NAY!M<5UN-.-QJ&ZQVR>JVLWD%9LTIK4N/]7RJY M@EO4!5QRMN"".SD'K/=;CO[_K_.@)1L<-#1)4UW1):$K BC77"OIF&E%*&,@ M?<']!$>[ZEPS]+?JW$WB3EOH^I/=$11_3%Z=1KC5$ K4*]\GG8I*VKHWM*MM M*Y[X#A3^#:_[^!73*RX-"%P2-#H=T,'JNC?6$ZM*WUX6RE*S\L.H70#M M+Q5]>,W$$;0_J/$?4$L#!!0 ( .^#8E.&PO M=V]R:W-H965T,?;U[N+D'!=:&*2 JB3CIW(\_"1.@#JAIR[T8)':_77V[?$*>[1G_ M+"( B1[2)!-S*Y(R?V/;(H@@I>*F4)C9Q'-]. M:9Q9BUDY=\L7,U;(),[@EB-1I"GECTM(V'YN8>MI8AWO(JDG[,4LISO8@/R4 MWW(ULFN4,$XA$S'+$(?MW+K ;U9DHAU*BS]CV(O6/=)+N6/LLQY+N:,"+EGR5QS*:&Y-+!3" MEA:)7+/]>Z@6Y&F\@"6B_$7[RM:Q4% (R=+*6660QMGA2A\J(EH.!/W-O MT44DB:A7&V0VV;TQ5(&B?BE;:F(D+O M5.>@]Q#NM.7Z!,49^B-BA5"^XC7Z=CRSI4I9![:#*KWE(3W2D]X&\G/D.J\1 M<0C^M%FATY-7'2B7/X"R7%^CTW4GS,H,\Z'(OI.,K=BO2T#J$I 2=M0#J_I7 M=6>&WCX$$Q?&.LZYC>J6K)QZXV]Y_%._-\ MTAUP7 <<#]@X:OI&1L 1U9R8^FA2QY\,W$?3&GGZRPPI[34YE&J+#[?W3X"\EO5 V/AB:_$2AL5B@S^=YS M6J=]_=[H%#8+U8M9S0NC3N!&J/!X: (;$<*30?:<"N87-AW?+-U72J T96FU(HS;DY[Z'EN2YTA#? M'1W3VV'ECG /O8T@$;,@F>@=;*\EC5J1H=6*-&I%S&IE[O')\Z]$,IGBXRIT MF+FNZQ^5P6Z="O49_B/EZI F4 );Y>>%8?!A(EI<'Q3LFU;&SO(V MAL"U@7J^94P^#?39L_YS8O$?4$L#!!0 ( .^#8E,%]A6TY@, #(0 9 M >&PO=V]R:W-H965TMX=A#XQT;0F52(^DXVS8C]^E)$N*+2LMYG8OED3>#YY[ MQ"->CW=2?=4Q@"'/62KTQ(F-V;QS71W&D'%]+3<@<&8E5<8-/JJUJS<*>)0[ M9:G+/&_@9CP1SG2X9-;18F2#(1.I" *5A/G/7TW9[YUR"U^36"G&_?$0GF4\JM] M6$03Q[,K@A1"8T-PO#S!'-+41L)U_%D&=:J/8!ZYAKE,?TLB M$T^>7<8F4YK!MN^'2LY(XH:XW1[$U>F]P;T23"TK@T M"F<3]#/3&U#)$[>EU.2*W*Y66%Y-Y(HT)RYNP/ DU9=H\F5Y0R[>7)(W)!'D MEUAN-1>1'KL&%V-#NF&9>%8D9B<2^^2S%";6Y%9$$+WT=Q%$A83MD2)ER0![!T\335'>](4"TB.//;-ZPB#SOA72Q$*#.X MW!. 6AY*A5O8ZD'X#52VD34\XJ''A@=<'=M<^>U,C2HHHQ_,E#4M-]B2I]#% M'/5J1?;.S!UMJ#W]V=I19NR_)AYM=AWJ05F-B?UX&N],# K)S/ P%-M3"E:_ M>-/)Q2>I]657^>MO CWW1X'67P7:_5GHW)AW\T4K=[TC3H+!$7''1E=^,#A! M6ZWZM%OVESN^P<(O]H+^@"\C*0>/B.NJ4"W,='#NZM=Z2X.?+XMESF;EAX-# M76PSHB>4D=8J3[ME_KO8:1J>_BZ_7$DMTG1T9M98+;7,^Q^.'F725\X>K5:G M#A^L5GC6K?#?2]Q_$3Y6:S1CYR:Q%E7FGUWXRI#-H^Q5X!]NK5:KH[WE-KJO M#-0Z;THU;OJM,$7[4HU6C>_[O-T[&)]A0URTKW68HIO^S!72I4D**PSI70?X MUJBB02T>C-SD/=ZC--@QYK;H/J;8/HO4$L#!!0 ( M .^#8E.#MS?=J , #$- 9 >&PO=V]R:W-H965T^*B2PQ(+RS ^#8.CG+.7>=&S'[N5T+$J=I1SN)5%EGC-Y MN(9,["<>]9X&'M+-5IL!?SHNV :6H#\5]Q)[?L.2I#EPE0I.)*PGWHQ^N*%7 M!F!7_)'"7AVUB7%E)<07T[E-)EY@+((,8FTH&/[L8 Y99IC0CK]K4J_9TP"/ MVT_L'ZWSZ,R**9B+[,\TT=N)-_)( FM69OI!['^&VJ&!X8M%INQ_LJ_7!AZ) M2Z5%7H/1@CSEU2][K -Q!*##%P!A#0B_!O1? $0U('HMH%\#^J\%#&J ==VO M?+>!6S#-IF,I]D2:UH]+/BT7Y-W;]^0M23GY?2M*Q7BBQKY&8PRE']<; M7U<;AR]L')$[P?56D1N>0/(<[Z,3C2?ADR?7H9-P"46/1,$%"8.0=M@S=\-_ M*3.$4PL/.^ +-_R.R08>=,!O7KT[O70$(VK2&EF^Z&1:R>=?<8[<:LC57P[F M?L/O-9"PD'F3"%&$XGA>" [>.IGR'+2$/7=$??5,? M=!!>=E?'56/WU8GJD/'6'D0RVTB W!CR^0[R%4A77&C0BF9PYIC3(T&F9SQ@ MUS7;:T\8#5L[PO\?1?(O7A :)& M/V!5D.6>%2[W6^&BYU8NVDH7/:=V+>BW MXD4'CM"VZD7=HG(/,L9HXD.L.A]U("4&LC/%;K:@-PQ_=,6G52;JEB:\A0[V M!CI'QEO]HN<6,-HJ&'5+V/<>IBXY>I;QZC(_O>ZYO:UR4;=T?5]EW)Q@H[U1 M% XZ:\,_>C+F(#?VK:Y0N#$RU>NQ&6V^!V;V%>RWRZN/"12*C;D?,E@C-.A= M8KG*ZGU>=;0H[ -T)30^9VUSB]\T(,T"G%\+H9\Z9H/F*VGZ'U!+ P04 M" #O@V)3M8@/=W # ;#@ &0 'AL+W=OU#*ZU-XA N$R"U=-,VM5)5UNVS@0.QEMC,=J#]][.= M-!<*II7*%XB3VG?W8CSDN4HI@WN!9)YE1#Q?0\JW M(R_T7EX\T%6BS M_/%R3%4Q!/:[OA6[YEJ@>^_0[E@&*C-^>IM+]H6\3& P_-I\3="!?I-TAS0'1"9"]!KI"0ZNP%%:"K/T05Z MG-Z@LT_GZ!.B#/U*>"X)6\BAKW3_1L6?EWU=%WWA WU%Z(XSE4CTE2U@L2=_ MXLX/L4/ UP.O1H]?1G^-G8I36%^B*/B,<(##?4#N])\Y.Y3>PHFJQ8BL7N> MWBUL($4NI4ZEU+%*T?%EY4MT)268-;VE9$93JBC(>Q%+=3B!L0NIBNBA=BK$'M.Q!],SZ&>/B2( B2W9+T/ MK'<4S!71 NM78'TGV$17&V4KO:IHSK5SZZDCUGRM__[+J:2FN7<>^T=Q71$M MW$&%.WA#^6#'S@Z#VA:#TQ50V'#?\(-*J!1R3:@SI V(:T#\H>53RC49+N(N MWB5]'86#^ !K[9ZAVS[?5D>E2(L0Q[U=PCU1@\$AQ-J6P\[)*JJ4=NX 5T@; MN3;YT.WR155%KNU>>W'8/6%5U7X:N@WU'55UW%6=(6W VE=#M[&^NZJ.NZDS MI(U9^VGH-M0W%M3@.)PKI'URJQT:!R=2XZ/0[N]A'PPITOW'\SD"L M[*U$:JJ(D7KVM;CY7]KSOU^'%M>F.B!5E$J6PU*G!94]/F2AN(D5#\;4] MS,^XTE<#^YCHVQL($Z"_+SE7+PW3074?'/\'4$L#!!0 ( .^#8E.GTR)\ M]0( +H* 9 >&PO=V]R:W-H965T187O 5,/TFY2+'2D_%TI]L$#66;*// G MHQ5>PAS4X^I>Z)E?>TE(#DP2SI" =.Q=A9>ST JLQ1.!C=P9(Q/*,^O:82[XZWW&QN\#N892YAR^H,D*AM[ M P\ED.*"J@>^^0)50%WC;\&IM+]H4]D&'EH44O&\$FN"G+#R'[]6B=@1:#_- M@J@21,<*XDH0_RGH'1!T*D''9J8,Q>9AAA6>C 3?(&&LM3,"T W0&6A0"]J4JB3^@J28C9&DS1+2L/F-FHTQDH3*@\ MTR:/\QDZ/3E#)X@P]#WCA<0LD2-?:3#CWE]4$-NZX/*^M9RPE*'F.E,!,IB!0*GB. M**R!HA I7@VCIFR6B_3L(N:F6T^"D;_>39C+8H^\6Y-W/X(\>B-O/ ?E(ET' MN.):<$/Q.J/W-X9^)[K?@NBSW\?HW?_S#\MNSW6_%=%GOX@QI_ M\.YSHV'U!;H;0-Q$/6BE=EGL40]KZN'_)?U(]&$K^O#8#S4,WDI&%$V2N5$ M\95M'9ZYTHV('6:ZN01A#/3[E'.UG9@%ZG9U\AM02P,$% @ [X-B4SD MQSY3!P $2H !D !X;"]W;W)K&ULQ9IM;]LV M$,>_"F'T10LTM?@HJ4@")'&'9D"[H&FWUXK,V%IET9/HIAWVX4?)BNF(1\9. M8_1-(LEWU)\\\7FQ6NFRJ.15C9K58I'5 M/\YEJ>Y.1GAT?^%3,9OK]L+X]'B9S>2UU%^65[4Y&V]:F18+636%JE M;T]& M9_CM1"2M0V?Q9R'OFJUCU';E1JFO[I/ZNZ][#O$ MV_9R53;=7W37VT8CE*\:K1:]LU&P**KU_^Q[/Q!;#J8=V('T#F3HP#P.M'>@ MNSJPWH%U([/N2C<.DTQGI\>UND-U:VU::P^ZP>R\3?>+JHW[M:[-KX7QTZ?G MJ\9<:1IT+63J3. MBK)Y9?R^7$_0RQ>OT(O6\?-J5TX4'?9)+57?1N*S6 # 3*= ^V[3/NO:9I_V/AC9-5DHPW9,0)9P.MKE$240$K%1NE(ABC3S)755Z4O59U:Z9$KA82W4@3 M*GE_IK/O9@YIAYK)&O424U)#%Q[DZ2)!U(A(QP!"M,-PK3 MYWWJTEV>.M?(_]3AR-(\"FJ]UBK_>M0FPBDR$6]'U"NS;VI;0C00"9CPK;G^ M4.16RL%!D29AFW1K7**K6DU7^7 Z/:ST+ %)=)!A)19?)(ROX+ 2ESXX)628 MIR S3A//Y"<64B0,J3^6YDGM>GU?Q(>Z;)E"#E-R$LL8\A-%9^_[$/Q U0G8 MA)AJH*L!/8]!)97),RK8#'9ZQ/.G2FCD2,0,..8>&8_ ML>PC8?8=KCPFEH[DL<)SGP*9N!P$*F3 *E B$TM+$J;ESD4R<'B<^]90MWR$I@ED)5WEE"+<1K&^(6J#-_M(I0Y8!2IU:G,)#>>2 M 2W0$?JLM*G?&C E]HK=U $!$3+S Y':!$/#"6;'EPOJ)@R11F8V#%XN0+N4 M1SZ=-K70<&IQZPOT']KUC8/:_$ /4QM32W_Z$[4Q!3 .O7% =H$W#FIY3Y]Y MR8&Z1!>,#%_G(2M.//.-6>ZS,/=WJ#>8RW 2"QH/EPU=,QKAR*?0LI[A7U1O M,$MS%J;YWC%E+M*!F$)6_IA:\K-'5A&>P% &4!\*LFL6"O+6LG48^SLRE+D( MYW'JO/E.(+N44U_AP2SK69CU($/W66-@%M F8@I33PJ+>-YF/$@._=<2^1;GQOY0?#)+:!Y MN)X.XI.[JR_06B)DYE]+Y!;M/(SV_:>;RW&&';6 $?-IM:CG8=3O@$\.?!O$ M=/B"!UCA-"8>?1;O//U%^!06X>*9EV>$6XV[\82,?/$4%O4BC/JGX%- GP>= M -6_@ +RWOQ+%\'!0#O&./A^SMD)A(?Y(6%O A#?K/F%7J@+(S%8;X+"@M@ M\N86L9]V>PP9U.]O6.\HV5S?[&L^Z MW7R#Z^?X[<5Z=Z)M9KU9\D-6SXJJ0:6\-4U&;V(SO/5Z_^'Z1*MEMR/O1FFM M%MWA7&936;<&YO=;I?3]27N#S2[0T_\!4$L#!!0 ( .^#8E,V!W[.$ , M #$1 - >&POWW./[XX:9=KH-:?7 M2TJUMZJX:%)_J77]*0B:Q9)6I#F3-14&*:2JB#93509-K2C)&W"J># >C>*@ M(DSXLZEHJ\M*-]Y"MD*G?C28/'O[FJ=^&'_P/4N7R9RF_NWIVU^MU!=O/'L_ M>7]R,KI]=W%H/^V =W[@)#U_!.G9".+S\ -C,0R#@?!(Y]:YA-:Z(U5>+23+K%G?$!Y/7CFW5M%):*K,/Q MN;]UZ&XFR%RJG*HA3.AO3+,IIP7(4:QY=V]"1>KV9W4G]IS79$ M-X=VH5>*%FS5S5?%( !C#W%V4M=\_9FS4E34;O[1 6=3LO'SEE*Q>Q,-6F5A M#%3YWAU5FBUV+;\5J6_H2F_::57@FL>O4/._S7-)!56$[XHVO?^2L_QDQ='' MYY+<_5N#58/WA]2_P>\ MK_!M4&_>,JZ9Z&=+EN=4/#C>#+TF<_,^N,=OUN>T("W7-P.8^MOQ=YJSMDJ& M55>0B'[5=OP-MA?&P\N+B<5$3EPN-X+Y6,R- M (;%P11@/M8+B_,_[6>"[L=BF+:)$YF@/A/4QWJYD*S[8''94D&%YBV/XNMDP;>"!Q8%(?Y=KO-IXAQSO ZRFQSH$VRG>B=A.\5P# MXLX;>"2)N]I8'/# JH#U#L1WQX&>CNT3A&LA/# MQUT?["F)HB1Q(X"Y%401AL#3B".8 M" (5'4G8,'YU&P.:>"[8\DLS]02P,$ M% @ [X-B4Y>*NQS $P( L !?3T\$MP>:4#M.*2V MBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YV MX$G1H2)8%II%R=.B':5_'LD&\V+&)[VXN848AOGL\'O>W:^OBG]8Z_4#_)/*:29!4=K3[?CLO75];/88WRK+,"V[?9T'S6;" E%SRDO]D^2R8!,0G16G->2.[DU38NG^F3J067 S<1T67!O;M&CZIX[QE;G& M[5UEU3T7ENF$6O:W5M6)RT/=C1O%& RCF8?NVD[BK?X_TZB*@F=1,U(#2'/G)!$32DLV"K@FA,B=+:=TDD95LNW)MZY&Z1Z_R=M36X8(YU+?< M5>A5WH#[@UQLUNGF<97,=\N$I#MW>5JN=RG9W)/-=OD,(",$,AH,KB?>IX^ ,@;!/)F M.,B'^1I ?D(@/PT(^3T"D)\1R,]^(1-F,LU/=3E1!;FK#)?,& #W!8'[XA M]S!1T7@VS1T55&:,-.;NX.I65-1:A)B8:D+/KDG8WD(6S"BA9Z4\UX4L)UNJ M7>ZPTU0:VF1D<(&$F%)"WTY19KTYR%2_)$,#--%Z-D7 M:$CN22W$Q!$.:8[O,8@URYC:A@YD\( MA2DD\JP0$/M^RX;)(_(LCPM!L..$F)@^(L_Z. N&OYU(S":19YO@X68*,3&K M1)ZM@H2;A!NX 8TPQT2^'7,9I+>]HVO:XWRT4EQ,*5;>2CHGGWQJQ[V_?M7U!+ P04 " #O@V)3 MOLLS09D! !U&0 &@ 'AL+U]R96QS+W=O^/6__9;+]K?XY_#'8_37<*I?+;-NO9/,I0Y2"-+T009!ECXHAZ \?= 8 M@L;I@R80-$D?-(6@:?J@&03-T@?-(6B>/DA&*..((*F'-8'6@EP+@=>"8 N! MV()D"X'9@F@+@=J"; N!VX)P"X'<@G0+@=V"> N!WHIZ*X'>BGHK@=[:>]DF MT%M1;R706U%O)=!;46\ET%M1;R706U%O)=!;46\ET%M1;R70VU!O(]#;4&\C MT-M0;R/0VWH?2PCT-M3;"/0VU-L(]#;4VPCT-M3;"/0VU-L(]#;4VPCTSE'O MG$#O'/7."?3.4>_\G7J'>*U\>/8\UGC_=U(=;]?ZY^WOR\=F[[G<<7;PEV7U M"U!+ P04 " #O@V)3(]5N#:@! "X&0 $P %M#;VYT96YT7U1Y<&5S M72YX;6S-F60U_ 338D(HDMVU!X^SKA1VI% MHR(J=2ZQ$N_.C+W2=\GT;6?(#;9UU;A95'AO'AAS:4&U-Z&SZ[4S2RR5+EH\+@O;+UF MD3*F*E/EPS[;--DWE]'!(0Z=78TK2N.&H2!B9QW:G9\-#GVO&[*VS&BP4-:_ MJ#I4L6W%G-]5Y.)^B3,9=9Z7*64Z7=>A)7;&DLI<0>3K*MZ+#ON=?;AAVC_Y MU?Z=3)]AJ%Q8;5R8F*7+[8XC:;M')@B1]67_$4^.0?KJ\U$[[8RR7WJ'Z_W0 M=M7-P[%NN?Z.O\[XI']A#@&20X+D2$!RW(#DF(#DN 7)<0>2XQXD!Q^C!$$A M*D=!*D=A*D>!*D>A*D?!*D?A*D&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( M .^#8E-FRE"KVP4 ) 8 8 " @0P( !X;"]W;W)K*G12T$ !V#@ & M @($=#@ >&PO=V]R:W-H965T&UL4$L! A0# M% @ [X-B4Z5/\R,V P -@D !@ ("!@!( 'AL+W=O MP5 !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ [X-B4R=^()%A M!@ !D !@ ("!A1\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ [X-B4VVHD]])!P JA$ !@ M ("!*2T 'AL+W=O&UL4$L! A0#% @ [X-B4UF6?(?G"@ H1T !D M ("!^3H 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ [X-B4T\-J>?7 @ ( 8 !D ("! M%E, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ [X-B4R UJ^Q!0 A \ !D ("!TFH 'AL+W=O)%T04 /8/ 9 " @3!W !X M;"]W;W)K&UL4$L! A0#% @ [X-B4WYSZ.:V M @ 4P< !D ("!.'T 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ [X-B4^@',JU] @ N@4 !D M ("!EHH 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ [X-B4P">^,HH! %PP !D ("!C)0 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M[X-B4[UQB B\ P 9 T !D ("!P: 'AL+W=O&PO=V]R:W-H965T 9 " @3ZT !X;"]W;W)K&UL4$L! A0#% @ [X-B4_LBQ%]^ @ UP4 !D M ("!P[H 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ [X-B4P7V%;3F P ,A !D ("!:\0 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ [X-B M4Z?3(GSU @ N@H !D ("!#M 'AL+W=O&PO=V]R:W-H965T'B !X;"]?7!E&UL4$L%!@ R - #( E0T (OF $! end XML 55 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 56 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 141 286 1 false 51 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.pahc.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 2 false false R3.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 00300 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.pahc.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 00305 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) Sheet http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals CONSOLIDATED BALANCE SHEETS (Parentheticals) Statements 5 false false R6.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00500 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 00505 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) Sheet http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) Statements 8 false false R9.htm 10101 - Disclosure - Description of Business Sheet http://www.pahc.com/role/DisclosureDescriptionOfBusiness Description of Business Notes 9 false false R10.htm 10201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards Summary of Significant Accounting Policies and New Accounting Standards Notes 10 false false R11.htm 10301 - Disclosure - Statements of Operations - Additional Information Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation Statements of Operations - Additional Information Notes 11 false false R12.htm 10401 - Disclosure - Balance Sheets - Additional Information Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation Balance Sheets - Additional Information Notes 12 false false R13.htm 10501 - Disclosure - Debt Sheet http://www.pahc.com/role/DisclosureDebt Debt Notes 13 false false R14.htm 10601 - Disclosure - Related Party Transactions Sheet http://www.pahc.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 10701 - Disclosure - Commitments and Contingencies Sheet http://www.pahc.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 10801 - Disclosure - Derivatives Sheet http://www.pahc.com/role/DisclosureDerivatives Derivatives Notes 16 false false R17.htm 10901 - Disclosure - Fair Value Measurements Sheet http://www.pahc.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 11001 - Disclosure - Business Segments Sheet http://www.pahc.com/role/DisclosureBusinessSegments Business Segments Notes 18 false false R19.htm 20202 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies Summary of Significant Accounting Policies and New Accounting Standards (Policies) Policies http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 19 false false R20.htm 30203 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables Summary of Significant Accounting Policies and New Accounting Standards (Tables) Tables http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 20 false false R21.htm 30303 - Disclosure - Statements of Operations - Additional Information (Tables) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables Statements of Operations - Additional Information (Tables) Tables http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation 21 false false R22.htm 30403 - Disclosure - Balance Sheets - Additional Information (Tables) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables Balance Sheets - Additional Information (Tables) Tables http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation 22 false false R23.htm 30503 - Disclosure - Debt (Tables) Sheet http://www.pahc.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.pahc.com/role/DisclosureDebt 23 false false R24.htm 30803 - Disclosure - Derivatives (Tables) Sheet http://www.pahc.com/role/DisclosureDerivativesTables Derivatives (Tables) Tables http://www.pahc.com/role/DisclosureDerivatives 24 false false R25.htm 30903 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pahc.com/role/DisclosureFairValueMeasurements 25 false false R26.htm 31003 - Disclosure - Business Segments (Tables) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsTables Business Segments (Tables) Tables http://www.pahc.com/role/DisclosureBusinessSegments 26 false false R27.htm 40201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) Sheet http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails Summary of Significant Accounting Policies and New Accounting Standards (Details) Details http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables 27 false false R28.htm 40301 - Disclosure - Statements of Operations - Disaggregated Revenue (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails Statements of Operations - Disaggregated Revenue (Details) Details 28 false false R29.htm 40302 - Disclosure - Statements of Operations - Interest Expense and Depreciation and Amortization (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails Statements of Operations - Interest Expense and Depreciation and Amortization (Details) Details 29 false false R30.htm 40303 - Disclosure - Statements of Operations - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails Statements of Operations - Additional Information (Details) Details http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables 30 false false R31.htm 40401 - Disclosure - Balance Sheets - Additional Information - Schedule of inventory (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails Balance Sheets - Additional Information - Schedule of inventory (Details) Details 31 false false R32.htm 40402 - Disclosure - Balance Sheets - Additional Information - Other balance sheet items (Details) Sheet http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails Balance Sheets - Additional Information - Other balance sheet items (Details) Details 32 false false R33.htm 40501 - Disclosure - Debt - Summary of long-term debt (Details) Sheet http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails Debt - Summary of long-term debt (Details) Details 33 false false R34.htm 40502 - Disclosure - Debt - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails Debt - Additional Information (Details) Details 34 false false R35.htm 40601 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 35 false false R36.htm 40701 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 36 false false R37.htm 40801 - Disclosure - Derivatives - Company's Outstanding Derivatives (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails Derivatives - Company's Outstanding Derivatives (Details) Details 37 false false R38.htm 40802 - Disclosure - Derivatives - Effects of Derivatives (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails Derivatives - Effects of Derivatives (Details) Details 38 false false R39.htm 40803 - Disclosure - Derivatives - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails Derivatives - Additional Information (Details) Details 39 false false R40.htm 40901 - Disclosure - Fair Value Measurements (Details) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.pahc.com/role/DisclosureFairValueMeasurementsTables 40 false false R41.htm 40902 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 41 false false R42.htm 41001 - Disclosure - Business Segments - Segments in Significant Accounting Policies (Details) Sheet http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails Business Segments - Segments in Significant Accounting Policies (Details) Details 42 false false All Reports Book All Reports pahc-20210930x10q.htm pahc-20210930.xsd pahc-20210930_cal.xml pahc-20210930_def.xml pahc-20210930_lab.xml pahc-20210930_pre.xml pahc-20210930xex31d1.htm pahc-20210930xex31d2.htm pahc-20210930xex32d1.htm pahc-20210930xex32d2.htm http://xbrl.sec.gov/dei/2021 http://xbrl.sec.gov/country/2021 http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 true true JSON 60 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "pahc-20210930x10q.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 141, "dts": { "calculationLink": { "local": [ "pahc-20210930_cal.xml" ] }, "definitionLink": { "local": [ "pahc-20210930_def.xml" ] }, "inline": { "local": [ "pahc-20210930x10q.htm" ] }, "labelLink": { "local": [ "pahc-20210930_lab.xml" ] }, "presentationLink": { "local": [ "pahc-20210930_pre.xml" ] }, "schema": { "local": [ "pahc-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 368, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 26, "http://xbrl.sec.gov/dei/2021": 6, "total": 32 }, "keyCustom": 18, "keyStandard": 268, "memberCustom": 19, "memberStandard": 31, "nsprefix": "pahc", "nsuri": "http://www.pahc.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards", "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Statements of Operations - Additional Information", "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation", "shortName": "Statements of Operations - Additional Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Balance Sheets - Additional Information", "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation", "shortName": "Balance Sheets - Additional Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Debt", "role": "http://www.pahc.com/role/DisclosureDebt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Related Party Transactions", "role": "http://www.pahc.com/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Commitments and Contingencies", "role": "http://www.pahc.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Derivatives", "role": "http://www.pahc.com/role/DisclosureDerivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Fair Value Measurements", "role": "http://www.pahc.com/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Business Segments", "role": "http://www.pahc.com/role/DisclosureBusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies)", "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerSharePolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables)", "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Statements of Operations - Additional Information (Tables)", "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables", "shortName": "Statements of Operations - Additional Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "pahc:ScheduleOfAdditionalInformationOfBalanceSheetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - Balance Sheets - Additional Information (Tables)", "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables", "shortName": "Balance Sheets - Additional Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "pahc:ScheduleOfAdditionalInformationOfBalanceSheetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - Debt (Tables)", "role": "http://www.pahc.com/role/DisclosureDebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Derivatives (Tables)", "role": "http://www.pahc.com/role/DisclosureDerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - Business Segments (Tables)", "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details)", "role": "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "shortName": "Summary of Significant Accounting Policies and New Accounting Standards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2020_To_9_30_2020_poEsSV6NfUSU2S3tlyanUw", "decimals": "-3", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_qCVPFxi4j0a2zeg5BQ2xMg", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Statements of Operations - Disaggregated Revenue (Details)", "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails", "shortName": "Statements of Operations - Disaggregated Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_StatementGeographicalAxis_country_US_y94py84bT0mWFPOtM5DuSg", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Statements of Operations - Interest Expense and Depreciation and Amortization (Details)", "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails", "shortName": "Statements of Operations - Interest Expense and Depreciation and Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "pahc:ScheduleOfAdditionalInformationOfStatementsOfOperationsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "lang": null, "name": "us-gaap:InterestExpenseOther", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - Statements of Operations - Additional Information (Details)", "role": "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails", "shortName": "Statements of Operations - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "pahc:ScheduleOfAdditionalInformationOfBalanceSheetsTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Balance Sheets - Additional Information - Schedule of inventory (Details)", "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails", "shortName": "Balance Sheets - Additional Information - Schedule of inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "pahc:ScheduleOfAdditionalInformationOfBalanceSheetsTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - Balance Sheets - Additional Information - Other balance sheet items (Details)", "role": "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "shortName": "Balance Sheets - Additional Information - Other balance sheet items (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Debt - Summary of long-term debt (Details)", "role": "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails", "shortName": "Debt - Summary of long-term debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermLineOfCredit", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - Debt - Additional Information (Details)", "role": "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "shortName": "Debt - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermLineOfCredit", "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_TypeOfArrangementAxis_pahc_CreditAgreementMember_5KN95kXQeEe1lzrKDiPxUA", "decimals": "-3", "lang": null, "name": "us-gaap:LongTermLineOfCredit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_pahc_CompensationAndBenefitForServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_M_StxxHgNU-H-fd8AggZjA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Related Party Transactions - Additional Information (Details)", "role": "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related Party Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_RelatedPartyTransactionAxis_pahc_CompensationAndBenefitForServicesMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_M_StxxHgNU-H-fd8AggZjA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "INF", "first": true, "lang": null, "name": "pahc:NumberOfPotentiallyResponsibleParties", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_WvjGU5MsHUmwQdvBcZ-4wA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "role": "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "INF", "first": true, "lang": null, "name": "pahc:NumberOfPotentiallyResponsibleParties", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_WvjGU5MsHUmwQdvBcZ-4wA", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_PositionAxis_us-gaap_LongMember_kzoJa-HtXUKAwv4t3CZ4UQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeAssetNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_BRL_-yaIcaoV8EmVryfUNS3Xyw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Derivatives - Company's Outstanding Derivatives (Details)", "role": "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "shortName": "Derivatives - Company's Outstanding Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_PositionAxis_us-gaap_LongMember_kzoJa-HtXUKAwv4t3CZ4UQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeAssetNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_BRL_-yaIcaoV8EmVryfUNS3Xyw", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - Derivatives - Effects of Derivatives (Details)", "role": "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "shortName": "Derivatives - Effects of Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeOptionMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_PositionAxis_us-gaap_LongMember_38s2E3sJfUePVjfVMOFORg", "decimals": "-3", "lang": null, "name": "us-gaap:GainLossOnSaleOfDerivatives", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_7_31_2022_Wd63BVa9YkStTIsVF0pIMw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40803 - Disclosure - Derivatives - Additional Information (Details)", "role": "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "shortName": "Derivatives - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_onv2A3Ro_EukTwU1lIEqHw", "decimals": "-3", "lang": null, "name": "pahc:RealizedGainLossOnMaturedContractsRecordedAsInventory", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.pahc.com/role/StatementConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "lang": null, "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_4se_cADxs0GfsKCEii0pdg", "decimals": "-3", "first": true, "lang": null, "name": "pahc:TimeDepositsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_4se_cADxs0GfsKCEii0pdg", "decimals": "-3", "first": true, "lang": null, "name": "pahc:TimeDepositsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - Fair Value Measurements - Additional Information (Details)", "role": "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "shortName": "Fair Value Measurements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - Business Segments - Segments in Significant Accounting Policies (Details)", "role": "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "shortName": "Business Segments - Segments in Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_tZD6vhH6202KrDuC111yvA", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_p8ok_z1jp0mhcPoUWktw8g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)", "role": "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_6mPu1PpHjUqreOlHQQHecQ", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_p8ok_z1jp0mhcPoUWktw8g", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "-3", "lang": null, "name": "us-gaap:DeferredIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nspnf5sqgkGFH3-Oba5wnA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00500 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nspnf5sqgkGFH3-Oba5wnA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_yjN95rlPAkG_K2ZX_huFiQ", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_p8ok_z1jp0mhcPoUWktw8g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00505 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals)", "role": "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_p8ok_z1jp0mhcPoUWktw8g", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Description of Business", "role": "http://www.pahc.com/role/DisclosureDescriptionOfBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "pahc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_Eb027WQSwk2Rn_JTVrsfoA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 51, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "pahc_AccruedAndOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accrued expenses and other current liabilities.", "label": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedAndOtherCurrentLiabilitiesMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "domainItemType" }, "pahc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 2.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, before tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 4.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of Income tax (provision) benefit on derivative instruments.", "label": "Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments", "verboseLabel": "Benefit for income taxes on derivative instruments" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 6.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "accumulated amount of income tax (provision) benefit on pension gains (losses).", "label": "Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses", "verboseLabel": "Provision for income taxes on net pension losses" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 3.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax", "negatedLabel": "Unrecognized net pension losses" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjusted earnings before interest taxes depreciation and amortization.", "label": "Adjusted Earnings Before Interest Taxes Depreciation And Amortization", "terseLabel": "Adjusted EBITDA - Total segments", "verboseLabel": "Adjusted EBITDA" } } }, "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "pahc_AmortizationOfOtherAssets": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": 3.0, "parentTag": "us-gaap_DepreciationDepletionAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amortization of other assets.", "label": "Amortization Of Other Assets", "verboseLabel": "Amortization of other assets" } } }, "localname": "AmortizationOfOtherAssets", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "pahc_AnimalHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information of segment Animal health.", "label": "Animal Health" } } }, "localname": "AnimalHealthMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_AverageCustomerCollectionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent information related to average worldwide collection period for accounts receivable after the revenue is recognized.", "label": "Average Customer Collection Period", "verboseLabel": "Average worldwide collection period for accounts receivable" } } }, "localname": "AverageCustomerCollectionPeriod", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "pahc_BalanceSheetsAdditionalInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheets - Additional Information" } } }, "localname": "BalanceSheetsAdditionalInformationAbstract", "nsuri": "http://www.pahc.com/20210930", "xbrltype": "stringItemType" }, "pahc_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents commitments and contingencies.", "label": "Commitments And Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "pahc_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents commitments and contingencies.", "label": "Commitments And Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "pahc_CompensationAndBenefitForServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the compensations and benefit received by the employee or consultants for the services provided by them.", "label": "Compensation and benefit for services provided" } } }, "localname": "CompensationAndBenefitForServicesMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_ContingentConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents contingent consideration paid", "label": "Contingent consideration" } } }, "localname": "ContingentConsideration", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "pahc_CreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents of the types of agreements.", "label": "Credit Agreement" } } }, "localname": "CreditAgreementMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_CurrentAndLongTermLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents current and long term liabilities.", "label": "Current And Long Term Liabilities" } } }, "localname": "CurrentAndLongTermLiabilitiesMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent a customer member.", "label": "Customer" } } }, "localname": "CustomerMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_DescriptionOfBusinessAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "localname": "DescriptionOfBusinessAbstract", "nsuri": "http://www.pahc.com/20210930", "xbrltype": "stringItemType" }, "pahc_EuropeMiddleEastAndAfricaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent a Europe, middle east and Africa.", "label": "Europe, Middle East and Africa" } } }, "localname": "EuropeMiddleEastAndAfricaMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 5.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income tax (provision) benefit on long-term intercompany loans.", "label": "Income Tax Provision Benefit On Long Term Intercompany Loans", "verboseLabel": "Benefit for income taxes on long-term intercompany investments" } } }, "localname": "IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_InsuranceInvestment": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the insurance investment.", "label": "Insurance Investment", "verboseLabel": "Insurance investments" } } }, "localname": "InsuranceInvestment", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_InternationalRetirementPlans": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represent amount of International retirement plans.", "label": "International Retirement Plans", "verboseLabel": "International retirement plans" } } }, "localname": "InternationalRetirementPlans", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_July2017AgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to July 2017 agreement.", "label": "July 2017 Agreement [Member]" } } }, "localname": "July2017AgreementMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_LatinAmericaAndCanadaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent a Latin America and Canada.", "label": "Latin America and Canada" } } }, "localname": "LatinAmericaAndCanadaMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_March2020AgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to March 2020 agreement.", "label": "March 2020 Agreement [Member]" } } }, "localname": "March2020AgreementMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_MedicatedFeedAdditivesAndOthersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent a medicated Feed Additives and others.", "label": "MFAs and other" } } }, "localname": "MedicatedFeedAdditivesAndOthersMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_MineralNutritionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents segment manufactures and markets trace minerals for the cattle, swine, poultry and pet food markets.", "label": "Mineral Nutrition" } } }, "localname": "MineralNutritionMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_NumberOfPotentiallyResponsibleParties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of parties.", "label": "Number Of Potentially Responsible Parties", "verboseLabel": "Number of potentially responsible parties" } } }, "localname": "NumberOfPotentiallyResponsibleParties", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "pahc_NutritionalSpecialtiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent a nutritional Specialties member.", "label": "Nutritional Specialties" } } }, "localname": "NutritionalSpecialtiesMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_PaymentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent information related customers payment term.", "label": "Payment Term", "verboseLabel": "Payment term" } } }, "localname": "PaymentTerm", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "pahc_PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Pension And Other Postretirement And Postemployment Benefit Plans Assets Noncurrent", "terseLabel": "U.S. pension plan" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_PerformanceProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the performance products segment that manufactures and markets a variety of products for use in the personal care, automotive, chemical catalyst and electronics industries, and includes PhibroChem (a division of PAHC), Ferro Metal and Chemical Corporation Limited and Phibro-Tech.", "label": "Performance Products" } } }, "localname": "PerformanceProductsMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "pahc_RealizedGainLossOnMaturedContractsRecordedAsInventory": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This is the amount of gain (loss) on matured contracts, that we record to Inventory.", "label": "Realized Gain Loss On Matured Contracts Recorded As Inventory", "verboseLabel": "Realized gains related to matured contracts recorded as a component of inventory" } } }, "localname": "RealizedGainLossOnMaturedContractsRecordedAsInventory", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "pahc_ReconciliationOfAdjustedEbitdaToIncomeBeforeIncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation Of Adjusted Ebitda To Income Before Income Taxes [Abstract]", "terseLabel": "Reconciliation of income before income taxes to Adjusted EBITDA" } } }, "localname": "ReconciliationOfAdjustedEbitdaToIncomeBeforeIncomeTaxesAbstract", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "pahc_ScheduleOfAdditionalInformationOfBalanceSheetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of additional Information of balance sheets.", "label": "Schedule Of Additional Information Of Balance Sheets [Table Text Block]", "verboseLabel": "Schedule of additional information of balance sheets" } } }, "localname": "ScheduleOfAdditionalInformationOfBalanceSheetsTableTextBlock", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationTables" ], "xbrltype": "textBlockItemType" }, "pahc_ScheduleOfAdditionalInformationOfStatementsOfOperationsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of additional Information of statements of operations.", "label": "Schedule Of Additional Information Of Statements Of Operations [Table Text Block]", "verboseLabel": "Schedule of additional information of statements of operations" } } }, "localname": "ScheduleOfAdditionalInformationOfStatementsOfOperationsTableTextBlock", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables" ], "xbrltype": "textBlockItemType" }, "pahc_StatementsOfOperationsAdditionalInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statements of Operations - Additional Information" } } }, "localname": "StatementsOfOperationsAdditionalInformationAbstract", "nsuri": "http://www.pahc.com/20210930", "xbrltype": "stringItemType" }, "pahc_StatementsOfOperationsAdditionalInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line item represents Statements of Operations Additional Information.", "label": "Statements Of Operations Additional Information [Line Items]" } } }, "localname": "StatementsOfOperationsAdditionalInformationLineItems", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "stringItemType" }, "pahc_StatementsOfOperationsAdditionalInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Statements of Operations Additional Information.", "label": "Statements Of Operations Additional Information [Table]" } } }, "localname": "StatementsOfOperationsAdditionalInformationTable", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "stringItemType" }, "pahc_TermALoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Term A Loan" } } }, "localname": "TermALoanMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_TermALoansAndRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related to term A loans and revolving credit facility.", "label": "Term A Loans And Revolving Credit Facility [Member]" } } }, "localname": "TermALoansAndRevolvingCreditFacilityMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information of term loan.", "label": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "domainItemType" }, "pahc_TimeDepositsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of time deposits fair value disclosure.", "label": "Time Deposits Fair Value Disclosure", "terseLabel": "Short-term investments" } } }, "localname": "TimeDepositsFairValueDisclosure", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "pahc_TwoThousandTwentyOneCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member defines 2021 credit agreement.", "label": "2021 Credit Agreement" } } }, "localname": "TwoThousandTwentyOneCreditAgreementMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pahc_VaccinesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent a vaccines member.", "label": "Vaccines" } } }, "localname": "VaccinesMember", "nsuri": "http://www.pahc.com/20210930", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r95", "r137", "r150", "r151", "r152", "r153", "r155", "r157", "r161", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r224", "r226", "r228", "r229" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r95", "r137", "r150", "r151", "r152", "r153", "r155", "r157", "r161", "r216", "r217", "r218", "r219", "r220", "r221", "r223", "r224", "r226", "r228", "r229" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r168", "r281", "r285", "r490" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r234", "r269", "r299", "r300", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r487", "r491", "r509", "r510" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r234", "r269", "r299", "r300", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r487", "r491", "r509", "r510" ], "lang": { "en-us": { "role": { "label": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r168", "r281", "r285", "r490" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r164", "r281", "r283", "r439", "r486", "r488" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r164", "r281", "r283", "r439", "r486", "r488" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r234", "r269", "r289", "r299", "r300", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r487", "r491", "r509", "r510" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r234", "r269", "r289", "r299", "r300", "r414", "r415", "r416", "r417", "r418", "r419", "r438", "r487", "r491", "r509", "r510" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r165", "r166", "r281", "r284", "r489", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r165", "r166", "r281", "r284", "r489", "r498", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies and New Accounting Standards" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r34", "r407" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r20", "r170", "r171" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "auth_ref": [ "r201", "r210", "r211" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.", "label": "Accrual for Environmental Loss Contingencies", "terseLabel": "Accrual for environmental loss contingencies" } } }, "localname": "AccrualForEnvironmentalLossContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedInsuranceCurrent": { "auth_ref": [ "r9", "r10", "r38" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Insurance, Current", "terseLabel": "Insurance-related" } } }, "localname": "AccruedInsuranceCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities [Abstract]", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "totalLabel": "Accrued expenses and other current liabilities, total", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r9", "r10", "r38" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "verboseLabel": "Professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r9", "r10", "r38" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Sales Commission, Current", "verboseLabel": "Commissions and rebates" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r23", "r55", "r56", "r57", "r476", "r496", "r497" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Accumulated other comprehensive loss", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r54", "r57", "r64", "r65", "r66", "r97", "r98", "r99", "r333", "r492", "r493", "r524" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "verboseLabel": "Statements of Operations - Additional Information" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r21" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r97", "r98", "r99", "r303", "r304", "r305", "r365" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r301", "r302", "r307", "r308" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r86", "r254", "r264", "r265", "r392" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Financing Costs and Discounts, Total", "verboseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r86", "r194", "r196" ], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": 1.0, "parentTag": "us-gaap_DepreciationDepletionAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "auth_ref": [ "r55" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 1.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax", "verboseLabel": "Derivative instruments" } } }, "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r92", "r145", "r152", "r159", "r179", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r330", "r334", "r377", "r405", "r407", "r455", "r475" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Identifiable assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r48", "r92", "r179", "r216", "r217", "r218", "r220", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r330", "r334", "r377", "r405", "r407" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r347", "r351" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r320", "r321", "r323" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "negatedLabel": "Contingent consideration on acquisitions", "verboseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r320", "r322" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r31", "r88" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r83", "r382" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r90", "r92", "r113", "r117", "r118", "r120", "r122", "r128", "r129", "r130", "r179", "r216", "r221", "r222", "r223", "r229", "r230", "r267", "r268", "r270", "r271", "r377", "r516" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r211", "r460", "r480" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "verboseLabel": "Commitments and contingencies (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r207", "r208", "r209", "r212", "r499" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common stock-Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common stock-Class B" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared per share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r97", "r98", "r365" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r273" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "verboseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValueOutstanding": { "auth_ref": [ "r19" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.", "label": "Common Stock, Value, Outstanding", "verboseLabel": "Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,337,574 shares issued and outstanding at September 30, 2021 and June 30, 2021; 30,000,000 Class B shares authorized, 20,166,034 shares issued and outstanding at September 30, 2021 and June 30, 2021" } } }, "localname": "CommonStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r60", "r62", "r63", "r71", "r463", "r482" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total", "totalLabel": "Comprehensive income (loss)", "verboseLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r279", "r280", "r282" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "verboseLabel": "Current deferred revenue, included in accrued expense and other current liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r155", "r161", "r163" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r74", "r439" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Consolidated statement of operations - total cost of goods sold", "verboseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r89", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r248", "r255", "r256", "r258", "r266" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r15", "r259", "r456", "r473" ], "calculation": { "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Term A Loan due April 2026" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentCovenantCompliance": { "auth_ref": [ "r15", "r471" ], "lang": { "en-us": { "role": { "documentation": "States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure.", "label": "Debt instrument, covenant compliance" } } }, "localname": "DebtInstrumentCovenantCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCovenantDescription": { "auth_ref": [ "r15", "r471" ], "lang": { "en-us": { "role": { "documentation": "Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.", "label": "Debt Instrument, Covenant Description", "terseLabel": "Covenant requirement, permitted leverage ratio" } } }, "localname": "DebtInstrumentCovenantDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r231", "r262", "r263", "r391", "r393", "r394" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r40", "r232" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Percentage of interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Maturity dates" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r42", "r91", "r95", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r244", "r245", "r246", "r247", "r249", "r250", "r251", "r252", "r253", "r254", "r257", "r262", "r263", "r264", "r265", "r274", "r275", "r276", "r277", "r390", "r391", "r393", "r394", "r472" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r244", "r260", "r262", "r263", "r392" ], "calculation": { "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedLabel": "Unamortized debt issuance costs" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "verboseLabel": "Weighted-average interest rates" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r33", "r244", "r392" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "verboseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r309", "r310" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r86", "r93", "r312", "r316", "r317", "r318" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r309", "r310" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "verboseLabel": "Long-term and deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r33" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Deposits Assets", "verboseLabel": "Deposits" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r86", "r197" ], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": 2.0, "parentTag": "us-gaap_DepreciationDepletionAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation of property, plant and equipment" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization [Abstract]", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortizationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r86", "r140" ], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "totalLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotionalAmount": { "auth_ref": [ "r340", "r341", "r343" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative asset.", "label": "Derivative Asset, Notional Amount", "verboseLabel": "Notional amount" } } }, "localname": "DerivativeAssetNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r49", "r50", "r51", "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "verboseLabel": "Asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r338" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "verboseLabel": "Foreign currency derivatives" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "verboseLabel": "Percentage of interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r51", "r348", "r350", "r354", "r357" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedges": { "auth_ref": [ "r47" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the asset arising from derivative instruments and hedging activities, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.", "label": "Derivative Instruments and Hedges, Assets", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativeInstrumentsAndHedges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r364", "r368" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "verboseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r345", "r348", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r49", "r50", "r51", "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "verboseLabel": "Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "verboseLabel": "Derivative instruments" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.", "label": "Derivative, Maturity Date", "verboseLabel": "Maximum maturity period for Foreign Currency Derivatives" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r341", "r343" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r339", "r342", "r343", "r345", "r346", "r352", "r354", "r359", "r360", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "verboseLabel": "Schedule of revenues disaggregated by major product category and geographic region" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsAdditionalInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r278", "r470" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends", "negatedLabel": "Dividends declared" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r72", "r102", "r103", "r104", "r105", "r106", "r111", "r113", "r120", "r121", "r122", "r125", "r126", "r366", "r367", "r464", "r483" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "basic (in dollars per share)", "verboseLabel": "basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Net income per share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r72", "r102", "r103", "r104", "r105", "r106", "r113", "r120", "r121", "r122", "r125", "r126", "r366", "r367", "r464", "r483" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "diluted (in dollars per share)", "verboseLabel": "diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net Income per Share and Weighted Average Shares" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations": { "auth_ref": [ "r382" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations", "verboseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Employee-related" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r64", "r65", "r66", "r97", "r98", "r99", "r101", "r107", "r109", "r127", "r180", "r273", "r278", "r303", "r304", "r305", "r313", "r314", "r365", "r383", "r384", "r385", "r386", "r387", "r388", "r492", "r493", "r494", "r524" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r32", "r146", "r178" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": { "auth_ref": [ "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value, Assets, Level 1 to Level 2 Transfers, Amount", "terseLabel": "Fair value assets, transfer from level 1 to level 2" } } }, "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount": { "auth_ref": [ "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value, Assets, Level 2 to Level 1 Transfers, Amount", "terseLabel": "Fair value assets, transfer from level 2 to level 1" } } }, "localname": "FairValueAssetsLevel2ToLevel1TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "verboseLabel": "Fair Value of Assets (Liabilities)" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r369", "r375", "r376" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r246", "r262", "r263", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r370", "r411", "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value, Hierarchy [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r246", "r290", "r291", "r296", "r298", "r370", "r411" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r246", "r262", "r263", "r290", "r291", "r296", "r298", "r370", "r412" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r246", "r262", "r263", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r370", "r413" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount", "terseLabel": "Fair value liabilities, transfer from level 1 to level 2" } } }, "localname": "FairValueLiabilitiesLevel1ToLevel2TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesLevel2ToLevel1TransfersAmount": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount", "terseLabel": "Fair value liabilities, transfer from level 2 to level 1" } } }, "localname": "FairValueLiabilitiesLevel2ToLevel1TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Fair value assets, transfer to and from level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "verboseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Fair value liabilities, transfer to and from level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r246", "r262", "r263", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r411", "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r173", "r174", "r175", "r176", "r177", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r257", "r272", "r364", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r516", "r517", "r518", "r519", "r520", "r521", "r522" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r195", "r440" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Intangibles, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r378", "r379", "r380", "r381" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign currency (gains) losses, net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r87", "r380", "r381" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Unrealized", "negatedLabel": "Foreign currency (gains) losses, net" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).", "label": "Foreign Exchange Option" } } }, "localname": "ForeignExchangeOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfDerivatives": { "auth_ref": [ "r86", "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.", "label": "Gain (Loss) on Sale of Derivatives", "negatedLabel": "(Income) expense recorded in consolidated statement of operations" } } }, "localname": "GainLossOnSaleOfDerivatives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "Corporate costs" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r191", "r192", "r407", "r454" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "verboseLabel": "Goodwill roll-forward" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r73", "r92", "r145", "r151", "r155", "r158", "r161", "r179", "r216", "r217", "r218", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r377" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember": { "auth_ref": [ "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Family member whom a principal owner or a member of management might control or influence, or by whom they might be controlled or influenced, because of the family relationship.", "label": "Certain relatives of Jack C. Bendheim" } } }, "localname": "ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r69", "r145", "r151", "r155", "r158", "r161", "r453", "r461", "r468", "r484" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest", "terseLabel": "Income before income taxes", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r199", "r203" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r94", "r108", "r109", "r143", "r311", "r315", "r319", "r485" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "verboseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "verboseLabel": "Accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories, net" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities, net of business acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r114", "r115", "r116", "r122" ], "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants", "verboseLabel": "Dilutive effect of restricted stock units" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "negatedLabel": "Interest income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r67", "r139", "r389", "r392", "r467" ], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense, Total", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Expense [Abstract]", "verboseLabel": "Interest expense, net" } } }, "localname": "InterestExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r76", "r252", "r261", "r264", "r265" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest expense, net" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "verboseLabel": "Other" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r465" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net, Total", "negatedLabel": "Interest expense, net", "negatedTerseLabel": "Consolidated statement of operations - total interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of nonoperating interest income (expense).", "label": "Interest Income (Expense), Nonoperating, Net", "negatedTotalLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNonoperatingNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateDerivativeAssetsAtFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.", "label": "Interest Rate Derivative Assets, at Fair Value", "negatedTerseLabel": "Interest rate swap" } } }, "localname": "InterestRateDerivativeAssetsAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r28", "r190" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "verboseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r46", "r407" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r30", "r190" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "verboseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r29", "r190" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "verboseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "verboseLabel": "Outstanding letters of credit" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r37", "r92", "r153", "r179", "r216", "r217", "r218", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r331", "r334", "r335", "r377", "r405", "r406" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r92", "r179", "r377", "r407", "r457", "r478" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r39", "r92", "r179", "r216", "r217", "r218", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r331", "r334", "r335", "r377", "r405", "r406", "r407" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line of Credit Facility, Interest Rate Description", "verboseLabel": "Interest rate, description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "verboseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "verboseLabel": "Remaining borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "one-month LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Brazilian Real calls" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r15" ], "calculation": { "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Capital Lease Obligations", "totalLabel": "Long-term debt after debt issuance costs" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-term Debt and Capital Lease Obligations, Current, Total", "negatedLabel": "Less: current maturities", "verboseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLineOfCredit": { "auth_ref": [ "r42", "r213", "r214" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit, Noncurrent", "verboseLabel": "Revolving credit facility" } } }, "localname": "LongTermLineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r42" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Loans Payable, Noncurrent", "terseLabel": "Long-term debt" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtSummaryOfLongTermDebtDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r42", "r215" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "verboseLabel": "Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r83" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r83" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r83", "r84", "r87" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r58", "r61", "r66", "r70", "r87", "r92", "r100", "r102", "r103", "r104", "r105", "r108", "r109", "r119", "r145", "r151", "r155", "r158", "r161", "r179", "r216", "r217", "r218", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r367", "r377", "r462", "r481" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "netLabel": "Net income", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "New Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r145", "r151", "r155", "r158", "r161" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r396" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "verboseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r396" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "verboseLabel": "Long-term operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r395" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU operating lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r155", "r161" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r96", "r110", "r132", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies and New Accounting Standards" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "verboseLabel": "Other long term liabilities" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r47", "r407" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r347", "r361" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.", "label": "Other Assets, Miscellaneous, Noncurrent", "verboseLabel": "Other" } } }, "localname": "OtherAssetsMiscellaneousNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "totalLabel": "Other assets, total", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent": { "auth_ref": [ "r328", "r329", "r332" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive (income) loss for defined benefit plan, attributable to parent entity.", "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax, Portion Attributable to Parent, Total", "negatedLabel": "Unrecognized net pension gains" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": { "auth_ref": [ "r328", "r329", "r332" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent, Total", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location in other comprehensive income.", "label": "Other Comprehensive Income Location [Axis]" } } }, "localname": "OtherComprehensiveIncomeLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in other comprehensive income.", "label": "Other Comprehensive Income Location [Domain]" } } }, "localname": "OtherComprehensiveIncomeLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": { "auth_ref": [ "r55" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax, Portion Attributable to Parent, Total", "verboseLabel": "Change in fair value of derivative instruments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r53", "r55", "r349", "r353", "r362" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "negatedLabel": "(Income) expense recorded in OCI" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r59", "r62", "r328", "r329", "r332" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r328", "r329", "r332" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "negatedLabel": "Provision for income taxes" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeMember": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.", "label": "Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities [Abstract]", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r8", "r9", "r38", "r407" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 10.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "verboseLabel": "Other" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r347", "r361" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other liabilities" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Other liabilities, total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails", "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r87" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": { "auth_ref": [ "r16", "r286", "r287", "r288" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.", "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent", "verboseLabel": "Supplemental retirement benefits, deferred compensation and other" } } }, "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r77", "r79" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r81" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r78", "r324", "r325", "r326" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "auth_ref": [ "r79" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Payments to Acquire Short-term Investments", "negatedLabel": "Purchases of short-term investments" } } }, "localname": "PaymentsToAcquireShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r267" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r267" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValueOutstanding": { "auth_ref": [ "r18" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.", "label": "Preferred Stock, Value, Outstanding", "verboseLabel": "Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding" } } }, "localname": "PreferredStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r80" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-term Lines of Credit", "terseLabel": "Revolving credit facility borrowings" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": { "auth_ref": [ "r77", "r79" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments", "verboseLabel": "Maturities of short-term investments" } } }, "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfNotesPayable": { "auth_ref": [], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.", "label": "Proceeds from (Repayments of) Notes Payable", "verboseLabel": "Payments of long-term debt and other" } } }, "localname": "ProceedsFromRepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r198", "r407", "r469", "r479" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "verboseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r297", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r399", "r402" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "verboseLabel": "Aggregate compensation and benefits" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r297", "r399", "r400", "r402" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r297", "r399", "r402", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r397", "r398", "r400", "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r82" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-term Lines of Credit", "negatedTerseLabel": "Revolving credit facility repayments" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r14", "r202", "r205" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring costs" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r278", "r306", "r407", "r477", "r495", "r497" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r97", "r98", "r99", "r101", "r107", "r109", "r180", "r303", "r304", "r305", "r313", "r314", "r365", "r492", "r494" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r68", "r92", "r136", "r137", "r150", "r156", "r157", "r164", "r165", "r168", "r179", "r216", "r217", "r218", "r221", "r222", "r223", "r225", "r227", "r229", "r230", "r377", "r468" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "positiveVerboseLabel": "Total", "verboseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving credit facility (the \"Revolver\")" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsInterestExpenseAndDepreciationAndAmortizationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r42", "r95", "r262", "r264", "r274", "r275", "r276", "r277", "r390", "r391", "r394", "r472" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "verboseLabel": "Schedule of long term debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r348", "r354", "r358" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "verboseLabel": "Schedule of fair value of derivative instruments based upon pricing models" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of net income per share and weighted average shares" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r145", "r148", "r154", "r193" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r145", "r148", "r154", "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "verboseLabel": "Schedule of information regarding reportable segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r133", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r155", "r156", "r157", "r158", "r159", "r161", "r168", "r204", "r206", "r486" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Segments" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r133", "r134", "r135", "r145", "r149", "r155", "r159", "r160", "r161", "r162", "r164", "r167", "r168", "r169" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Business Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "verboseLabel": "Segment Reporting Information" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r75" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "verboseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r85" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Brazilian Real puts" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r13", "r458", "r459", "r474" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "verboseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r133", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r155", "r156", "r157", "r158", "r159", "r161", "r168", "r193", "r200", "r204", "r206", "r486" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBusinessSegmentsSegmentsInSignificantAccountingPoliciesDetails", "http://www.pahc.com/role/DisclosureStatementsOfOperationsDisaggregatedRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r17", "r18", "r19", "r90", "r92", "r113", "r117", "r118", "r120", "r122", "r128", "r129", "r130", "r179", "r216", "r221", "r222", "r223", "r229", "r230", "r267", "r268", "r270", "r271", "r273", "r377", "r516" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DocumentDocumentAndEntityInformation", "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r45", "r64", "r65", "r66", "r97", "r98", "r99", "r101", "r107", "r109", "r127", "r180", "r273", "r278", "r303", "r304", "r305", "r313", "r314", "r365", "r383", "r384", "r385", "r386", "r387", "r388", "r492", "r493", "r494", "r524" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r97", "r98", "r99", "r127", "r439" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheetsParentheticals", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r24", "r25", "r92", "r172", "r179", "r377", "r407" ], "calculation": { "http://www.pahc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedBalanceSheets", "http://www.pahc.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "verboseLabel": "Balance Sheets - Additional Information" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SwapMember": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "A forward-based contract in which two parties agree to swap streams of payments over a specified period. The payment streams are based on an agreed-upon (or notional) principal amount. The term notional is used because swap contracts generally involve no exchange of principal at either inception or maturity. Rather, the notional amount serves as a basis for calculation of the payment streams to be exchanged.", "label": "Swap" } } }, "localname": "SwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "verboseLabel": "Income and other taxes" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureBalanceSheetsAdditionalInformationOtherBalanceSheetItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r173", "r174", "r175", "r176", "r177", "r257", "r272", "r364", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r516", "r517", "r518", "r519", "r520", "r521", "r522" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDerivativesCompanySOutstandingDerivativesDetails", "http://www.pahc.com/role/DisclosureDerivativesEffectsOfDerivativesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails", "http://www.pahc.com/role/DisclosureDerivativesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r112", "r122" ], "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Weighted average number of shares - diluted (in shares)", "verboseLabel": "diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "verboseLabel": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r111", "r122" ], "calculation": { "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "basic (in shares)", "verboseLabel": "Weighted average number of shares - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.pahc.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsDetails", "http://www.pahc.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1828-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r266": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125514181&loc=d3e34841-113949" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r404": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.13(h))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(g)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r511": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r512": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r513": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r514": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r515": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r516": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r517": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r518": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r519": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r520": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r521": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r522": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r523": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r96": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" } }, "version": "2.1" } ZIP 61 0001104659-21-133045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-133045-xbrl.zip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end